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Thesis Abstract 
 
 
 
 
The periplasm of E. coli has been recognized a suitable location for the production of 
large quantities of many industrially important soluble recombinant proteins, and offers 
some important advantages over both intracellular and extracellular production. The 
oxidative environment of the periplasm promotes correct disulphide bonding and protein 
folding; there is reduced risk of proteolytic attack in the periplasm; and the periplasm 
accounts for <5% of total cell protein, so that selective release reduces subsequent 
purification demands. Despite these merits, periplasmic expression systems have not 
yet fulfilled their true potential, largely due to the lack of reliable general methods for 
efficient selective release of periplasmically expressed proteins at large-scale. The 
classical osmotic shock procedure, the only reliable method for releasing proteins from 
the periplasmic space of E. coli, is expensive and time-consuming, and thus it is not 
feasible at large scale. The main objective of this study has been to develop a gentle 
chemical permeabilisation method for selective release of periplasmically-expressed 
proteins from recombinant E. coli. In the first experiments, the titre, location and form of 
anti-lysozyme Fab D1.3 were determined during fed-batch cultivation of E. coli. It was 
shown that the Fab produced as both soluble and insoluble forms and released into the 
culture medium over the course of fed-batch fermentation. Purification of Fab D1.3 was 
then performed using various chromatographic methods, and the most effective target 
Fab purification was achieved by using sequential cation exchange – Protein G affinity 
chromatography route with an overall yield of 83%. Pure model proteins typically 
secreted to the periplasm (i.e. beta-lactamase, alpha amylase and Fab D1.3 fragment) 
were subsequently exposed to various chemicals, and alterations in the secondary 
structure of the proteins in the presence of various chemicals were investigated by high 
throughput circular dichroism (ht-CD) system. Chemicals such as 0.1% Triton X-100, 
0.05% benzalkonium chloride (BAC), 0.1% cetyltrimethylammonium bromide (CTAB), 
and 2 M urea remarkably changed the secondary structure of beta-lactamase and 
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alpha-amylase. The secondary structure of Fab D1.3 was more vulnerable to the tested 
chemicals. The biological activity of the target proteins in the presence of various 
chemicals was also measured and it was revealed that changes in the secondary 
structure of proteins do not necessarily cause reduction in the biological activity and vice 
versa. Concentrations of chemicals which did not reduce the biological activity of the 
proteins were eventually examined in subsequent periplasmic release experiments 
using recombinant E. coli strains producing the same target proteins, and the 
performance of various chemical permeabilisers were evaluated by comparing to 
classical osmotic shock and mechanical cell disruption. It was demonstrated that low 
concentrations of chemicals such as sodium deoxycholate (DOC) and/or chelating 
agents, isoamyl alcohol released the periplasmic proteins as efficient as or more 
efficient (up to 168%) than osmotic shock treatments. It was also proved that chemicals 
could increase the periplasmic release efficiency when they used in combinations. For 
instance, 1 M EDTA in combination with detergents could increase the periplasmic 
release of beta-lactamase and Fab D1.3 up to 80% and 130%, respectively. Such 
synergetic effect for release of alpha-amylase and Fab D1.3 was also observed when 
1% solvents (hexane, xylene, benzene, toluene, and isoamyl alcohol) were combined 
with detergents such as 0.025% DOC, 0.01% CTAB and 0.1% Triton X-100.  
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1   Introduction  
 
1.1 Manufacture of recombinant proteins in E. coli 
 
Escherichia coli is a very well studied bacterium, and since the advent of 
recombinant DNA technology has been the host of choice for the manufacture of 
many non-glycosylated proteins (Blattner et al., 1997; Choi and Lee, 2004; 
Schumann and Ferreira, 2004). There are three locations for the manufacture of 
proteins in E. coli: the cytoplasm, moving into the culture media (excretion), and 
moving into the periplasm (secretion).  
 
Proteins are usually over-expressed for high-level production which is a prerequisite 
for subsequent purification. A frequent consequence of the over-expression of 
eukaryotic proteins in the cytoplasm of E. coli is the accumulation within the cell of 
insoluble bodies known as inclusion bodies (IBs; Ventura and Villaverde, 2006). IBs 
can contain the target protein in up to 90% pure form, and insolubility appears to 
result from the formation of intracellular protein aggregates of misfolded product 
(Carrió and Villaverde, 2002; Heebøll-Nielsen et al., 2003). Complete denaturation is 
essential for the efficient solubilisation of the recombinant product and specific 
renaturation conditions are required for significant yield recovery of the soluble 
protein (Radolph and Lilie, 1996; Vallejo and Rinas, 2004).  
 
The physical properties of IBs (strong, large, dense and highly refractile particles with 
defined size and optical properties) are exploited to good effect in industrial recovery 
and monitoring processes (Fischer et al., 1993; Georgiou and Valax, 1999; Jin et al., 
1994; Singh and Panda, 2005; Taylor et al., 1986). The conventional route for 
purifying proteins produced in IB form follows a lengthy and highly conserved 
sequence of operations involving mechanical cell disruption, separation of the 
insoluble IBs using centrifugation or diafiltration, washing, solubilisation using a 
highly concentrated chaotrope such as 8 M urea or guanidine hydrochloride, and 
eventually several chromatographic purification stages followed by dilution refolding 
of the target protein (Singh and Panda, 2005). Not surprisingly, therefore, 
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manufacturing a protein by an IB route is very costly and tends to be reserved for 
high-value human biotherapeutic agents.  
 
In molecular terms secretion is simply defined as the movement of a protein across a 
cell membrane or envelope either in the extracellular culture medium and/or within 
the cell which in the case of E. coli is the periplasm (or periplasmic space). 
Promoters and secretion signals from a few outer membrane proteins (e.g. OmpA 
and OmpF) and naturally occurring periplasmic proteins (e.g. alkaline phosphates 
and beta-lactamase) have been used to direct extracellular and periplasmic secretion 
respectively (Table 1.1). Targeting protein to the extracellular culture medium 
(excretion) can facilitate downstream processing. With ATP hydrolysis, excretion of 
proteins to the extracellular culture medium of E. coli can be accomplished by the 
type I secretion mechanism (HlyA/HlyD/TolC pathway), or by the type II mechanism 
mediated by some secreton components named as main terminal branch (MTB) 
components (Mergulhao et al., 2005; Pugsley et al., 1997; Sandkvist, 2001). Proteins 
can also reach the culture medium by nonspecific periplasmic leakage during cell 
division and accumulation of recombinant protein in the periplasm which builds up an 
osmotic pressure (Mergulhao et al., 2005). Despite its many advantages (the most 
obvious being minimum product contamination by host proteins as well as no 
requirement for cell disruption; Mergulhao et al., 2005) development of E. coli as a 
useful host for the excretion of commercially important proteins to the culture broth 
suffers major drawbacks. The most serious obstacle is the structure of the cell 
envelope of E. coli (Fig. 1.1), which in the majority of cases leads to the proteins 
ending up in the periplasm rather than the culture medium. Furthermore, when the 
product is excreted into the culture medium, it becomes highly diluted, which 
demands not only the use of high volume capture or concentration steps, but it can 
also result in considerable physical damage as a direct consequence of the shear 
forces generated by some microbial fermentation processes (Humphreys, 2007).  
 
The periplasm, on the other hand, seems a much better location for the production of 
large quantities of soluble recombinant proteins (Joly et al., 1998; Laird et al., 2005; 
Carter et al., 1992; Chen et al., 2004), and proffers advantageous over the 
cytoplasmic route. The oxidizing environment of the periplasm in cooperation with  
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Table 1.1 Heterologous protein secretion in E. coli. aIs a theoretical value at specific 
cell density of OD600=60 and assumes a linear correlation between biomass and yield 
(in reality in very few cases production has been measured at such high cell density); 
bEE-IGF-1 is a fusion protein; IGF-1 (insulin-like growth factor) was fused to two 
copies of the E-domain of S. aureus  protein A; the promoter & secretion signal are 
also from protein A; cPrecise location of bPTI is unclear because it is not released 
from the cells by cold osmotic shock procedures (Table taken from Moir and Mao, 
1990). 
    
Protein Secretion 
signal 
Promoter Projected yielda 
(mg/L) 
Location 
EE-IGF-1b proA proA 190 broth 
Chicken Ovalbumin ovab Lac 90 periplasm 
Epidermal Growth 
Factor (EGF) 
phoA phoA 75 periplasm 
Staphylococcus aureus 
nuclease 
ompA Lpp 30 periplasm 
β–endorphin ompF ompF 28 broth 
β–endorphin ompF trp 24 broth 
Bovine pancreatic 
trypsin inhibitor (bPTI) 
phoA phoA 7.8 periplasm ?c 
Human Growth 
Hormone (hGH) 
ompA Lpp/Lac 0.9 periplasm 
Proinsulin bla bla 0.006 periplasm 
 
 
periplasmic proteins assists the formation and isomerisation of disulphide bonds, 
resulting in a firmly folded structure resistant to proteases (Berkmen et al., 2007; 
Derman and Beckwith, 1991). Chaperon properties of certain periplasmic proteins 
can also hamper the aggregation of target products (Betton, 2007; Richarme and 
Caldas, 1997). Furthermore, the outer membrane of gram negative bacteria is 
penetrable to small (≤ 600 Da) solutes (Nakae and Nikaido, 1975), and as a result 
the periplasm can be manipulated by being exposed to extracellular chemical agents, 
which assist the folding and modification of periplasmically-expressed proteins (Barth 
et al., 2000; Sandee et al., 2005; Wunderlich and Glockshuber, 1993). Additionally, 
the periplasmic space of E. coli contains only 4-8% of the total cell protein (Park and 
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Lee, 1998) whereas problematic cytoplasmic components (particularly nucleic acids 
and proteases), which pose additional purification challenges during product 
recovery, are not present. 
 
 
cytoplasm
periplasmic space
~7 nm thick
peptidoglycan
~2 nm thick
outer membrane
~8 nm thick
cytoplasmic membrane
~8 nm thick
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1 Schematic illustration of the envelope structure of E. coli and other gram-
negative bacteria. 
 
 
1.2 Periplasm 
 
1.2.1 History 
 
Periplasm is a separate compartment within gram-negative bacterial cells, with its 
singular components and characteristics. The exceptional disposition of the 
periplasm has been disclosed through many research works. The existence of 
distinctive periplasmic proteins was proved by Harold Ne and Leon Heppel in 1964 
(Neu and Heppel, 1964). These scientists demonstrated the release of ribonuclease 
from E. coli cells by converting them into spheroplasts by the EDTA-lysozyme 
treatment in sucrose. Prior to these studies it was not manifest that how E. coli could 
endure the presence of destructive enzymes such as ribonuclease and phosphates 
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which could raze vital components of the living cells, the existence of which was 
obvious by releasing upon cell breakage. Neu and Heppel discovery showed that 
they were kept in the periplasmic space, away from the cytosol, in gram-negative 
bacteria.   
 
The name ‘outer membrane’ was used for the first time in the electron microscopy 
study of a periodontal pathogen Veillonella by Howard Bladen and Stephan 
Mergenhagen in 1964  (Bladen and Mergenhagen, 1964), the year in which the 
release of periplasmic ribonuclease was ascertained by Neu and Heppel.  
 
Donnan potential across the outer membrane was found out in 1977 (Stock et al., 
1977), illustrating that the periplasm and its surrounding environment are dissimilar in 
terms of their composition of small molecules. The inside-negative potential results in 
the accumulation of small cations in the periplasm. The presence of polyanionic 
oligosaccharides in periplasm, responsible for the generation of Donnan potential, 
was demonstrated by Howard Schulman and Eugene Kennedy in 1979 (Schulman 
and Kennedy, 1979). The two barriers of the periplasm are not fully detached; for 
instance, “adhesion sites” between the two barriers were discovered in 1968 (Bayer, 
1968). The periplasm makes cells robust and competitive, and has numerous 
similarities with the endoplasmic reticulum of eukaryotic cells, with regard to protein 
transfer and folding. The periplasm has been attracting attentions for production of 
recombinant proteins containing disulphide bonds. 
 
1.2.2 Protein secretion to the periplasm of E .coli 
 
It has been approximated that 450 proteins are exported across the cytoplasmic 
membrane in E. coli (Palmer and Berks, 2007). Two distinct pathways exist for the 
secretion of protein into the periplasm of E. coli. The majority of the secreted proteins 
are transported in an unfolded form via the general secretory (Sec) pathway (Fig. 
1.2). A fundamentally different pathway for periplasmic protein localization in E. coli is  
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Fig. 1.2 The SRP and Sec targeting pathways in E. coli. The SRP binds to a specific 
highly hydrophobic signal sequence in nascent proteins at L23. FtsY binds to the 
ribosome-SRP complex and supports targeting to the inner membrane through its 
affinity for lipids and, probably, a proteinaceous membrane factor. In a GTP-
dependent reaction, the nascent protein is transferred to the Sec-translocon. TF, a 
cytosolic protein, interacts with less hydrophobic signal sequence in nascent 
polypeptide at L23 and may affect the interaction of the SRP. Sec B binds to the 
secretory proteins with a mild hydrophobic signal peptide and guides this to the Sec-
translocon which is identical to the translocon via the SRP-pathway. The model is not 
drawn to scale (Figure taken from Luirink and Sinning, 2004). 
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the twin arginine translocation (Tat) pathway, in which Arg-Arg motif found near the 
N- terminus of the leader peptide of folded proteins are engaged in the export of from 
the cytoplasm. 
 
In the Sec pathway, co- and posttranslational targeting systems are the two 
pathways, joining at the SecYEG translocon located in the cytoplasmic (inner) 
membrane, in E. coli, through which targeting of secretory and membrane proteins 
takes place (Fig. 1.2).  
 
Although many secretory proteins in E. coli use the posttranslational pathway, some 
of them such as inner membrane proteins (IMPs) are inserted/translocated through 
the cotranslational system. The cotranslational pathway is mediated by the signal 
recognition particle (SRP) system, which is responsible for the targeting of ribosomes 
translating SRP substrates to the SecYEG translocon. Cotranslational (SRP) system 
in E. coli involves two essential proteins, namely Ffh and FtsY, and 4.5S RNA. 
Proteins chosen for SRP system, which include inner membrane protein of E. coli, 
have a highly hydrophobic N-terminal (signal peptide). Various domains of Ffh are 
engaged with hydrophobic signal peptide in the nascent polypeptide, with the 4.5S 
RNA, with the ribosome and with FtsY. Ffh binds to the signal peptide of the 
polypeptides as they emerge from the ribosome, but not if they have been fully 
released from the ribosome. The cotranslational targeting is started by the interaction 
of Ffh with L23 ribosomal protein, near the nascent chain exit site, and with 
hydrophobic signal peptide as it comes out from ribosome; interaction which requires 
4.5S RNA and results in a ribosome-SRP complex. FtsY binds to this complex, being 
GTP-dependant, and support targeting to the inner membrane through its affinity for 
inner membrane. GTPase activity of both Ffh and FtsY leads to the GTP hydrolysis, 
which is a fundamental step for dissociation of SRP from the ribosome translating 
nascent chain and for transferring the growing protein to the Sec-translocon 
(SecYEG complex). 
 
However, most secretory proteins in E. coli are first synthesised in the cytoplasm and 
then targeted to the translocon via posttranslational targeting, in which specific 
chaperones are involved. TF (trigger factor), which is a cytosolic protein, is engaged 
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in posttranslational pathway. Both SRP and TF recognize and attach to the 
hydrophobic signal sequences in the growing polypeptide at ribosomal L23 protein, 
but TF interacts with less hydrophobic ones. Upon release of the TF-polypeptide-
complex from the ribosome, SecB chaperone interact with the polypeptide, leading to 
the dissociation of TF. SecB also hinders protein premature folding and aggregation. 
For appropriate targeting to the translocon, the Sec B-preprotein complex must 
interact with SecA which is the membrane peripheral ATPase subunit of the 
translocon; the interaction after which the SecB is released from the preprotein. 
ATPase activity of SecA mediates the translocation step in the context of the 
SecYEG translocon. 
 
Outer membrane proteins (OMPs). OMPs are targeted to the cytoplasmic membrane 
via the posttranslational (Sec B/Sec A) pathway after being biosynthesised, and next 
transported in an unfolded form into the periplasm via the Sec YEG translocon. The 
signal sequences of the OMPs are removed by peptidase. The unfolded 
periplasmically-located OMPs are kept soluble by the action of periplasmic 
chaperones, having been demonstrated to function without requiring ATP in their 
catalytic cycles – as there is no ATP in the periplasm. Overproduction of OMPs, 
accumulation of unfolded OMPs or misfolded OMPs (for example, as a consequence 
of stress such as heat) in the periplasm activates the stress σ-factor, σE (RpoE), in 
the cytoplasm, which subsequently results in production of periplasmic chaperones 
(such as Skp, SurA, FkpA, and Deg) and proteases (such as DegP). After accurate 
folding in the periplasm, OMPs are targeted to or assembled into the outer 
membrane by a process, the mechanism of which has not been fully known 
(Kleinschmidt, 2007; Mecsas et al., 1993). 
 
A subset of secreted proteins in E. coli uses the Tat pathway for translocation to the 
periplasm. The Tat protein export pathway involves Tat A, B, and C components (Fig. 
1.3). It has been demonstrated that 26 E. coli proteins have Tat signal peptides, the 
most distinctive characteristic of which is having consecutive (or twin) arginine 
residues. The Tat pathway is responsible for translocation of proteins that are 
incompatible with the Sec pathway such as those requiring the association of 
subunits or integration of cofactors before export (Delisa et al, 2003; 1996; Palmer 
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and Berks, 2007). For these Tat substrates, there is a complex chain of events that 
must happen prior to transport of the proteins to the periplasm (Palmer and Berks, 
2007). For example, proteins must bind their cofactors in the cytoplasm prior to 
transport, and this binding requires the proteins to fold (this is why these class of  
 
 
∆P
∆P ?
∆P ?
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Fig. 1.3 The Tat translocation pathway. In the resting state, TatA and TatBC form 
separate, oligomeric complexes (top). The twin-arginine motif of the signal peptide of 
a substrate binds to a site in TatC (right). The TatBC-substrate complex now 
interacts with TatA in an energy-dependent step (bottom). The substrate is 
transported through a channel made up of TatA. The energetic requirements for this 
are unknown (left). During the transport cycle the signal peptide is cleaved by signal 
peptidase LepB, and the exported protein is released at the periplasmic face of the 
membrane. The TatA and TatBC components dissociate and the system returns to 
the initial state (top). (Figure redrawn from Berks et al., 2005). 
 
proteins cannot use the Sec pathway for transport). In addition, many of the Tat 
substrates are exported as heterodimers or heterotrimers, while the twin-arginine-
containing signal exists on only one of the subunits. In this case, non-signal bearing 
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subunit(s) should attach to the signal-bearing subunit prior to transportation via Tat 
pathway. The cell wall amidases are another major class of proteins exported by the 
E. coli Tat system (Berks, 1996; Palmer and Berks, 2007). These classes of proteins 
do not contain cofactors, and it is not clear why these proteins must require the Tat 
pathway for their transport to the periplam.  
 
1.2.3 Disulphide bond formation and modification in the periplasm 
 
Three proteins including alpha-amylase, beta lactamase, and Fab D1.3 – all 
expressed in the periplasm of E. coli – were studied in this thesis.  
 
Alpha-amylase is an enzyme that hydrolyses alpha-bonds of large alpha-linked 
polysaccharides such as starch and glycogen, yielding glucose and maltose. Alpha-
amylase from Aspergillus oryzae (EC 3.2.1.1; α-1,4-glucanohydrolase) is a 
monomeric enzyme containing four disulphide bonds – linking cysteine residues 30–
38, 150–164, 240–283, and 439–474 – and one free sulfhydryl group in its tertiary 
structure (Kawata et al., 1998; Matsuura et al, 1984). 
Beta-lactamases are bacterial enzymes (EC 3.5.2.6) that catalyze the hydrolysis of 
the beta-lactam ring of some penicillins and cephalosporins, producing penicilloic 
acid and rendering the antibiotic ineffective. Plasmid pBR322-encoded beta-
lactamase contains a single disulphide bond linking cysteine residues 52–98 (Pollitt 
and Zalkin, 1983). 
Fab fragments typically contain two intrachain disulphide bonds in the variable 
domains (VH and VL) of the FV fragment and two disulphide bonds in constant 
domains (CL and CH1) plus one (or more) disulphide bridge which connects the 
heavy and light chains (Kikuchi et al., 1986; Venturi et al., 2002). According to 
communications with Merck Sharp and Dohme Ltd., the supplier of the E. coli strain 
producing anti-hen egg white lysozyme Fab D1.3 in the periplasm, there is no 
interchain disulphide bond between heavy and light chains of the Fab produced in 
this strain. 
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Disulphide bonds generally contribute to the three-dimensional structure of a protein, 
and are essential for the folding, stability, and full activity of many secreted proteins 
(Nakamoto and Bardwell, 2004).  Disulphide bonds diminish the conformational 
entropy leading to increase protein stability. For instance, alkaline phosphatise, a 
periplasmic protein, contains two disulphide bonds necessary for its correct folding, in 
the absence of which the protein is almost degraded in vivo (Bardwell et al. 1991). 
The formation of disulphide bonds is a crucial posttranslational modification directed 
by an oxidation process in which the thiol (SH) groups of two cysteines are 
connected by covalent linkage. In some proteins, disulphide bonds can be obliterated 
through a reductive process resulting in two free cysteines, or can be rearranged 
(i.e., the array of disulphide bonds is changed) via a process called disulphide bond 
isomerisation (Berkmen et al., 2007). 
 
Historically, Anfinsen and colleagues studied ribonuclease A (RNase A), containing 
four disulphide bonds all of which required for its full activity, and demonstrated that 
denatured and completely reduced RNase A could refold spontaneously to its active 
oxidized form in the presence of molecular oxygen (Anfinsen and Haber, 1961; 
Anfinsen et al., 1961; White, 1960). Goldberger and colleagues illustrated that the 
rate of disulphide bonds formation in vivo was extremely faster than that in vitro; the 
in vitro yield of corrected folded protein being low, with much of the protein containing 
the incorrect disulphide bonds (Berkmen et al., 2007; Goldberger et al., 1963). 
Hence, it was conjectured that there might be a biological system that corrected the 
erroneous disulphide bonds and led to the formation of native disulphide bonds. 
Protein disulphide isomerase (PDI), the eukaryotic endoplasmic reticulum enzyme, 
involved in this process was discovered in 1966 (De Lorenzo et al., 1966). For many 
years it was deemed that cells only needed the isomerase activity for disulphide bond 
formation, until divulging the periplasm disulphide bond-forming (Dsb) proteins in E. 
coli (Fig. 1.4) which were found to be integral for accurate disulphide bond formation 
of envelope proteins (Akiyama et al., 1992; Bardwell et al., 1991). 
 
Today, it is evident that disparate in vivo modifications are catalyzed by the function 
of a group of enzymes named disulphide oxidoreductases and isomerases which are 
existed in all domains of life (Berkmen et al., 2007). Disulphide bond formation and 
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isomerisation take place in dedicated oxidizing compartments in organisms; in gram 
negative bacteria being the periplasm. However, proteins with disulphide bonds are 
scarcely found in the cytoplasm of gram negative bacteria; for instance, the 
cytoplasmic enzyme ribonucleotide reductase. Disulphide bonds in such proteins are 
evanescent, being formed and reduced in the pathway of participating in electron 
transfer reactions (Berkmen et al., 2007; Prinz et al., 1997). 
 
Proteins necessitating disulphide bonds for their stability and activity are thought to 
be transferred into the periplasm co- or posttranslationally, via the Sec YEG 
translocon as discussed earlier, with their cysteines in a reduced state. In the 
cotranslational pathway, export of protein instigates shortly after initiation of its 
biosynthesis, eschewing cytoplasmic folding. In the posttranslational pathway, the 
attachment of antifolding agents, such as SecB protein, to the polypeptide retains 
them in an unfolded state and makes them export-competent. The construction of 
disulphide bonds between cysteines in proteins is catalyzed by periplasmic DsbA, a 
monomeric soluble protein analogous to thioredoxin.  DsbA itself is tranlocated into 
the periplasm via cotranslational pathway (Schierle et al., 2003), while most 
periplasmic proteins are translocated posttranslationally. The cotranslational export 
of DsbA seems to be crucial inasmuch as the protein folds quickly in the cytoplasm 
(Huber et al., 2005; Schierle et al., 2003). Appearing in the periplasm with reduced 
cysteines in its active sites, DsbA is oxidized by the membrane protein DsbB in order 
to function as a donor of disulphide bonds. Reduced DsbB is oxidized by ubiquinone 
or menaquinone, respectively, under aerobic and anaerobic conditions. It has been 
approximated that at least 90 per cent of the periplasmic proteins contain disulphide 
bonds, being operated on by DsbA (Berkmen et al., 2007). 
 
The gene dsbA is expressed constitutively in the periplasm at a basic rate of about 
850 molecules per cell; the expression of which is augmented in response to cell 
envelope-folding defects resulting from stress (Akiyama et al., 1992; Berkmen et al., 
2007). There is evidence that DsbA may indiscriminate in forming disulphide bonds in 
substrate. “Consecutive” model of disulphide bond formation can elucidate the 
reason for construction incorrect disulphide bonds. According to this model, DsbA 
reacts with the first cysteine of the polypeptide chain crossing into periplasm and link 
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it in a disulphide bond with the next one to emerge. Therefore, the product of 
interaction of DsbA with protein, in which four cysteines exist, would contain 
disulphide bonds between cysteines 1 and 2 and between cysteines 3 and 4 in the 
sequence. Should the mature protein have consecutive disulphide bonds, the product 
would contain the appropriate disulphide bonds and no corrections would be needed. 
Unless, correction by isomerisation activity of disulphide isomerase (DsbC) would be 
required. Based on this model and explanation, only proteins which contain non-
consecutive disulphide bonds in their final folded structure would be vulnerable to 
incorrect disulphide bond formation, consequently necessitating the action of cell 
isomerase (Berkmen et al., 2007). DsbC is expressed in E. coli and other bacteria, 
and promotes rearrangement of erroneous disulphide bonds allowing generation of 
the proper array in the final folded product. DsbC, a homodimer protein containing an 
uncharged hydrophobic pocket with room to accommodate misfolded proteins fully 
translocated into periplasm, functions as a protein-folding chaperone. As misoxidized 
proteins are most likely misfolded, chaperone property of DsbC recognizes them 
(Berkmen et al., 2007; Darby et al., 1998). Nevertheless, the mechanism by which 
the subsequent steps in disulphide bond isomerisation by DsbC occur has not been 
fully uncovered. 
 
DsbG is a second disulphide bond isomerase (245 amino acid sequence identity to 
DsbC) presented in the periplasm of E. coli. However, there are structural and 
biochemical differences in the peptide binding sites between DsbC and DsbG which 
can provide different substrate specificity and activity; for example, DsbG 
hydrophobic pocket is larger than DsbC one; and unlike the uncharged pocket of 
DsbC, there are seven negatively-charged amino acids within the pocket of DsbG. 
DsbG’s function is not known in E. coli as no substrate for it has been identified 
(Andersen et al., 1997; Berkmen et al., 2007; Heras et al., 2004; Messens and Collet, 
2006). 
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Fig. 1.4 Disulphide bond formation in the periplasm of E. coli. A protein requiring 
disulphide bonds for its stability is transported into the periplasm via the SecYEG 
translocon with its cysteines in a reduced state. Disulphide bond formation is 
catalysed by DsbA. DsbA is reoxidized to its active oxidized state by the inner 
membrane protein DsbB. DsbB is oxidized by ubiquinone in aerobic conditions or by 
menaquinone in anaerobic conditions. DsbA can form non-native disulphide bonds in 
proteins with more than two cysteine residues. If the substrate is misoxidized 
(misfolded), its disulphide bonds are isomerased to their native oxidized state by 
DsbC. DsbC and DsbG are kept in their active reduced forms by the inner-membrane 
protein DsbD. DsbD in turn is reduced by the cytoplasmic thioredoxin, which receives 
its reducing potential from cytoplasmic NADPH. (Figure adapted from Berkmen et al., 
2007; Nakamoto and Bradwell, 2004).  
 
DsbD, a 546-amino-acid cytoplasmic membrane protein, has been shown to be 
essential for keeping DsbC and DsbG in the reduced state (Bessette et al., 1999; 
Goulding et al., 2002). DsbD is reduced by the cytoplasmic thioredoxin TrxA 
receiving its reducing state from the cytoplasmic NADPH. 
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1.2.4 Periplasmic chaperones and isomerases 
 
Biogenesis of myriad proteins necessitates the presence of molecular chaperones to 
ensure their efficient folding. The cellular task of chaperone molecules include 
keeping newly synthesized polypeptides from misfolding or aggregation, and 
promoting disaggregation and refolding of stress-denaturated proteins (Bukau, 1999). 
In gram-negative bacteria, the periplasmic and outer membrane proteins are 
synthesized in the cytoplasm with a cleavable N-terminal signal sequence and 
transported to their final destinations in the cell envelope using different pathways 
mentioned earlier. Following translocation and signal sequence cleavage, the 
exported extracytoplasmic proteins acquire their final structure via different folding 
pathways exist in the periplasm. Firstly, the periplasm of gram-negative bacteria 
assist the formation of disulphide bonds as described above; secondly, it contains 
ATP-independent chaperones assisting protein folding. Genetic studies of E. coli 
periplasmic stress response induced by increased amounts of non native envelope 
proteins led to the discovery of the periplasmic chaperones and folding catalysts 
(Table 1.2).  
 
Table 1.2 Periplasmic chaperones and peptidyl-propyl isomerases (Table taken from 
Betton, 2007). 
 
Protein Chaperone 
activity 
PPIase family Oligomeric 
state 
Transcriptional 
control 
Skp (OmpH) +  Trimer Cpx, σE 
PpiA (RotA) - Cyclophilin Monomer Cpx 
FkpA + FKBP Dimer σE 
SurA + Parvulin Monomer σE 
PpiD - Parvulin Monomer Cpx, σ32 
 
 
Amongst the periplasmic folding proteins, Skp (OmpH) is the best-studied one, and 
scientists have shown that periplasmic Skp has a key role in the folding pathway of 
outer membrane proteins (Chen and Henning, 1996; Harms et al., 2001; Missiakas et 
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al., 1996). Although mutants lacking Skp have a markedly reduced production of 
outer membrane proteins, these mutants are viable; however, double mutants lacking 
both skp and the periplasmic Deg P can not survive at 37°C (Schäfer et al., 1999). 
Periplasmic peptidyl-prolyl isomerases (PPIases) are enzymes catalyzing cis-trans 
isomerisation of peptide bonds with amino acid proline during protein folding (Betton, 
2007). PPIases are categorized into three families, namely the cyclophilins, the 
FK506 binding proteins (FKBP), and the parvulins. Periplasmic proteins PpiA (or 
RotA), FkpA, and SurA and PpiD are respectively related to these three families of 
PPIases (Table 1.2). Like Skp, four PPIases are not individually essential for the 
viability in E. coli. Amongst PPIases, FkpA and SurA have chaperone activities as 
well.  
 
In addition to Skp, FkpA and SurA, two periplasmic oxidoreductase , DsbC and  
DsbG, also show chaperone activities (Chen et al., 1999; Shao et al., 2000). It is 
assumed that these periplasmic folding catalysts can also perform chaperone activity 
to compensate the dearth of the molecular chaperone machineries in the periplasm 
(Betton, 2007). 
 
1.2.5 Strategies for improving periplasmic protein accumulation  
  
Biosynthesis of all proteins initiates in the cytoplasm.Therefore, for efficient 
periplasmic protein accumulation, events (such as translation initiation and protein 
folding) need to be coordinated. An example showing the relationship of cytoplasmic 
events and their effects on periplasmic export and yield was demonstrated by 
Simmons and Yansura (1996). They showed that that by altering the translational 
strength, through changes in the Shine Dalgarno sequence and the first six codons of 
the signal sequence without changing the actual primary protein sequence, the 
amount of protein accumulating in the periplasm was modulated. There appeared to 
be an optimal level of translation for efficient periplasmic accumulation without 
precursor buildup. High levels of the precursor may overwhelm cytoplasmic factor(s) 
required for maintaining the protein in an export-competent conformation. As a result 
of inadequate levels of such cytoplasmic factors, the precursor folding into an export-
incompetent form or even forming inclusion bodies may occur. There are many 
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reports demonstrating the positive effects of certain cytoplasmic proteins on 
periplasmic indigenous and/or recombinant protein accumulation (Berges at al., 
1996; Phillips and Silhavy, 1990; Wild et al., 1992, 1996). The molecular explanation 
is that the chaperonic properties of such cytoplasmic proteins (e.g., DnaK, DnaJ, and 
GroEL) prevent the target preprotein from premature folding and inclusion body 
formation, keeping the protein in an unfolded state and allowing efficient export to the 
periplasm.  
 
Changing signal sequences is a common strategy to improve periplasmic protein 
production (Le Calvez et al., 1996; Rathore et al., 1996; Humphreys et al., 2000; 
Laird et al, 2004b). The alternative signal sequences could target the protein for post- 
or cotranslational export; they may interact differently with different cytoplasmic 
proteins; and they can cause changes in mRNA secondary structures that affect 
translational speed, mRNA stability, and mRNA translational strength, impacting the 
level of protein production.  
 
A considerable percentage (in the 20 to 40% range) of the total cell protein can be 
exported to the periplasm (Joly et al, 1998; Jeong and Lee, 2001; Laird et al., 2005) 
when conditions for periplasmic accumulation are optimized. These figures have 
been reported without overexpression of the components of secretory pathways (i.e., 
Sec and Tat pathways). It has been shown that it is feasible to increase the efficiency 
of protein export into the periplasm of E. coli by providing the host with additional 
copies of key components of Sec protein export machinery (Perez-perez et al., 
1994). Also, overexpression of the TAT export machinery has been achieved and 
elevated yields (over 20-fold) of recombinant proteins exported to the periplasm 
(Barrett et al., 2003).   
 
The folding environment in the periplasm plays a key role in the final form of a 
secreted protein. Following export from the cytoplasmic membrane machinery, 
periplasmic proteins require to fold into their correct conformations and form 
protease-resistant structures. There are three possibilities for newly secreted upon 
release into the periplasm (Fig. 1.5). Firstly, proteins may missfold and aggregate  
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Fig. 1.5 Possible destinies of proteins after secretion into the periplasm (adapted 
from Joly and Laird, 2007). 
 
 
which result in insoluble inclusion bodies (IBs). Aggregation occurs among 
intermediates with exposed hydrophobic patches, which are buried in the correctly 
folded protein (Carrio and Villaverde, 2002; Vallejo and Rinas, 2004) Secondly, 
proteins can be digested by periplasmic/membrane proteases. Finally, proteins can 
successfully fold into their correct soluble, biologically active conformations; this is 
usually preferred for those trying to exploit the periplasm as a location of recombinant 
protein production. The IB formation in the periplasm is not favourable as solubilising 
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and refolding of IBs are costly requiring many operations, as mentioned earlier in this 
chapter. 
 
Elevated yields of recombinant protein production can be attained by other strategies 
which ere overexpression and deletion of certain periplasmic enzymes. The normal 
periplasmic level of the enzymes involved in disulphide bond formation and 
isomerisation, being sufficient for bacterial cells growth under normal laboratory 
conditions, can be inadequate for production of recombinant proteins. Many 
periplasmic proteins in E. coli do not contain more than two disulphide bonds; in 
contrast, eukaryotic proteins such as tissue plasminogen activators and 
immunoglobulin proteins contain great number of disulphide bonds (Simmons et al., 
2002; Qiu at al., 1998) and boosting the periplasmic proteins involved in disulphide 
bond formation is necessary for efficient production of such proteins. Therefore, such 
enzymes have been overexpressed by many researchers to enhance the yield of 
periplasmic recombinant protein production (Bessette et al., 2001; Humpherys et al., 
1996; Joly et al., 1998). Also, overexpression of proteins involved in the periplasmic 
folding process such as Skp and FkpA (Kleinschmidt, 2007), has been shown to 
augment the expression of periplasmic recombinant proteins, particularly the 
production of antibody fragments (Bothmann and Pluckthun, 1998; Hayhurst and 
Harris, 1999). As highlighted earlier, removal of deleterious periplasmic proteases is 
the other strategy for increasing yield of periplasmic recombinant protein production. 
This has been accomplished by obliterating the genes encoding periplasmic 
proteases without compromising the normal robustness and viability of the host 
(Baneyx and Georgiou 1990, 1991; Chen et al., 2004; Laird et al., 2004a). The 
removal of ompT gene, encoding OmpT protein, is frequently required for recovering 
periplasmically recombinant proteins without proteolysis. It is common to use hosts 
lacking ompT, such as E. coli B laboratory strain, BL21, to avoid such proteolysis 
(Joly and Laird, 2007; Laird et al., 2004a; Meerman and Georgiou, 1994). 
Furthermore, in order to increase recombinant protein production and to protect the 
protein production factory from extraneous assaults, such as bacteriophages, the 
genes encoding outer membrane protein (such as TonA, OmpC and OmpF), being 
bacteriophage receptors, have been eliminated without causing any detrimental 
growth defects (Hancock and Braun, 1976; Xiong et al., 1996). 
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In addition, there are also chemical approaches for improving protein folding; that is, 
the solute composition of the periplasm can be manipulated by regulating the 
medium composition. The outer membrane of gram-negative bacteria is permeable 
to solutes having molecular weight 600Da and less (Nakea and Nikaido, 1975). Thus, 
this could be utilized to improve protein folding by including components such as 
sucrose, glycerol, betaine, small thiol/disulphide reagents and etc., while 
overexpressing recombinant proteins in the periplasm. These solutes may help 
protein folding in the periplasm via triggering protective stress response attributable 
to their high osmolarity, or interacting directly with a folding intermediate (Barth et al., 
2000; Blackwell and Horgan, 1991; Joly and Laird, 2007).  
 
Eventually, the combination of overexpression of periplasmic components 
contributing in protein folding pathway and the inclusion of chemical additives has 
been reported to be considerably fruitful (Sandee et al., 2005; Wunderlich and 
Glockshuber, 1993). 
 
As a major category of biotherapeutic proteins, antibodies are increasingly used in 
the clinic, and their importance is rising as more drugs in this class progress through 
clinical trials. E. coli is currently the host of choice for manufacturing antibody 
fragments in the periplasm due to the characteristics discussed above.   
 
1.3 Antibodies and antibody fragments 
 
Intact antibodies, or immunoglobulins, (IgG, IgM, IgA, IgE) are highly specific 
targeting reagents and provide our key defence against pathogenic organisms and 
toxins. Antibodies are able to selectively bind molecules, so called ‘antigens’ 
recognised as foreign to the organism. In 1930’s, antibodies were identified as the 
protective agent in the serum (Kuby, 1997), and the basic structure of 
immunoglobulins was elucidated during 1950’s and 1960’s by Rodney Porter and 
Gerald Edelman (Bak, 2004). ‘Polyclonal antibodies’ are a combination of 
immunoglobulin molecules identifying many antigen determinants or ‘epitopes’ on an 
antigen with a range of affinities (Bak, 2004), and these antibodies are usually 
produced by immunization of mammal, such as a mouse, rabbit or goat. Ployclonal 
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antibodies have variety of applications. They can be exploited as a mean of inducing 
passive immunisation (e.g. for treatment against Hepatitis A, snakebites and 
tetanus); they are also extensively employed in diagnostics, immunoturbidemetry, 
and immunohistochemistry (Bak, 2004). ‘Monoclonal antibodies’, developed by 
Köhler and Milstein (1975), are identical antibodies identifying one epitope on 
antigen. Monoclonal antibodies can be produced by fusing antibody-excreting B-cells 
and myeloma (cancer) cells, the cell resulted in from this fusion being called 
hybridoma cell. Because of their single epitope specificity, monoclonal antibodies 
have wide applications in diagnostics, research, and therapeutics, ranging from in 
vitro pregnancy tests against the hCG hormone to in vivo cancer treatments (Bak, 
2004).  
 
IgG, the main serum antibody, is a Y-shaped molecule composed of 12 globular 
domains, named as Ig fold, that are rich in β-sheet and have a conserved disulphide 
bond (Humphreys, 2007). The Ig folds are connected by short interdomain linkers, 
named as elbow, or longer linkers known as hinges (Fig. 1.6). Most antibodies have 
two light chains and two heavy chains; each chain has a variable N-terminal region 
(fragment variable, Fv) known as VL and VH, respectively. Each variable region has 
three hypervariable loops (complementary determining regions, CDRs) that together 
form a common six-loop antigen binding site. The Fv region in each chain is followed 
by a different number of constant regions, as shown in figure 1.6.  
 
Antigen-binding antibody fragments could be resulted in by proteolysis of whole 
antibodies. The protease papain digests the full-length IgG and releases the four N-
terminal domains; the fragment produced is called the Fab fragment (fragment 
antigen binding), and has a molecular weight around 50 kDa. Pepsin cleaves the 
heavy chains slightly after hinge; thus, the dimeric Fab’ fragment, or F(ab)’, is 
produced (Fig. 1.7). Both enzymes release the C-terminal four domains or Fc 
fragment, which is glycosylated in the CH2 domain and has effector functions such as 
serum half-life, complement activation, and recruitment of immune cells (Holliger and 
Hudson, 2005; Humphreys, 2007).  
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Fig. 1.6 Schematic representation of full-length IgG. Each heavy chain is composed 
of four domains: one variable (VH) and three constant (CH1, CH2, and CH3). Each light 
chain has two domains: one variable (VL) and one constant (CL). The two heavy 
chains are covalently attached by disulphide bonds between hinges and each light 
chain is attached to a heavy chain by a disulphide bond.  
 
The minimal fragment (~30 kDa) that still contains the whole antigen binding site of  a 
whole IgG antibody is composed of both the variable heavy chain (VH) and variable 
light chain (VL) domains. This heterodimer fragment, called Fv fragment (for fragment 
variable), is still capable of binding the antigen, but native Fv fragments are unstable 
since the non-covalently associated VL and VH domains tends to dissociate from one 
another. 
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Fig. 1.7 IgG molecules can be digested with the enzymes papain or pepsin. Papain 
digestion results in cleavage of the immunoglobulin into Fab and Fc fragments, and 
pepsin digestion causes cleavage of the IgG molecule into F(ab)'2. Pepsin also 
digests the Fc regions into fragments.  
 
 
The production of antibody fragments in E. coli (e.g. Fab, Fv, scFv, VHs, diabodies, 
triabodies, etc.) has been successfully achieved (Holliger and Hudson, 2005; 
Humphreys, 2007 and references therein). These smaller fragments have altered 
features (e.g., monomeric binding, lack of effector functions, rapid systemic 
clearance, and rapid tissue penetration). However, it turned out to be difficult to 
produce fragments such as single domain antigen binding fragment (VHs) in soluble 
form, due to the sticky behaviour of the fragment which would cause aggregation. 
Such recombinant antibodies are increasingly used over a broad spectrum of 
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therapeutic and research applications. In the clinic, antibodies can be fused to 
species such as enzymes, viruses, radionuclides and toxins for drug therapy, cancer 
targeting, tumour and clot imaging (Hudson, 1998; Humphreys et al., 1997; Jurado et 
al., 2002; Natarajan et al., 2008; Wörn and Plückthun, 2001). In human medicine, a 
completely new approach, which is referred to ‘magic bullet’, is the fusion of an 
effector protein to an antigen recognising antibody fragment (Joosten et al., 2003). 
The gene encoding the effector protein can be directly fused to the gene of an 
antibody fragment, resulting in new bi-functional proteins (Neuberger et al., 1984). An 
example is the employemnet of cancer-specific bi-functional antibodies targeting 
cytotoxic molecules to tumour cells and consequently eliminates these tumour cells 
without harming healthy cells (Boleti et al., 1995).  In the laboratory, antibodies can 
be used in immuonoblotting, enzyme-linked immunosorbent assay (ELISA), and 
affinity purification. The increasing demand for recombinant antibodies has been 
driving the development of a variety of production systems as diverse as yeasts, 
mammalian cells, transgenic plants and animals, and Escherichia coli (Andersen and 
Reilly, 2004; Hudson, 1998; Joosten et al., 2003)). In comparison to other expression 
systems, E. coli has much to offer for low-cost and high-speed protein production, 
based on perfect familiarity with the genetics, physiology and regulatory systems of 
this organism; limitations for high-level expression in E. coli have been overcome by 
the engineering of the host. For example, there has been report on production of 
aglycosylated Fc-containing antibody in the periplasm of E. coli (Simmon et al., 
2002). Although, it is deemed that manufacturing of full-length antibody is very 
difficult in E. coli because this organism is not especially well-adapted for the 
expression of very large, disulphide bond-rich and multimeric proteins. For many of 
the mentioned applications, the presence of glycosylation in the Fc constant regions 
is unnecessary or fruitless; thus, in these applications, aglycosylated full-length 
antibodies or smaller antibody fragments can be employed (Andersen and Reilly, 
2004).  
 
As a type of antibody fragments, the Fab fragment of an antibody contains the 
antigen-binding site and the four domains (i.e. VH, CH1, VL and CL); VH and VL 
domains are fused to the following constant antibody domains CH and CL, 
respectively. The smaller size of Fab is more suitable for applications such as tumour 
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penetration and imaging, and Fab exhibits a shorter half-life than full-length 
immunoglobulin G molecules (Andersen and Reilly, 2004), resulting in the faster 
clearance of the toxic labelled antibody fragments from the circulation in normal 
organ. However, the short circulating half-life of Fab fragment can be a drawback for 
therapeutic applications, but this constraint can be overcome by approaches such as 
attachment of polyethylene glycol (PEG) (Chapman et al., 1999; Chapman, 2002; 
Leong et al., 2001) and albumin-binding peptide (Dennis et al., 2002), which have 
been proved to increase the circulating half-life. In contrast to some of the heavily 
engineered antibody fragments, the Fab has native sequence; subsequently, it is less 
likely for the Fab to be immunogenic when used as therapy. The thermal (> 60°C) 
and chemical (> 2 M guanidine hydrochloride) stability of Fab make it resistant to 
strident bioprocessing and modification processes (Humphreys, 2007).  
 
As mentioned earlier, there are three locations for the manufacture of soluble 
proteins in E. coli: the cytoplasm, the periplasm, and secretion into the culture media. 
The periplasm is preferable for expression of soluble antibodies, mainly because it 
facilitates the formation of disulphide bonds, the retention of correct N-terminus, and 
the exposure to extracellular chemical agents (<500 Da in size) which aid the folding 
and modification of antibodies (Humphreys, 2007). A diversity of approaches, 
including optimising the expression of light and heavy chains to obtain augmented 
titres of antibody fragments (Humphreys et al., 2002), host cell engineering to hinder 
proteolysis of the light chain (Chen et al., 2004), and co-expression of chaperones to 
ameliorate folding or disulphide bond formation (Ramm and Plückthun, 2000; 
Humphreys et al., 2002) have been implemented to enhance the periplasmic 
production level of antibody fragments up to 2 g/L using the E. coli system (Carter et 
al., 1992; Chen et al., 2004).  
 
Having achieved desirable levels of expression in the periplasm, it is required to 
develop the extraction processes to release the maximize amount of the recombinant 
protein while minimizing the release of other host proteins and biomolecules. At large 
scale, the prevalent technique for purifying proteins from periplasm includes breaking 
the cytoplasmic membrane and the outer membrane and discharging the entire 
content of the bacterial cells. Inasmuch as approximately 80 per cent of the total 
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cellular protein is located in the cytoplasm, this method of non-selective- protein 
release makes the purification process burdensome (Joly and Laird, 2007). At 
laboratory small scale, the frequent methods for cell fractionation and isolating 
periplasmic fraction are spheroplasting and osmotic shock treatment (Neu and 
Heppel,1965), but these techniques are not practicable when culture volume reaches 
above 10 litres (Joly and Laird, 2007). Finding disruptions techniques which can 
selectively release periplasmic fraction at large scale and alleviate the subsequent 
protein recovery processes is still a goal to be achieved.   
 
1.4 Agents permeabilising the outer membrane 
 
As illustrated in figure 1.8, the cell wall of gram-negative bacteria consists of an outer 
membrane (OM) and a peptidoglycan or murein layer. Peptidoglycan layer composed 
of glycan chains consisting of N-acetylglucoseamine and N-acetylmuramic acid 
linked by β (1-4)-glycosidic bonds, and the glycan chains are crosslinked by 
formation of peptide bonds between amino acid side chains. The wall grants 
mechanical strength to the cell due to the crosslinked peptidoglycan layer, the 
thickness of which alters in different growth phases of the cell, in particular, over the 
course of transition from exponential phase to stationary phase. Stationary-phase 
bacteria have generally a thicker and more highly crosslinked peptidoglycan layer 
(Middelberg, 1995; Volmer, 2007). 
 
The OM is a lipid bilayer containing transmembrane proteins (porins), lipoproteins, 
phospholipids and lipopolysaccarides (LPS). Lipoproteins join the lower section of the 
lipid bilayer to the peptidoglycan layer. The outer leaflet of the OM is believed to 
contain only lipopolysaccharides, which are crossbridged by divalent cations (e.g., 
Mg2+ and Ca2+) and do not have a high degree of permeability to hydrophobic 
molecules. The inner leaflet of the OM consists of phospholipids (Vaara, 1992). 
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Fig. 1.8 Simplified structure of the cell wall of E. coli showing its relationship with the 
cytoplasmic membrane (redrawn from Middelberg, 1995). 
 
 
It has been demonstrated that phospholipid bilayers are permeable to hydrophobic 
molecules, and bacteria in which the OM contains phospholipid bilayer regions (e.g., 
Nisseria gonorrhoeae) are more vulnerable to hydrophobic agents such as 
erythromycin, Triton X-100, and crystal violet (Lysko and Morse, 1981; Sarubbi et al., 
1975). Therefore, the LPS layer in gram negative bacteria is deemed to protect the 
phospholipids in the inner leaflet of the OM and in the inner (cytoplasmic) membrane 
from pernicious agents such as neutral and anionic detergents, hydrophobic 
antibiotics, and hydrophobic dyes (e.g., brilliant green, methylene blue and eosine). 
Small hydrophilic compounds can diffuse through the OM via the water filled porin 
channels (Nikaido and Vaara, 1985). 
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Release of all intracellular components requires complete destruction of the cell wall, 
and it is usually achieved by mechanical techniques (e.g., high-pressure 
homogenization and bead milling); however, gentler disruption techniques, such as 
chemical and enzymatic methods, can be employed for this purpose. Chemicals 
interacting selectively with components of the cell wall and cell membrane may allow 
product to leak through the peptidogylcan; in which case, there is no need to raze the 
peptidoglycan layer. Otherwise, the disruption of petidoglycan in gram negative 
bacteria is needed, which generally involves enzymatic method (e.g., lysozyme) 
attacking the peptidoglycan layer (Middelberg, 1995). 
 
Various chemicals (e.g., antibiotics, chelating agents, chaotropes, detergents, and 
solvents) can be applied, singly or in combination, in order to disrupt or permeabilise 
the OM of gram negative bacteria.  
 
Cationic antibiotics (e.g., polymyxin), which are too large to go through the narrow 
channels of porins of the OM, can gain access to their final target in the cytoplasmic 
membrane of gram-negative bacteria via binding to LPS and thus disrupting the OM. 
It is also demonstrated that polymyxin could indeed enhance the permeability of the 
OM to many agents such as hdrophobic antibotics, detergents, and lysozyme 
(Middelberg, 1995; Nikaido, 2003; Nikaido and Vaara, 1985; Vaara, 1992). Despite of 
their ability to cause cell lysis, antibiotics can be used neither for large-scale lysis, as 
they are generally costly, nor for selective release of periplasmically-located proteins. 
 
Chelating agents, such as EDTA, nitrilotriacetate, and sodium hexametaphosphate, 
have been demonstrated to permeabilise the OM of gram-negative bacteria by 
chelating Mg2+ and Ca2+, which crossbridge adjacent LPS molecules, leading to the 
release of a considerable proportion of LPS from the cells (Hancock, 1984; Hancock 
and Wong, 1984; Vaara, 1992; Vaara and Jaakkola, 1989). The space generated by 
LPS release is most likely filled with phospholipid molecules from the inner leaflet of 
the OM; the created phospholipid bilayer patches can then function as channels 
through which hydrophobic compounds can diffuse.  
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The primary amine as well as an organic cation, Tris, not only synergistically assists 
the function of chelating agents, such as EDTA, but also singly and at moderately 
high concentration (e.g., up to 200 mM) can permeabilise the OM (Hancock, 1984; 
Nikaido and Vaara, 1985; Vaara, 1992). This is supposed to be attributed to Tris 
ability to interact with LPS which replaces stabilizing cations, and as a result 
weakens the interaction between LPS molecules. It has been shown that the impact 
of EDTA on LPS structure has been diminutive in the presence of buffers such as 
phosphate buffer and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
but strong in the presence of Tris. Hence, it can be construed that a maximal OM 
destabilization requires not only the removal of divalent cations, but also replacement 
of those and other cations by Tris (Middelberg, 1995; Vaara, 1992). 
 
Chaotropes, such as urea and guanidinium chloride, disorganize the structure of 
water rendering it less hydrophilic, and weaken solute-solute interaction. Therefore, 
hydrophobic compounds such as membrane proteins can be solubilised in 
reasonably concentrated chaotropic solutions. Although chaotropes should usually 
be employed at high concentration while they use singly, effectual protein release 
has been reported at low chaotrope concentration (e.g., 0.1 M guanidinium chloride) 
in combination with non-ionic detergent Triton X-100, which can be fruitful for large-
scale application of chaotropes for cell permeabilisation (Bansal-Mutalik and Gaikar, 
2003; Hettwer and Wang, 1989; Middelberg, 1995). Ethanol, usually categorized as 
an organic solvent, is also an effective chaotrope inasmuch as it disrupts the 
hydrogen bonding in water (Middelberg, 1995). 
 
Having an ionic hydrophilic region and a hydrophobic hydrocarbon portion and hence 
being amphipathic molecules, detergents (surfactants) are able to interact both with 
water and lipid to form micelles containing lipid. Detergents may be categorized as 
anionic (e.g., sodium dodecyl sulphate (SDS) and sodim deoxycholate), cationic 
(e.g., cetyltrimethylammonium bromide (CTAB) and benzalkonium chloride (BAC)), 
and non-ionic (e.g., Triton X and Brij series). A crucial parameter in choosing a 
detergent for permeabilisation purpose is its impact on the target product. For 
instance, while SDS causes protein denaturation in most cases, non-ionic detergents 
(e.g., Triton X-100) solubilise membrane proteins without a loss of activity 
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(Middelberg, 1995; Schnaitman, 1971). The outer membrane of gram negative 
bacteria is resistant to non-ionic detergents, and the recovery of cytoplasmic 
membrane proteins from pretreated cells (for example, with EDTA-lysozyme) by 
detergents proves the specificity of most non-ionic detergents for the cytoplasmic 
membrane (Burman et al., 1972; Filip et al., 1973). Cationic detergents operate on 
the OM by binding to the negatively charged LPS, and also modify the conformation 
of membrane proteins leading to cell disruption (Bansal-Mutalik and Gaikar, 2003). 
Given their specificity for the inner (cytoplasmic) membrane, it is liable that 
detergents continue to attract attentions for extraction and recovery of specific 
membrane proteins at process scale. Although it is implausible that detergents 
individually receive approval for whole cell disruption because of process cost and 
complicated downstream processing, it is likely that they will be considered to be 
employed at low concentration and in combination with other treatments (e.g., EDTA 
and chaotropes) for destabilizing the OM of gram-negative bacteria and cell 
disrupting (Hettwer and Wang, 1989). 
 
Solvents, such as toluene, chloroform, ether, can also permeabilise cells, allowing 
soluble protein release. They most likely operate by dissolving hydrocarbon 
components, such as phospholipids, in the cell wall of gram-negative bacteria. An 
increase in release by solvents in the presence of chemicals destabilizing the OM 
(e.g., EDTA) has been reported. Also, it has been demonstrated that OM stabilizing 
agents, such as Mg2+ and Ca2+, diminish the protein release by solvents. Therefore, 
the release by solvents relies on the selected conditions (Ames et al., 1984; Bansal-
Mutalik and Gaikar, 2003; De Smet et al., 1978; Jackson and Demoss, 1965). 
 
The final objective of all bioprocess production and recovery works is to obtain 
correctly-folded and biologically-active target biomolecules such as proteins. During 
various stages of biomolecules extraction and recovery, it is favourable to study the 
structures of the molecules. Circular dichroism, discussed below, is one of the most 
powerful tools for this purpose.  
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1.5 Circular dichroism and its applications 
 
When circularly polarized light passed through an optically active substance, the left- 
and right-circularly polarized rays are absorbed to a different extent; that is, εL ≠ εR.  
The difference Δε = εL - εR is called circular dichroism (CD) (Woody, 2000). For a 
quantitative and standard description of CD, the Beer-Lambert law is addressed. 
 
In absorption spectroscopy the fraction of light absorbed by a sample follows the 
Beer-Lambert law: 
 
Aλ = log10 (I0/I) = εlC 
 
Where Aλ is the optical density or absorbance, I0 is the intensity of light entering the 
sample, C is the concentration of the sample given in moles L-1, l is the path length of 
in cm and ε is the molar extinction coefficient and has units of litres (moles-cm)-1 
(Miles and Wallace, 2006; Woody, 2000).  
 
In an optically active medium, this equation also applies in CD spectroscopy. In this 
case, CD is the difference in absorption of left- and right-circularly polarized light by 
optically active molecules; that is, 
 
CD =  ΔA = AL – AR = εLlC - εRlC 
 
Where the subscripts indicate the direction of rotation of light. CD instruments (known 
as spectropolarimeter) usually generate the data in mdegrees or ellipticity (θ) units 
(Woody, 2000; Miles and Wallace, 2006). 
 
There is a numerical correlation between ΔA and ellipticity (in degrees), namely θ = 
32.98 ΔA. The CD spectrum is acquired when the “dichrograph” is gauged as a 
function of wavelength; this is the way a spectrum is stored in a computer (Kelly et 
al., 2005). Figure 1.9 illustrates a schematic diagram of a spectropolarimeter.  
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The salient optically active groups in proteins are the amide bond of the peptide 
backbone (absorption below 240 nm) and the aromatic side chains (absorption in the 
range 260 to 320 nm) (Greenfield, 1996; Kelly et al., 2005). As shown in Fig. 1.10, 
various secondary structures, such as α-helices and β-pleated sheets, have their own 
distinctive CD spectra, regarding shape and magnitude (Johnson, 1988).  
 
 
 
 
Fig. 1.9 Diagram of a spectropolarimeter (Jasco J-810). Passage of light from the 
source (LS) through 2 prisms (P1 and P2) and a series of mirrors (M0 to M5) and slits 
(S1 to S3) produces plane polarised light. After being focused by a lens (L), the 
ordinary ray (O) produces circularly polarised light by passing through a filter (F) and 
modulator (CDM). The circular polarised light is then passed through the shutter (SH) 
and the sample, and is detected by the photomultiplier (PM) (Figure redrawn from 
reference: Kelly et al., 2005). 
 
 
The most effective region of the CD spectra is the far-UV region (approx. 240-190 
nm). Conformational changes which involve modification to aromatic side chains of 
proteins can be monitored in the near-UV region (300-240nm); however, the CD 
signals in near-UV region are less intense (Wallace and Janes, 2001). 
 
As it is shown in figure 1.10, the CD spectrum for an α-helix takes over the region 
between 240 and 200 nm, with two reasonably intense negative bands at about 222 
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and 208 nm. The CD spectrum of the α-helix also dominates the region between 200 
and 174 nm, with a strong positive band at 192 nm. The CD spectrum derived from 
β-sheet is characterised by a small negative band near 217 nm and a fairly intensive 
positive band near 195 nm that has approximately half the intensity of the α-helix 
positive peak in this region. β-sheets give rise to considerably less intense signals 
than helices; show more variations in spectral characteristics, due to more 
vulnerability to distortions caused by the CD signals arisen from aromatic side 
 
random coil 
 
Fig. 1.10 Circular dichroism of “pure” secondary structures. (Figure taken from 
Johnson, 1988). 
 
 
chains. Analyses of β-sheet rich proteins are thus less accurate than those of their 
helical counterparts (Miles and Wallace, 2006). The CD spectrum of random coil is 
identified by a small positive band between 215 and 230 nm and a strong negative 
band at 198 nm. The CD spectrum of polyproline (PPII) helix, the conformation which 
is found in collagen and in short segments of some globular proteins, is generally 
similar to the one arisen from random coil (also known as unordered or disordered 
structure (Greenfield, 1996; Miles and Wallace, 2006).  
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The foremost application of CD is for analysis of secondary structure, as the CD 
spectrum is susceptible to the small alterations in the secondary structure of proteins, 
and thus provides information on conformational alterations in proteins (Dafforn and 
Rodger, 2004; Johnson, 1988; Wallace and Janes, 2001), particularly while no data 
are available from X-ray technique. For instance, the CD spectra for 36 salt-extracted 
ribosomal proteins from Escherichia coli have been reported, denoting that 30S 
proteins tend to have a high content of α-helix, while the 50S proteins have very 
dissimilar structures (Johnson, 1988). 
 
As the CD spectra in near-UV (260-320 nm) derive from the aromatic amino acids, 
thus this technique can be used for study of the tertiary structure of proteins. Each 
amino acid has a unique wavelength profile. Trp has a band between 290 and 305 
nm, Tyr shows a band between 275 and 282 nm, and Phe has sharper bands 
between 255 and 270 nm (Johnson, 1988). The near-UV CD spectrum can be 
applied to compare wild type and mutant form of proteins; for example, this 
application has been reported for wild type and mutant (R23Q) type II 
dehydroquinase from Streptomyces coelicolor (Kelly et al., 2005; Krell et al., 1996). 
 
CD can also provide information on cofactor binding sites in proteins. Organic 
cofactors, such as pyridoxal-5´-phosphate, heam and flavin, have weak CD signals 
when they are free in solution. Binding to their partner proteins, these cofactors 
confer chirality and thus CD spectrum in the specific region can indicate the integrity 
of the cofactor binding site. CD spectrum has been employed to provide structural 
information about haem site in cytochrome P450s and bacteriochlorophyl1 sites in 
LH2 (light harvesting) complex from Rhodopseudomonas acidophila (Alden et al., 
1997; Anderson and Peterson, 1995; Hope et al., 1996; Kelly et al., 2005). 
 
There are numerous examples of the application of CD for studying protein structure, 
protein folding and protein conformational alterations. CD has been used for 
evaluating the structural relationship between wild type and mutant protein (Krell et 
al., 1996). Conformational modifications in proteins can be due to the binding of 
ligands, for instance, binding of molybdate to molybdate-sensing protein ModE from 
E. coli. In this case, CD data are invaluable for finding the range of ligand 
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concentrations over which structural changes occur, the extent of the changes in the 
protein of interest, and the rate at which such modifications take place (Boxer et al., 
2004; Kelly et al., 2005). The switch between α-helix and β-sheet structures in prion 
peptides and the switch between helical hairpin and coiled-coli motifs in designed 
peptide sequence have been investigated using CD (Hope et al., 1996; Pandya et al., 
2004). A particular type of structural change happens throughout the gaining of the 
native structure of a protein during biosynthesis, and CD has been employed to 
measure the rate of acquisition of secondary and tertiary structures. For example, it 
has been revealed that small proteins (fragments less than 100 amino acids) can fold 
rapidly with no detectable intermediates; whereas, the folding of larger proteins is a 
multi stage pathway at which intermediates, namely “molten globule”, are appeared 
(Jemth et al., 2004; Kelly et al., 2005). 
 
Preparation of protein samples for CD studies should be done carefully. The 
important conditions for protein sample preparation have been discussed below. 
 
1.5.1 Protein preparation, characterisation and storage 
 
The majority of proteins are currently produced by over-expression of their relevant 
encoding genes in an appropriate host system (such as E. coli, yeast or animal cells). 
For conducting CD experiments, proteins should be free of optically active impurities, 
such as nucleotide fragments or optically active buffers and chemicals, which might 
largely contribute to the final CD spectrum (Greenfield, 1996; Kelly et al., 2005).  
 
Sometimes in order to improve protein purification, a small tag (such as hexa-His) is 
attached to the protein encoding gene, or the protein of interest is expressed as a 
fusion protein with glutathione S-transferase (GST) or maltose-binding protein (MBP). 
These additional components provide a recognition site for purification using affinity 
chromatography. The tag should be obliterated using an appropriate protease if its 
presence influences the folding and stability of the protein. For instance, GST or MBP 
segments (26 kD and 40 kD, respectively) of fusion proteins must be eliminated 
before structural studies by CD spectroscopy, due to extensive contribution of these 
large moieties to the CD spectra of the fusion protein (Kelly et al., 2005) .  
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 The protein solution should be also free from chiral components. Nucleic acids (or 
nucleotide fragments) should be eliminated by adding a suitable nuclease to the 
extract obtained from cell lysis before conducting protein purification.  
 
Dialysis or gel permeation can be utilised in order to abolish buffer ions which might 
cause problems with CD. For example, imidazole employed to elute His-tagged 
proteins from immobilised metal chromatography (Ni-NTA) column, and chloride ions 
(NaCl) used to elute proteins from ion-exchange columns, show high absorbance in 
the far-UV and must be removed from the solution using dialysis or gel permeation 
(Kelly et al., 2005). 
 
Protein solution should be transparent with no insoluble protein aggregates, 
inasmuch as these alter the shape and magnitude of the CD spectra and also 
decrease the signal/noise ratio (Kelly et al., 2005). Spectrophotometry and analytical 
ultracentrifugation (AUC) can be utilised to corroborate the presence of aggregates. 
In the spectrophotometric technique, the absorption spectrum of the protein sample 
is measured at the wavelengths generally ranged from 400 nm to 240 nm. If there is 
a gradually increasing baseline optical density as the wavelength decreases, this 
shows that light scattering exists. Sensitive to the mass and shape of the protein, 
sedimentation velocity experiments can be done using an analytical ultracentrifuge in 
order to monitor the aggregation of proteins (Berkowitz, 2006; Cole and Hansen, 
1999; Liu et al., 2006). Protein solution can be centrifuged (e.g., at 5000×g, for 5 min) 
or passed through a 0.2 μm Millipore filter to reduce or eliminate aggregated 
materials or dust particles for CD studies (Kelly et al., 2005). 
 
1.5.2 Selection of buffer/solvent system for CD measurements 
 
A minimum ionic strength is usually needed to disperse the surface charges of the 
protein; suitable buffer systems are hence required. Buffers should be used within a 
range of approximately 1 pH unit on either side of the appropriate pKa and should be 
prepared at a sufficient concentration to avoid changes in pH on addition of a highly 
charged ligand (Kelly et al., 2005). 
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 Chloride ions are one of the worst interfering components. Chloride ions are part of 
phosphate buffered saline (PBS) or Tris buffers, in which HCl is used to adjust the 
required pH. Sodium chloride should be replaced by either sodium fluoride (unless 
this interferes with the protein structure or function) or sodium sulphate; In addition, 
Tris buffer should be acidified by using sulphuric or phosphoric acid instead of HCl. 
Anions such as sulphate or fluoride do not absorb significantly in far-UV (Kelly et al., 
2005; Miles and Wallace, 2006).  
 
Buffers such as HEPES, MOPS, MES and PIPES also absorb strongly in the far-UV; 
therefore, increasing the cut off wavelength (the lowest wavelength at which a 
spectrum can accurately be measured) and should only be used at low 
concentrations for detailed far-UV CD studies (Kelly et al., 2005; Miles and Wallace, 
2006). The interfering problem also greatly occurs in the pH range 4 to 6, inasmuch 
as most of buffer such as citrate, acetate and glycine have carbonyl groups 
absorbing strongly in the far-UV (Kelly et al., 2005; Miles and Wallace, 2006). It 
should be mentioned that imidazole, which is employed at concentrations of 100 mM 
or above to elute His-tagged proteins from immobilised metal chromatography (Ni-
NTA) columns, absorbs considerably in the far-UV; ideally, the concentration of 
imidazole should be reduced to lower than 1 mM (Kelly et al., 2005). 
 
Moreover, protective agents; for instance salts (e.g., (NH4)2 SO4), osmolytes such as 
proline, sugars, sucrose, EDTA, protease inhibitors and dithiothreitol, can be included 
in the protein solution. By adding glycerol to 50% (v/v), the protein solutions can be 
stored at -20°C without being frozen. EDTA is frequently added as stabilizing agent 
because it chelates trace metal ions required for the action of some proteases, and 
also it chelates the metal ions which have detrimental effects on cysteine residue of 
the side chains. Addition of 1 mM EDTA does not significantly cause problem for CD 
experiments using a short path length cell (e.g., 0.02 cm), although the carboxylic 
groups of EDTA absorb below 200 nm. Dithiothreitol, reducing agent which maintains 
Cys side chains in their reduced state, absorbs significantly below 220 nm; hence, 
the absorbance of a buffer containing this agent should be meticulously tested in far-
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UV region (Arakawa and Timasheff, 1982; Bolen, 2004; Kelly et al., 2005; Parkins 
and Lashmar, 2000; Wang, 1999). 
 
Chemicals such as urea (8 M) and guanidinium chloride (6 M), which normally used 
for denaturation of proteins, greatly absorb below 210 nm. These chemicals at such 
concentrations do not permit reliable CD data to be collected below 210 nm, even by 
using cells of short path length (20 µm) (Kelly et al., 2005). 
 
Detergents are usually applied to extract membrane proteins from their membrane 
milieu, the choice of which should be such as to sustain the structure integrity of the 
protein but should not cause excessive absorbance in the far-UV. Amongst 
commonly used detergents, Triton X-100 has high absorbance around 280 nm and it 
is difficult to remove from proteins. SDS is a useful detergent for CD studies because 
it lacks absorbance in the far-UV (Kelly et al., 2005). 
 
Solvents containing carbon-chloride bonds to absorb significantly below 230 nm; 
dimethylsulphoxide and dimethyl formamide absorb strongly below 240 nm and 250 
nm, respectively. Organic solvent such as acetonitrile ethanol and methanol (HPLC 
grade) can be applied down to 190 nm. 2,2,2-trifluoroethanol (TFE)  is a useful 
solvent for studying peptides and protein fragments,  having been demonstrated to 
enhance the dehydration of specific residues within a helix and as a result promote 
helix stability, can be used for CD studies (Kelly et al., 2005; Starzyk et al., 2005). 
 
Overall, during CD measurements, it is important to maintain the total absorbance of 
the sample (i.e., protein and buffer or solvent) within rational ranges to avoid 
excessive noise. The appropriateness of any buffer/solvent system for CD should be 
checked by measuring blank spectra to ensure that the absorbance is not too high. 
The absorbance of the sample can be simply checked by tracing of High Tension 
(HT) voltage, which is the voltage applied to photomultiplier. HT should be generally 
less than 700 V for getting reliable data (Kelly et al., 2005). In general any 
buffers/solvents that absorb significantly in the wavelength range of interest should 
be removed or substituted with a non-absorbing buffer. In some cases, this drawback 
can be resolved by applying low concentration of buffers and short path length (50 to 
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100 µm) cells. Phosphate buffer systems are preferable, generally being used at 
concentrations up to 100 mM in cells with path lengths of less than 50 µm (Miles and 
Wallace, 2006). For measurements below 195 nm, in particular, it is vital to employ 
transparent buffers, such as 10 mM potassium phosphate (Greenfield, 1996).  For 
measurements in low wavelength (below 170 nm), samples may also require to be 
degassed immediately before measuring a spectrum to eliminate dissolved oxygen 
(Miles and Wallace, 2006).    
 
1.6 Aims and outline of the thesis 
The broad objective of this thesis has been to design improved new processes for 
extraction and purification of periplasmically expressed proteins. Three 
periplasmically expressed proteins, namely beta-lactamase, alpha-amylase, and 
D1.3 Fab fragment, were selected as model proteins for the studies in this thesis. 
Antibody Fab fragments are more useful than full-length immunoglobulin G 
molecules in diagnostic applications, tumour therapy and tumour imaging. The 
smaller size of antibody Fab fragments causes rapid tissue penetration and the 
shorther half-life of the molecules results in rapid clearance from the blood or kidney. 
Due to these features, the production of Fab fragments is industrially highly 
demanded; and several Fab fragments are in clinical and preclinical development 
(Holliger and Hudson, 2005). Successful production of soluble and correctly folded 
Fab fragments in the periplasm of E. coli has been achieved.  E. coli CLD048 
produces Fab D1.3 (first model protein chosen for this study) in the periplasm, and it 
has been shown that the amount of periplasmic production of the Fab is higher at 25 
and 30 degrees (information received from Shagayegh Arasteh). Fab D1.3 is anti-
lysozyme antibody fragment; therefore, lysozyme can not be used in the cold osmotic 
shock to digest the peptidoglycan layer of the bacterial cell wall; therefore, partial 
recovery of the Fab is expected. At the very beginning of this study (Chapter 2), 
experiments were conducted to compare osmotic shock and mechanical cell 
disruption methods for the recovery of this ‘difficult-to-release’ antibody fragment 
(Fab) from the recombinant E. coli, and to show how product titre, location and form 
varied during fed-batch cultivation. Chapter 3 of this thesis describes purification of 
D1.3 Fab using affinity and ion exchange chromatography (IEC) techniques; the 
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purified Fab was used in further structural studies (Chapter 4). In Chapter 4, the 
effects of various concentrations of a large number of cell permeabilisation reagents 
on the secondary structure of three different pure ‘periplasmic’ target proteins (i.e. 
beta-lactamase, alpha amylase and Fab D1.3) were studied by a newly developed 
high throughput circular dichroism (ht-CD) system. The model proteins used in the 
study contain differing amounts of α-helix and β-sheet to aid the resolution of the data 
interpretation later, as β-sheets give rise to considerably less intense signals than 
helices, and show more variations in spectral characteristics (Miles and Wallace, 
2006). The impact of cell permeabilisation chemicals on the biological activity of the 
model proteins was studied and correlations between the CD results and activity 
were drawn. Reagents classified as ‘safe’ in the chapter 4 study were subsequently 
evaluated in ‘periplasmic release’ tests (Chapter 5) conducted with E. coli cells 
harbouring the same target species.  
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2   Fed-batch cultivation of E. coli CLD048 and production of anti-
lysozyme Fab D1.3 
 
 
Abstract 
 
The bacterium E. coli CLD048 produces Fab D1.3 which is an anti-hen egg white 
Lysozyme (HEWL) antibody fragment. Fed-batch cultivation for production of Fab 
D1.3 was carried out at 37°C, and the bacterial cells were induced by adding 0.1 mM 
IPTG to the culture medium. The vessel was sampled over the course of 
fermentation and the bacterial cells were disrupted by osmotic shock (with excluding 
HEWL) and sonication. Amount of soluble Fab D1.3 in different locations (i.e. the 
culture broth, the periplasm, and the cytoplasm) was quantified during fed-batch 
cultivation. It was revealed that Fab D1.3 could be directed to different sites (i.e 
within and outside the cells) soon after induction. It was divulged that the Fab was 
saliently located in the cytoplasm and the periplasm 2 h after induction. After 2 h post 
induction, the Fab increasingly leaked into the culture medium, and reached its 
maximum culture medium titre of ~78 mg/L after 6 h post induction. After 16 h 
cultivation (6 h post induction) the amount of Fab remained constant in different 
locations within and outside the cells, and the culture medium was the place where 
the majority of the soluble Fab was located in. Western blot analysis of different cell 
fractions showed that a considerable amount of the Fab was produced in the cells as 
insoluble form.  
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2.1 Introduction 
 
Antibodies and their fragments have been found to be of huge academic, clinical, and 
commercial value. Several new antibodies and antibody fragments (such as Fab, 
scFv, VHs, diabodies, triabodies) have been designed using recombinant DNA 
technology (Humphreys, 2007). Antibody fragments, lacking the glycosylated Fc 
constant regions, have the advantage over whole antibodies in applications requiring 
rapid tissue penetration and rapid clearance from the blood or kidney (Yokota et al., 
1992).  These features make antibody fragments useful in diagnostic applications, 
tumour therapy and tumour imaging (Holliger and Hudson, 2005; Wu and Senter, 
2005). Development of bifunctional antibodies, through fusing the gene of antibody 
fragment to the gene of an effector protein (e.g. cytokine), have been a new 
approach for eliminating tumour cells without harming healthy cells (Boleti et al., 
1995, Neuberger et al., 1984; Ortiz-Sánchez et al., 2008). Usually, a systematic high 
dose administration of cytokines (e.g. interleukin-2, granulocyte macrophage colony 
stimulating factor (GM-CSF), tumour necrosis factor (TNF)-α, and interleukin-12) is 
required to obtain a concentration in the tumour microenvironment that is capable of 
activating an immune response, and this frequently cause devastating toxic side 
effects in the cardiovascular and respiratory systems (Dela Cruz et al., 2004; Ortiz-
Sánchez et al., 2008). The use of bifunctional antibody-cytokine fusion proteins 
recognizing a tumour associated antigen reduces prolonged systematic cytokine 
exposure, resulting in less side effects of the drug towards healthy tissue. 
 
The Fab fragment of an antibody contains the antigen-binding site and the four 
domains (i.e. VH, CH1, VL and CL). The heavy and light chains are covalently attached 
by a disulphide bridge, and VH and VL domains are fused to the following constant 
antibody domains CH and CL, respectively (Humphreys, 2007). The smaller size of 
Fab is more suitable for applications such as tumour penetration and imaging, and 
Fab exhibits a shorter half-life than full-length immunoglobulin G molecules 
(Andersen and Reilly, 2004). The short circulating half-life of Fab fragment can be 
occasionally a drawback for therapeutic applications, and this constraint can be 
overcome by approaches such as attaching polyethylene glycol (PEG) (Chapman et 
al., 1999; Chapman, 2002; Leong et al., 2001) and albumin-binding peptide (Dennis 
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et al., 2002), which have been proved to increase the circulating half-life. In contrast 
to some of the heavily engineered antibody fragments, the Fab has native sequence; 
subsequently, it is less likely for the Fab to be immunogenic when used as therapy. 
The thermal (> 60°C) and chemical (> 2 M guanidine hydrochloride) stability of Fab 
make it resistant to strident bioprocessing and modification processes (Humphreys, 
2007).  
 
As an expression system, the bacterium Escherichia coli has been the host of choice 
for the manufacture of many antibody fragments because its physiology and genetics 
has been known and it is therefore easily accessible for genetic modifications, and it 
requires simple inexpensive media for rapid growth. Over expression of recombinant 
proteins in the cytoplasm of E. coli may lead to the formation of inclusion bodies (IBs) 
within the cell which can contain the target protein in an misfolded form (Carrió and 
Villaverde, 2002; Heebøll-Nielsen et al., 2003; Ventura and Villaverde, 2006). 
Manufacturing a protein by an IB route is very costly, due the large number of 
operation units needed for product recovery (Singh and Panda, 2005). Production 
hosts have been genetically manipulated to gain more oxidizing environment in the 
cytoplasm needed for disulphide bond formation and appropriate protein folding; 
nonetheless, it has been unproven whether high level (hundreds of milligrams per 
litre) of protein production can be achieved in such strains (Besette et al., 1999; 
Derman et al., 1993; Prinz et al., 1997). The periplasm, on the other hand, has been 
shown to be a much better site for the production of large quantities of soluble 
recombinant proteins, and promoters and secretion signals from a few outer 
membrane proteins have been used to direct recombinant proteins into the periplasm 
(Carter et al., 1992; Chen et al., 2004; Joly et al., 1998; Laird et al., 2005; Moir and 
Mao, 1990). The oxidizing environment of the periplasm in cooperation with the 
periplasmic disulphide oxidoreductases/isomerases (Berkmen et al., 2007) and 
periplasmic chaperones (Betton, 2007) assists the formation of correctly folded 
recombinant proteins. Also, the periplasm can be manipulated by being exposed to 
extracellular chemicals assisting protein folding (Barth et al., 2000; Sandee et al., 
2005; Wunderlich and Glockshuber, 1993). 
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A common feature of many E. coli secretion systems is that the product may appear 
in many various locations within and outside the cells. In this chapter, experiments 
were carried out to show how anti-lysozyme Fab D1.3 titre, location, and form varied 
over the course of fed-batch cultivation. Also experiments were done to compare the 
efficiency of osmotic shock and mechanical cell disruption methods for the recovery 
of the antibody fragment from E. coli.  
 
2.2 Materials and Methods 
 
2.2.1 Materials 
 
The tetracycline resistant E. coli CLD048 harbouring pAVE046 (Hodgson et al., 
2007), expressing the antibody fragment Fab D1.3 (secreting as heavy and light 
chains into the periplasm) was provided by Merck Sharp and Dohme Ltd. (Billingham, 
UK).  
 
Nutrient agar and phosphate buffered saline (PBS) were purchased from Oxoid 
(Basingstoke, Hampshire, UK). Yeast extract and trypton were obtained from Becton, 
Dickinson and company (BD) (Sparks, MD, USA). Sodium dodecyl sulphate (SDS) 
and Laemmli electrophoresis and running buffers were attained from Bio-Rad 
Laboratories (Hercules, CA, USA). Ammonium hydroxide; phosphoric acid; 
magnesium sulphate; calcium chloride dehydrate; manganese (II) sulphate 
fourhydrate; and HPLC grade methanol were purchased from Fisher Scientific 
(Loughborough, Leicestershire, UK). TMB microwell peroxidase substrate (2-C) and 
TMB membrane peroxidase substrate system (3-C) were obtained from KPL 
(Gaithersburg, MD, USA). Hybond-P PVDF membrane was obtained from Amersham 
Biosciences (Uppsala, Sweden). Bicinchoninic acid (BCA) protein assay kit and 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) were purchased from Thermo 
Scientific (Rockford, IL, USA). Tetramethylethylenediamine (TEMED) was supplied 
by Melford Laboratories (Suffolk, UK). SimplyBlue Safe Stain and SeeBlue Plus2 
Pre-Stained Standard were purchased from Invitrogen (Paisley, UK). Ammonium 
sulphate; glycerol; potassium phosphate monobasic and dibasic; citric acid; ferrous 
sulphate heptahydrate; zinc sulphate; sodium molibdate dehydrate; copper (II) 
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sulphate; boric acid; tetracycline; sodium chloride; sodium hydroxide; Tween 20; 
ethylenediaminetetraacetic acid (EDTA); sucrose; Trizma-base; sodium phosphate 
monobasic; sodium phosphate dibasic; sodium carbonate; sodium hydrogen 
carbonate; glycine for electrophoresis; chicken egg white lysozyme (HEWL); albumin 
from bovine serum (BSA); and anti-human IgG (Fab specific) - peroxidise antibody 
produced in goat, as well as all other chemicals used in this study were obtained 
from Sigma-Aldrich Co. (St. Louis, MO, USA).  
 
2.2.2 Methods 
 
2.2.2.1 Fed-batch fermentation 
  
Bacterial cells from the cell bank, stored at -80°C, were propagated overnight on 
Nutrient agar supplemented with 15 mg/L tetracycline. Starting cultures were 
prepared by inoculating 100 mL aliquots of Luria Bertani (LB) broth (comprising 1% 
NaCl, 0.5% yeast extract and 1% tryptone) containing 15 mg/L tetracycline with a 
fresh single colony of E. coli CLD048 and shaking at 37°C and 200 rpm for 13 h. A 
complex medium recommended by Merck Sharp and Dohme Ltd. (Table 1) was 
employed for the growth of E. coli in the fermentor. Fermentation was conducted 
using a 10 L Electrolab fermentor (Tewkesbury, UK) equipped with 6-bladed paddle-
type impellers and four baffles located around the edge of the vessel. The vessel 
containing 5 L medium (Table 2.1) was sterilised at 121°C for 0.5 h and allowed to 
cool; post sterilisation and the trace metal additions (Tables 2.1 and 2.2) were then 
added. The pH of the medium was adjusted to 7.0 using ammonium hydroxide. The 
fermentor was inoculated with 200 ml (~4% inoc./medium ratio) from a 13-hour shake 
flask inoculum, and operated in batch mode. The starting conditions were: 
temperature 37°C; agitator speed 250 rpm; air-flow rate 1.0 VVM; pH 7.0. Agitation 
rate was increased during the fermentation (up to maximum value of 1500rpm), in 
order to sustain the dissolved oxygen tension on a set point of 30%. The pH was 
maintained at 7.0 throughout the fermentation by the automatic addition of NH4OH. 
Once glycerol was depleted, being indicated by an increase in the dissolved oxygen 
measured in the fermentor (7.5 h cultivation), the glycerol/magnesium sulphate feed 
(Table 2.3) was initiated at a constant rate of 11.0 ± 2.0 (g glycerol/L/h). Fab D1.3  
 63
Table 2.1 Culture medium composition, the shaded part indicates the components 
which aseptically added after sterilisation and cooling of the medium to 37°C prior to 
inoculation of the fermentor. 
 
Component of medium Concentration required 
(NH4)2 SO4 14 g/L 
Glycerol 35 g/L 
Yeast extract 20 g/L 
KH2PO4 2 g/L 
K2HPO4 16.5 g/L 
Citric acid 7.5 g/L 
Conc. H3PO4 1.5 mL/L 
1 M MgSO4.7H2O solution 10 mL/L 
1 M CaCl2.2H2O solution 2 mL/L 
Antifoam AF204 0.2 mL/L 
15 mg/mLTetracycline 1 mL/L 
 
Table 2.2 Trace metal composition, 34 mL solution was sterilised through a 0.22 µm 
sterile filter into a suitable sterile container and added into 1 L medium in the 
fermentor. 
 
Component Concentration required 
FeSO4.7H2O 3.36 g/L 
ZnSO4.7H2O 0.84 g/L 
MnSO4.H2O 0.51 g/L 
Na2MoO4.2H2O 0.25 g/L 
CuSO4.5H2O 0.12 g/L 
H3BO3 0.36 g/L 
Conc. H3PO4 48 mL/L 
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Table 2.3 Glycerol and magnesium sulphate feed. 
 
Component of medium Concentration required 
Glycerol 714 g/L 
1 M Mg SO4.7H2O 30 mL/L 
   
 
expression was induced by the addition of IPTG to a final concentration of 0.1 mM 
after 10 h cultivation (OD600nm~50). The fermentor was sampled hourly; cell 
fractionation was made by sonication and osmotic shock, as described below, and 
various fractions were stored at -20 oC for further SDS-poly-acryl amide gel 
electrophoresis (SDS-PAGE), enzyme-linked immunosorbent assay (ELISA) and 
Western blot analyses.  
 
2.2.2.2 Biomass estimation and viability counts 
 
Optical density (OD600nm) measurements were performed at a wavelength of 600 nm 
in a KONTRON UNIKON 922 UV-VIS spectrophotometer (KONTRON Northstar 
Scientific, Bardsey, UK), using PBS for dilution of cultures (readout range of 0.2 to 
0.8 OD600nm units).  
 
Dry cell mass was measured as follows: 1 mL fermentation samples were centrifuged 
in pre-dried and pre-weighed 1.5 mL Eppendorf tubes using a Eppendorf 
microcentrifuge (Eppendorf Cenrifuge 5415D, Eppendorf, Hamburg, Germany) 
operated at 15,800 g for 5 minutes. The cell pellets were resuspended in 1 mL 
distilled water and then re-centrifuged. The supernatants were carefully discarded, 
the pellets were dried overnight in a hotbox oven (Gallenkamp, Riley Industries Ltd, 
Aldridge, UK) at 100°C, and the tubes were weighed once again. The biomass 
content in each tube was then calculated by difference. 
 
Serial dilutions of fermentation samples were prepared aseptically in PBS for viability 
counts. One hundred microlitres aliquots of serial dilutions were plated onto LB agar 
plates supplemented with 15 mg/L tetracycline, and following overnight incubation at 
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37°C, the number of colony forming units (CFU) was measured by counting colonies 
on plates containing less than 300 colonies according to following formula.  
 
CFU/mL = No. of colonies × dilution factor × 10 
 
2.2.2.3 Cell fractionation 
 
2.2.2.3.1 Osmotic shock 
 
Cell pellets obtained from 1 mL fermentation samples were resuspended in an 
osmotic shock solution (designated OS1) comprising 20 mM Tris-HCl buffer, pH 8.0, 
supplemented with 2.5 mM EDTA and 20% sucrose. After a static incubation on ice 
for 600 s, the cells were harvested by centrifugation (15,800 g, 120 s) and the 
supernatants were immediately frozen at -20°C. The resulting cell pellets 
(spheroplasts) were then resuspended in a second osmotic shock solution 
(designated OS2) lacking sucrose (i.e. 20 mM Tris-HCl buffer pH 8.0, containing 2.5 
mM EDTA) and incubated on ice for 600 s. Following centrifugation (15,800 g, 120 
s), the supernatants were then removed and stored at -20°C until required. The pellet 
was washed with a high salt buffer as described later. 
 
2.2.2.3.2 Sonication 
 
Cell pellets obtained from 5 mL fermentation samples were resuspended in 5 mL of 
100 mM Tris-hydrochloride buffer, pH 8.0. The resulting cell suspensions were then 
disrupted at 4°C by ultrasonication (ultrasonic liquid processor XL, Heat System 
Incorporated, Farmingdale, USA) at 55% amplitude for 300 s (15 cycles, each cycle 
lasted 10 s with intervals of 10 s between the cycles) to release intracellular protein. 
Successful cell disruption was confirmed with the aid of a phase contrast light 
microscopy. The bacterial cell debris was separated from the supernatants by 
centrifugation at 15,800 g for 300 s. The supernatant was frozen at -20°C for further 
analyses, and the pellet was used for high salt washing step as described bellow. 
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2.2.2.3.3 Washing the cell pellets obtained from osmotic shock and sonication 
cell disruptions with high salt buffer 
 
The cell debris obtained from osmotic shock and sonication cell disruptions were 
respectively resuspended in 5 mL and 1 mL of 20 mM sodium phosphate buffer 
supplemented with 0.5 M NaCl, pH 8.0. The suspensions were agitated for 1 h and 
centrifuged at 15800 g for 300 s. The samples were stored at -20°C for further 
analysis. 
 
2.2.2.3.4 Protein extraction from bacterial cell pellets 
 
Cell pellets were resuspended in 500 μL Tris/EDTA/SDS buffer (10 mM Tris-HCl, 1 
mM EDTA, 1% (w/v) SDS, pH 8.0) by mixing in a vibrax shaker (Clifton Cyclone, 
Scientific Laboratory Supplies, Notingham, UK) for 600 s followed by incubation at 
80°C for 0.5 h. The supernatant was recovered by centrifugation at 15,800 g for 600 
s, and total protein was measured using BCA assay employing BSA as standard. 
. 
2.2.2.4 Analytical techniques 
 
2.2.2.4.1 SDS-poly-acrylamide gel electrophoresis (SDS-PAGE) and Western 
blotting 
 
SDS-PAGE was performed on 15% gels at 150V/20mA for 2.5 using Laemmli 
electrophoresis and running buffers. Prior to electrophoresis, all samples were diluted 
1:1 with the sample buffer, boiled for 120 s, and then centrifuged briefly at high speed 
in a microcentrifuge, before loading into the wells of the gel. SeeBlue Plus2 Pre-
Stained Standard used for estimation of molecular weight of protein bands on the gel. 
Following electrophoresis, gels were rinsed three times with 100 mL distilled water 
and then stained, with sufficient SimplyBlue Safe Stain (~ 20 mL) to cover the gel, for 
1 h at room temperature with gentle shaking. The stain was discarded and the gel 
was subsequently washed twice with 100 mL distilled water for 1 h with gentle 
shaking.  
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For Western blotting, the stacking gel was removed and the resolving gel was 
soaked in the protein transfer buffer (3.03 g/L Trizma-base, 14.4 g/L glycine and 200 
ml/L methanol) for 0.3 h. Hybond-P PVDF membrane and the filter paper were cut to 
the dimension of the gel, soaked in 100% (v/v) methanol for 10 s, washed in distilled 
water for 300 s, and equilibrated in the protein transfer buffer for 0.3 h. The 
electroblotting cassette was assembled and placed between the electrodes in the 
blotting unit according to the manufacturer’s instructions (Mini Trans-Blot 
electrophoretic Transfer Cell, Bio-Rad, CA, USA). The band-transfer was carried out 
initially for 1 h at 100 V, with cold transfer buffer at 4°C, and was then perpetuated at 
4°C, at 30 V, overnight. Following transfer, the membrane was removed from the 
blotting cassette, the orientation of the gel on the membrane was marked, and the 
membrane was rinsed briefly in phosphate buffered saline (PBS; 11.5 g/L di-sodium 
hydrogen orthophosphate, 2.96 g/L sodium dihydrogen orthophosphate, and 5.84 g/L 
sodium chloride; pH 7.5). For immunodetection, non-specific binding sites on the 
membrane were blocked using 3% (w/v) BSA made in PBS, for 1 h, and then briefly 
rinsed twice with PBS containing 0.1% (v/v) Tween 20. The blot was washed with an 
excess volume of PBS/0.15 (v/v) Tween 20 for 300 s and incubated with anti-human 
IgG (Fab specific) - peroxidise antibody (which was diluted down in PBS 10-fold) for 
1 h. The blot was washed three times with PBS/Tween 20, and the enzyme substrate 
(TMB membrane peroxidise substrate system (3-C)) solution was added to the blot 
and incubated at room temperature until the desired band intensity was achieved. 
 
2.2.2.4.2 Sandwich ELISA method for Fab D1.3 
 
For this purpose, each well of a 96-well microtiter plate was coated overnight at 4°C 
with 100 μL of 0.1% HEWL, made in coating buffer (1.59 g/L Na2CO3 and 2.93 g/L 
NaHCO3). Blocking was made with 200 μL PBS-BSA (1 PBS tablet/1 g BSA in 
100mL distilled water) per well, with shaking (500 rpm) in a microplate incubator 
shaker (Infors AG type AK120, Infors HT, Bottmingen Switzerland) for 1 h, at 37°C. 
The wells were then washed three times with 300 μL wash buffer (1 PBS tablet and 
100 μl Tween 20 in 100 mL distilled water) per well and tap dried. Both standards 
and samples (100 μL), having been diluted in PBS on a separate plate, were 
transferred to the washed ELISA plate, incubated at 37°C, 500 rpm for 1 h, washed 
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again with the wash buffer three times and tap dried. The plate was then loaded with 
100 μL anti-human IgG (Fab specific) - peroxidase antibody produced in goat, which 
was diluted 10000-fold in the block buffer, incubated at 37°C, 500 rpm for 1 h, and 
then washed three times with the wash buffer and tap dried, before 100 μL of 
peroxidase substrate was added to each well. The reaction was stopped after 600 s 
by adding 100 μL of 1 M H3PO4 to each well, and the plate was read at the 
wavelength of 450 nm using a microplate reader (Promega Glomax-Multi detection 
system, Turner BioSystems Inc., Sunnyvale, CA, USA). 
 
2.3 Results and Disscusion 
 
During fed-batch fermentation, various parameters including OD600nm, CFU, DCW, 
were measured, and these are presented in Fig. 2.1. It is evident from this figure that 
optical density reached the plateau after 13 h cultivation (3 h post induction with 0.1 
mM IPTG), and started to reduce after 16 h cultivation (6 h post induction); however, 
there was a drop in CFU/mL after 2 h induction. Ideally, when cells are healthy, it is 
expected that both turbidity and CFU/mL follow each other. In this work, there was 
approximately 10-fold drop in CFU/mL for little increase in OD600nm between 2 and 5 h 
induction. The existence of ‘viable but nonculturable’ bacterial cells can be the 
reason for the CFU/mL drop after 2 h induction with 0.1 mM IPTG. The term ‘viable 
but nonculturable’ has been used for those bacterial cells which have detectable 
metabolic function, but do not undergo cell division on routinely employed 
bacteriological media (Roszak and Colwell, 1987). Sundstorm et al. (2004) studied a 
process for the production of the recombinant fusion protein, promegapoietin (PMP), 
in E. coli and reported that after induction the number of CFU/mL dropped to ~10% of 
its maximum while the biomass concentration continued to increase. By doing flow 
cytometric analysis and measuring intracellular concentration of PMP, they 
demonstrated that the cells were alive and contributed to the production, and the 
drop in the number of CFU/mL indicated a loss of cell division ability rather than cell 
death. Also, in the shake flask studies done at 37°C on E. coli CLD048, it was 
reported that after 1 h induction with 0.1 mM IPTG (at OD600nm = 10) there was a 10-
fold drop in CFU/mL for a little increase in OD600nm, and by flow cytometric analysis it 
was shown that this drop was due to the cells having broken cytoplasmic membrane 
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potential and as a result unable to recover and propagate on nutrient agar culture 
medium (Want, 2010). DCW figure was constantly increased during 16 h fed-batch 
cultivation, and afterwards there was an insignificant rise in this figure to the end of 
fermentation.   
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Fig. 2.1 Fed-batch fermentative production (initial volume 5 L) of Fab D1.3 (anti-
lysozyme) in recombinant E. coli at 37°C. Induction with 0.1 mM IPTG was performed 
after 10 h of cultivation (OD ~50). Results for CFU and OD are averages of two 
measurements; results for DCW are averages of three measurements. 
 
 
Two fractionation methods, including osmotic shock and sonication, were utilised to 
disrupt the bacterial cells present in the samples taken through the course of fed-
batch fermentation. Subsequent cell disruptions, the titre of soluble Fab D1.3 in each 
fraction was quantified using ELISA. Figure 2.2 shows the titre of Fab in the culture 
broth medium and in the osmotic shock solution 1 and 2 (OS1 and OS2) at the point 
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Fig. 2.2 ELISA of soluble and insoluble samples arising from osmotic shock 
fractionation. Induction was done by 0.1 mM IPTG after 10 h cultivation (OD~50).  
Amount of Fab quantified in osmotic solution 1 (  ), osmotic solution 2(  ), and culture 
broth(  ). 
 
 
of induction and later. The existence of Fab D1.3 in OS1 corroborates the periplasmic 
production of the protein, while the Fab titration in OS2 shows the amount remained 
in the cytoplasm of the bacterial cells. As illustrated in the figure, a low amount 
(approximately 4 mg/L) of the Fab was observed in the periplasm and in the culture 
broth just before induction with 0.1 mM IPTG (i.e.10 h cultivation), indicating that the 
promoter was induced to an insignificant extent in the absence of the real inducer, 
i.e. IPTG. The amount of Fab D1.3 in the periplasm increased after induction and 
reached a maximum titre of 47 mg/L after 4 h post induction. The Fab secretion 
and/or leakage into the culture broth was sharply augmented after 2 h post induction, 
reached a maximum of about 79 mg/L after 6 to 8 h post induction, and stopped 
afterwards. Besides after 6-8 h post induction, the Fab titration in either periplasm or 
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cytoplasm remained almost constant, indicating that soon after the bacterial cells 
become unhealthy, based on OD600nm measurements shown in figure 2.1, both 
cellular production and discharge of the recombinant protein are stopped in the cells. 
Based on these preliminary experiments, it is noticeable that if in a downstream 
processing the objective is to purify the secreted protein from the culture broth 
medium, there appears no benefit in perpetuating the fed-bath cultivation for a longer 
time (more than 16 h), like the one conducted for 35-45 post induction by Merck 
Sharp and Dohme Ltd. (Hodgson et al, 2007), as according to these results there is 
no further recombinant protein release into the culture broth and no product 
production in the cell after 6-8 h post induction.  
 
The pellet samples left after osmotic shock cell disruption were washed with a high 
salt buffer (sodium phosphate buffer containing 0.5 M NaCl, pH 8.0), to dissociate 
any electrostatically-bond Fab from the pellet, and centrifuged.  
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Fig. 2.3 ELISA analysis of soluble fractions obtained from washing post-osmotic 
shock bacterial cell debris with PBS supplemented with 0.5 M NaCl, pH 8.0.  
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ELISA analysis of the resulted soluble fractions showed that about 1.2 mg/L Fab 
D1.3 released by this washing procedure (Fig. 2.3). 
 
 Western blot analysis of these high salt-washed pellet samples, and of supernatants 
derived from OS1 and OS2 treatments have been shown in Fig. 2.4. As illustrated in 
this figure, it is evident that a fraction of Fab D1.3, as insoluble form, was in 
connection with the bacterial cell pellet shortly after induction (2 h post induction) with 
0.1 mM IPTG. The Western blotting figures respective to the soluble samples (i.e. 
CB, OS1 and OS2) were generally in agreement with the ELISA ones (i.e., Fig 2.2), 
and demonstrated that there was an increasing amount of the Fab production and 
release into the periplasm and culture broth, respectively.  
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Fig. 2.4 Western blot analyses of soluble and insoluble samples arising from osmotic 
shock fractionation. Prior to Western blotting, the samples were subjected to non-
reducing SDS-PAGE. Induction was made with 0.1 mM IPTG after 10 h cultivation 
(OD~50). Insoluble samples derived from osmotic shock were washed in a high salt 
buffer (sodium phosphate buffer containing 0.5 M NaCl, pH 8.0), centrifuged, and the 
obtained pellet samples were analysed. 
 
 
Cell disruption by sonication was also performed on the samples taken from the 
fermentor throughout fed-batch fermentation. This mechanical cell disruption 
experiment was conducted in order to measure the amount of the Fab released by 
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this technique, and to compare the efficiency of two different cell disruption methods 
for the Fab release from bacterial cells. ELISA results for soluble samples obtained 
from sonication disruption have been illustrated in Figs. 2.5. By comparing ELISA 
results of osmotic shock and sonication disruptions, it is evident that the amount of 
Fab recovered from the bacterial cells by sonication was approximately 20 to 45% 
less than Fab recovered by osmotic shock (i.e. OS1 plus OS2) treatment (see Fig 
2.2). This evinced that sonication had, most likely, deleterious impact on the Fab, 
afflicted its ability to attach to HEWL being coated onto ELISA plate. Therefore, 
lacking deleterious effects of sonication, osmotic shock seems to be a more effectual 
method for Fab recovery from the bacterial cells.  
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Fig. 2.5. ELISA of soluble samples arisen from sonication cell disruption. Induction 
with IPTG was after 10 h cultivation (OD~50). 
 
 
Sonication cell disruption samples were also analysed by Western blotting (Fig 2.6). 
Pellets, obtained from centrifugation of samples after sonication, were washed with a 
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high salt buffer (sodium phosphate buffer containing 0.5 M NaCl, pH 8.0), to detach 
any electrostatically-attached Fab, centrifuged, and the resulting insoluble fraction 
were analysed by Western blotting. Western blot analysis of these samples showed 
that a considerable amount of the Fab was existed as insoluble form after sonication 
and high salt washing procedure.  
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Fig. 2.6 Western blot analyses of soluble and insoluble samples arising from 
sonication cell disruption. Prior to Western blotting, the samples were subjected to 
non-reducing SDS-PAGE. Induction with 0.1 mM IPTG was after 10 h cultivation 
(OD~50). Insoluble samples derived from sonication treatment were washed in a high 
salt buffer (sodium phosphate buffer containing 0.5 M NaCl, pH 8.0), centrifuged, and 
the obtained pellet samples were then analysed. 
 
 
There was no increase in quantity of the Fab in different fractions (i.e. culture broth, 
OS1, OS2, and supernatant of sonication) between 18 and 22 h cultivation; therefore, 
the samples taken after 22 h cultivation were not subjected to cell disruption 
procedures. Instead, only the bacterial cells in the sample taken from the fermentor 
after 58 h (i.e. the end of fed-batch fermentation) cultivation were treated by osmotic 
shock and sonication. ELISA results for this fractionation have been illustrated in Fig. 
2.7, denoting that the amounts of Fab D1.3 in different fractions after 21 h and 58 h 
cultivation were the same. Also in this experiment, samples subjected to osmotic 
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shock treatment (i.e. OS2 pellets) were disrupted by sonication. it was demonstrated 
that no or very inconsiderable soluble Fab remained in the bacterial cells after 
osmotic shock treatment, since sonication following OS2  treatment did not release 
the Fab from the cell debris, of course with ignoring the portion of the recombinant 
protein possibly razed by sonication. This indicates that all soluble Fab fractions can 
be very effectively released from the cells by osmotic shock. 
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Fig. 2.7 ELISA analyses of soluble samples from osmotic shock and sonication 
treatments originating from 21 h and 58 h cultures. CB: culture broth, OS1: osmotic 
shock solution 1, OS2: osmotic solution 2, SOS2: sonication after OS2 and S: 
sonication. 
 
Measuring total protein extracted from cell pellets arisen from osmotic shock and 
sonication treatments (sample 21 h) showed that with increasing the number of cell 
disruption routes less protein remained in connection with the cells, (Fig. 2.8); for 
instance, less protein remained in the cells when sonication followed OS2 treatment. 
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Fig. 2.8 BCA analyses of insoluble samples from osmotic shock and sonication 
treatments originating from a 21 h culture sample. Protein was extracted from the 
pellets by solubilisation with an EDTA/SDS/Tris-HCl cocktail at 80°C for 0.5 h as 
described in materials and methods. P1: pellet of intact cells, P2: pellet of sonication, 
P3: pellet of OS2, P4: pellet of sonication after OS2. 
 
2.4 Conclusions 
 
Production of anti-lysozyme Fab D1.3 during fed-batch cultivation of E. coli CLD048 
at 37°C has been investigated. After induction with 0.1 mM IPTG, Fab D1.3 appears 
in different locations inside and outside the bacterial cells. Fab D1.3 in the periplasm 
reaches its maximum amount after 14 h cultivation (4 h induction with 0.1 mM IPTG). 
After 16 h cultivation, the majority of the Fab is appeared in the culture broth, and 
Fab titration remains constant in the cytoplasm, the periplasm, and the culture 
medium. D1.3 Fab is also produced in insoluble form and in attachment to the cell 
pellet as confirmed by cell fractionation with osmotic shock and sonication.  
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As the majority of the Fab is directed to the culture medium, this broth can be used 
for further Fab D1.3 purification work described in next chapter.  
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3   Chromatographic purification of Fab D1.3  
 
 
 
Abstract 
 
Affinity and ion exchange chromatography techniques were used in order to purify 
Fab D1.3 from culture broth and/or osmotic shock fluid samples. In the first 
purification experiment, direct purification of Fab D1.3 on HiTrap Protein G column 
from a culture broth sample, having high conductivity of ~40 mS/cm, was not 
promising. HEWL was coupled with CNBr-Sepharose 4 Fast Flow matrix and 
employed for capture of the Fab from culture broth and osmotic shock fluid samples. 
By doing this chromatography, 21 to 27% of the existing Fab in the samples was 
captured on the Lysozyme column, and 48 to 55% Fab purity was yielded. Further 
purification from the Lysozyme column’s eluates on HiTrap Protein G yielded 97% 
Fab D1.3 purity. The overall yield of the target Fab in the sequential Lysozyme 
affinity – Protein G affinity chromatography route was 18-33%. Cation Exchange 
chromatography, using HiTrap SP Sepharose XL, was also employed for capturing 
the Fab from a culture broth sample (pH 5.0, conductivity 5.0).  Capture of the Fab 
from the culture broth sample was very efficient (>97%) by CEX chromatography, 
and 14% Fab purity was achieved in the eluates of the CEX column. Additional Fab 
purification from desalted eluates originated from the CEX column yielded >97% Fab 
D1.3 purity. The overall yield of the target Fab in the sequential CEX – Protein G 
affinity chromatography route was 83%, which was much higher than the figure (18-
33%) achieved from the sequential Lysozyme affinity – Protein G affinity 
chromatography. 
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3.1 Introduction 
 
Proteins are purified using purification techniques that separate according to 
differences in specific properties such as ligand biospecificity, charge, size and 
hydrophobicity. Affinity chromatography (AC) separates proteins on the basis of a 
reversible interaction between protein(s) and a particular ligand coupled to a 
chromatography matrix. Being highly selective and the only technique that enables 
the purification of a protein on the basis of its biological function or individual 
chemical structure, AC is ideal for a capture with purification levels in the order of 
several thousand-fold whenever an appropriate ligand is accessible for the protein of 
interest. The technique can be utilised to separate active proteins from the denatured 
or functionally different forms (Cuatrecasas and Anfinsen, 1971; Hage, 1991; 
www.chromatography.amershambiosciences.com). Electrostatic or hydrophobic 
interactions, van der Waals’ forces and/or hydrogen binding can attach ligand and 
target protein. The interaction can be reversed to elute the target protein from the 
affinity medium by using a competitive ligand, or non-specifically, by altering the pH, 
ionic strength or polarity. Successful affinity purification requires a specific ligand that 
can be covalently attached to a chromatography matrix. The coupled ligand must 
retain its specific binding affinity for the target molecules and, after washing away 
unbound material, the binding between the ligand and target molecule must be 
reversible to allow the target molecules to be eluted in an active form. AC can be also 
used for removing specific contaminant, such as serine proteases, thrombin and 
Factor Xa. In typical affinity purification, affinity medium is equilibrated in binding 
buffer; sample is applied under conditions suitable for specific but reversible binding 
of target protein to a ligand; unbound materials are washed away, and by altering 
conditions favouring elution of the bound molecules, target protein is recovered in a 
purified concentrated form. 
 
There are few bacterial receptors as ligands for antibodies and/or antibody 
fragments. These ligands have been employed in packed bed chromatography for 
purification of Immunoglobulins. Protein A, a 42 kDa cell surface protein of 
Staphylococcus aureus, is a ligand extensively used for Immunoglobulin purification. 
The primary binding site of Protein A on IgG is situated at the junction between the 
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CH2 and CH3 domains on the Fc fragment (Bak, 2004; Lindmark et al., 1981). Protein 
G, a ~60 kDa cell surface protein from group C and G Streptococci, can bind to IgG 
with high affinity. The Fc part of IgG molecule is mainly responsible for the interaction 
with Protein G, however, CH1 domain of Fab also interact with Protein G (Björck and 
Kronvall, 1984; Derrick and Wigley, 1994). The native Protein G molecule also binds 
albumin; however, because serum albumin is a major contaminant of antibody 
sources, recombinant Protein G (rProtein G) lacking albumin domain has been 
developed and used for chromatographic purification of immunoglobulins.  Protein L, 
a 76-106 kDa surface protein from Peptostreptococcus magnu, was also found to 
bind immunoglobulin through kappa light chain interaction, from which the name was 
suggested (Björck, 1988). Since no part of the heavy chain is involved in the binding 
interaction, Protein L binds a wider range of antibody classes, including IgG, IgM, 
IgA, IgE and IgD, and antibody fragments such as ScFv and Fab. However, Protein L 
binding restricted to those antibodies containing kappa chains. In humans and mice, 
most antibody molecules contain kappa light chains and the remainder have lambda 
light chains. 
 
Ion exchange chromatography (IEC), which is based on the reversible interaction 
between charged solute molecules and oppositely charged moieties covalently linked 
to a chromatography matrix, is probably the most frequently used chromatographic 
technique for the separation and purification of proteins and other charged 
biomolecules (www.chromatography.amershambiosciences.com; Staby et al., 2000). 
It is feasible to have both positively and negatively charged exchangers. Positively 
charged exchangers have negatively charged counter-ions (anions) and are called 
anion exchangers (AEXs). Negatively charged exchangers have positively charged 
counter-ions (cations) and are termed cation exchangers (CEXs). The high capacity, 
the high resolving, the extensive applicability, the simplicity and controllability of the 
IEC are the reasons for the success for the method. Separation is obtained since 
different substances have different degrees of interaction with the ion exchanger due 
to differences in their charges, charge densities and distribution of charge on their 
surfaces. These interactions can be controlled by altering conditions such as ionic 
strength and pH. The differences in charge properties of biological compounds are 
often substantial, and as IEC is able to separate species with very minor differences 
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in properties, e.g. two proteins differing by only one charged amino acid, it is very 
powerful separation technique. 
 
IEC can be used at all stages of a purification process (see Fig 3.1), i.e. during 
capture, intermediate purification, and polishing.  
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Fig. 3.1 Chromatography at various stages in downstream processing (Redrawn 
from Theodossiou, 2004). 
 
 
In IEC, depending on the aim, one can select whether to bind the substances of 
interest and allow the contaminants to pass through the column, or to bind the 
contaminants and allow the substance of interest to pass through. The earlier method 
is generally more fruitful in the beginning of the purification process because it leads 
to a greater degree of fractionation and concentrates the substances of interest. 
 
Ion exchange experiments are conducted in four main steps (Theodossiou, 2004). 
The first step is equilibration in which the ion exchanger is brought to a starting state, 
in terms of pH and ionic strength, which permits the binding of the desired solute 
molecules. The second step is sample application and association of the exchanger 
groups via exchangeable counter-ions, in which solute molecules bind reversibly to 
the matrix. The third step is removal of substances from the column by applying 
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elution conditions, which normally is increasing the ionic strength of the eluting buffer 
or changing its pH. By the introduction of an increasing salt concentration gradient, 
solute molecules are released from the column in the order of their strengths of 
binding, the most weakly bound substances being eluted first. The fourth step is the 
removal of substances not eluted from the column under the previous experimental 
conditions and re-equilibration at the starting conditions for another cycle of 
purification. 
 
Ion-exchangers are applied in monoclonal antibody production. For example one-
step purification of IgG and albumin from serum using coupled DEAE (TSK gel 
DEAE-5PW) and Protein G columns have been reported (Qi et al., 2001). IEC is also 
employed as polishing steps downstream of initial capture (e.g. on Protein A) due to 
their efficiency in the removal of contaminants such as DNA, viruses and endotoxin 
(Bak, 2004). 
 
The aim of the work in this chapter was to highly purify Fab D1.3, which was needed 
for its structural studies in the presence of chemicals using high throughput circular 
dichroism (ht-CD) described in Chapter 4, from culture broth and/or osmotic shock 
fluid samples taken from fed-batch fermentation. In this work, purification of Fab D1.3 
using various affinity and IEC chromatography supports, i.e. Hitrap Protein G, 
Lysozyme-activated CNBr-sepharose matrix/Hitrap Protein G, and Hitrap SP 
Sepharose XL/Hitrap Protein G, was investigated. 
 
3.2 Materials and Methods 
 
3.2.1 Materials 
 
Chicken egg white Lysozyme (HEWL), sodium phosphate monobasic, sodium 
phosphate dibasic, Tris (hydroxymethyl)aminoethane hydrochloride, sodium 
bicarbonate, sodium chloride, sodium acetate, glycine, MES (2-(N-
Morpholino)ethanesulfonic acid), MES sodium salt, diethylamine and dialysis tubing 
cellulose membrane were purchased from sigma (St. Louis, MO,USA). CNBr-
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Sepharose 4FF matrix, HiTrap Protein G columns (1 mL), HiTrap SP XL columns (5 
mL) and PD10 columns were purchased from GE Healthcare (Uppsala, Sweden).  
 
3.2.2 Methods 
 
3.2.2.1 Fab D1.3 purification  
 
Purification from osmotic shock fluid and culture broth sample obtained from fed-
batch fermentation, described in chapter 2, was carried out as below. 
 
3.2.2.1.1 Fab D1.3 purification on HiTrap Protein G column 
 
For this purpose, 1-mL HiTrap Protein G was equilibrated with 20 mM sodium 
phosphate buffer, pH 7.0. A 21 h culture broth sample (120 mL) from fed-batch 
cultivation (11 h post induction) was centrifuged at 9390 g for 600 s (Sigma 3K30, 
SciQuip, Shropshire, UK) and clarified by filtration through 0.45 μm syringe filters 
(Millipore, MA, USA). The sample (pH 7.0) was put through the HiTrap Protein G 
column using an AKTA explore system (GE Healthcare, Life Sciences, 
Buckinghamshire, UK) at a flow velocity of 1 mL/minute. After loading, the column 
was extensively washed with 20 mM sodium phosphate buffer, pH 7.0, and elution 
was made with 0.1 M glycine-HCl, pH 2.7 at the same flow rate. The eluate was 
instantaneously neutralized with 1 M Tris-HCl, pH 9.0, and stored at 4°C. The amount 
of Fab D1.3 in various fractions was measured using ELISA.  
 
3.2.2.1.2 Fab D1.3 purification on HEWL-activated CNBr-Sepharose 4 Fast Flow 
matrix/ HiTrap Protein G column 
 
CNBr-Sepharose activation with HEWL 
 
Coupling HEWL to CNBr activated Sepharose was performed according to the 
manufacturer instruction. Briefly, 1 g CNBr-Sepharose 4FF matrix was washed with 
15 medium volumes of cold (4°C) 1 mM HCl. Small wash portions (1 medium 
volume, 5 mL) was used and the mixture left 120 s for equilibration during each 
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washing step. The washed medium was then added to 5 mL solution containing 0.1 
M NaHCO3 (pH 8.3), 0.5 M NaCl and 10 mg HEWL for overnight shaking at 4°C. The 
reaction was followed by measuring UV-absorbance (at the wavelength 280 nm). In 
the next step, CNBr-Sepharose was washed with 5 medium volumes (5 × 5 mL) of 
coupling buffer to wash away HEWL. HEWL-coupled CNBr Sepharose was 
contacted with 0.1 M Tris-HCl, pH 8.0, for 2 h to block non-reacted groups on the 
medium. The coupled medium was eventually washed for 4 cycles using alternate 
low and high pH (0.1 M acetate buffer, pH 3-4, containing 0.5 M NaCl and 0.1 M Tris-
HCl, pH 8.3, containing 0.5 M NaCl), in which 15 mL of each buffer applied and each 
buffer wash took 120 s. 
 
The coupled medium stored in 0.1 M Tris-HCl (pH 8.3) containing 0.5 M NaCl at 4°C 
until required for further column packing. The medium in the column (Tricorn 10/50, 
10 mm i.d.) was stored in 20% ethanol.  
 
Purification 
 
After developing HEWL-activated CNBr-Sepharose 4 Fast Flow matrix, the 
purification work was conducted. Purification from periplasmic fraction, i.e. osmotic 
shock fluid 1 described in chapter 2 (after 4 h post induction with 0.1 mM IPTG), and 
culture broth sample (after 11 h post induction) was performed on HEWL-activated 
CNBr-Sepharose 4FF column (5 mL).  For this purpose, 480 mL culture broth and 
250 mL OS1 fluid were filtered through 0.45 μm cellulose acetate Millipore filters and 
loaded on the column at a flow velocity of 3.8 mL/minute in separate experiments. 
Two regimes of column washing, at the same flow rate (i.e. 3.8 mL/minute), were 
employed after loading; one was washing with 20 mM phosphate buffer, pH 7.0, and 
another one was washing with 20 mM phosphate buffer, pH 7.0, followed by 50 mM 
Tris-HCl buffer supplemented with 500 mM NaCl, pH 8.5. Elution was made with 50 
mM diethylamine, pH 11.5. Eluted fractions containing Fab D1.3 from 
chromatography on the Lysozyme-Sepharose 4FF were pooled and desalted on 
PD10 columns prior to manual loading onto 1 mL HiTrap Protein G column pre-
equilibrated with 20 mM sodium phosphate, pH 7.0. After extensive washing with the 
equilibration buffer, bound material was eluted with 0.1 M glycine-HCl, pH 2.7. The 
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eluate was neutralized immediately with 1 M Tris-HCl, pH 9.0, and stored at 4°C. 
Various fractions were analysed using SDS-PAGE, Western blotting and ELISA.  
 
3.2.2.1.3 Fab D1.3 purification on HiTrap SP Sepharose XL/ HiTrap Protein G 
column 
 
Purification from culture broth sample (after 11 hours post induction with 0.1 mM 
IPTG) was performed on a 5-mL HiTrap SP Sepharose XL column. Prior to 
application of cell-free culture fluid onto the column, the feedstock was extensively 
dialysed overnight against 15 mM sodium acetate, pH 5.0, at 4°C with changing the 
buffer in order to reduce both the conductivity (from ca. 40 to 5.0 mS/cm) and pH 
(from 7.0 to 5.0) for optimal sorption of the Fab on the cation exchange (CEX) matrix, 
The Dialysed culture broth sample was re-centrifuged (9390 g for 10 minutes) and 
filtered through 0.45 μm cellulose acetate Millipore filters. The sample (480 mL) was 
then loaded at a flow rate of 3.4 mL/minute on the HiTrap SP XL column pre-
equilibrated with 15 mM sodium acetate buffer, pH 5.0. At the same flow velocity, the 
column was then washed with the equilibration buffer, and elution made with 20 mM 
MES (2-morpholinoethanesulfonic acid, 4.5 mM sodium MES, 1.5 M NaCl, pH 5.5). 
Eluted fractions containing Fab D1.3 from chromatography on HiTrap SP XL column 
were pooled and desalted on PD10 columns prior to manual loading onto a 1-mL 
HiTrap Protein G column pre-equilibrated with 20 mM sodium phosphate, pH 7.0. 
After extensive washing with the equilibration buffer, bound material was eluted with 
0.1 M glycine-HCl, pH 2.7. The eluates were neutralized immediately with 1 M Tris-
HCl, pH 9.0, and stored at -20 oC. Various fractions were analysed using SDS-PAGE, 
Western blotting and ELISA. 
 
3.2.2.2 Analytical methods 
 
SDS-poly-acryl amide gel electrophoresis (SDS-PAGE), Western blotting and ELISA 
were done as described in charter 2 (section 2.2.2.4). Mass spectrometry was 
performed by the Functional Genomics Laboratory at the University of Birmingham. 
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3.3. Results and Discussion 
 
Various chromatography methods were used in order to capture and purify Fab D1.3 
from the osmotic shock fluid and culture broth samples. 
 
3.3.1 Fab D1.3 purification on HiTrap Protein G column 
 
Though Protein G has strong affinity for the Fc regions of IgG molecule, it also shows 
weak affinity towards the CH1 domain of Fab (Derrick and Wigley, 1994). Purification 
of various Fab molecules from Chinese hamster ovary (CHO) cell supernatant and 
the periplasmic fraction of E. coli on immobilised Protein G have been reported in 
literature (Humphreys et al., 1997; Kwack, 2000; and Proudfoot et al., 1992).  
Proudfoot et al. (1992) exploited this low-affinity interaction for the purification of 
chimeric mouse-human B72.3 Fab and F(ab')2 fragments and showed that chimeric 
B72.3 Fab bound weakly to the Protein G-Sepharose so that it could be separated 
from F(ab')2 and eluted with a pH 7.0 wash, whereas B72.3 F(ab')2 required elution 
at pH 2.0. In the present work, purification of Fab D1.3 using Protein G affinity 
chromatography was experimented. The chromatogram and ELISA figures relevant 
to purification of the Fab from culture broth directly on HiTrap Protein G column have 
been illustrated in Fig. 3.2. As it is evident from the ELISA data (Fig. 3.2), most 
(>99%) of the Fab applied to the column failed to bind, and diminutive quantities of 
the Fab were detected in the wash and elution fractions. This indicated that Protein G 
had very weak ability to attach the Fab under the experimental conditions (i.e. 
conductivity ~40 mS/cm, pH 7.0, sample volume 120 mL). The high conductivity (i.e. 
the high concentration of salt) in the culture broth might prevent the binding of Fab 
D1.3 to the Protein G column. In the works performed by other scientists on direct 
purification of various Fab fragments on Protein G columns, no detailed data (e.g. 
chromatography/conductivity values) had been given; therefore, it was impossible to 
compare the experimental conditions (e.g. conductivity) in this work with theirs. 
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Fig. 3.2 Chromatogram (top) and ELISA data (bottom) for the purification of Fab D1.3 
from a 21 h culture broth sample on a HiTrap Protein G column. 
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 3.3.2 Fab D1.3 purification on HEWL-activated CNBr-Sepharose 4 Fast Flow 
matrix/ HiTrap Protein G column 
 
Protein and other molecules containing primary amino groups can be coupled directly 
to the CNBr-activated Sepharose gel. Basic amino acids in HEWL, i.e. twelve 
arginine residues and six lysine residues, could react with cyanate ester groups in 
CNBr-activated Sepharose (Sasaki et al., 2003). Purification of heavy and light chain 
variable domains (Fv) of the anti-Lysozyme D1.3 from culture broth and the 
periplasmic fraction of E. coli has been done on HEWL-Sepharose column (Cumber 
et al., 1992; Holmes et al., 1998; Winter et al., 2003). HEWL interacts extensively 
with VK and VH domains in Fab D1.3, forming three hydrogen bonds to the VK domain 
and nine hydrogen bonds to the VH domain (Ward et al., 1989). It has been shown 
that amongst various avian and human Lysozymes, D1.3 monoclonal antibody can 
specifically bind HEWL (Harper et al., 1987).  
 
In the present work, purification of Fab D1.3 from culture broth and the periplasmic 
fraction (OS1 fluid) on a Lysozyme-Sepharose affinity column was also tested. For 
purification of the Fab from culture broth on the Lysozyme-Sepharose column, the 
sample was loaded on the Lysozyme-Sepharose column and the column was then 
washed with 20 mM phosphate buffer, pH 7.0, and elution was made with 50 mM 
diethylamine, pH 11.5. The chromatogram, SDS-PAGE and Western blotting results 
relevant to this experiment have been shown in Fig. 3.3. Analysis of the elution 
fractions by SDS-PAGE confirmed the present of the Fab in the eluates, and showed 
that impurities accompanied with the Fab.  
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Fig. 3.3 Chromatogram (top), SDS-PAGE (middle) and Western blot (bottom) 
analyses for the purification of Fab D1.3 from culture broth (21 h culture) on a 
Lysozyme-activated Sepharose 4FF column. Phosphate buffer (20 mM, pH 7.0) was 
employed for equilibration and the post wash, and 50 mM diethylamine, pH 11.5 was 
used as the eluent. Lane: 1 – load; 2 – flow through; 3 – post wash; 4 to 10 – elution 
fractions; M – molecular weight markers. 
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For purification of Fab D1.3 from the periplasmic fraction (OS1 fluid, 14 h culture) on 
the Lysozyme-Sepharose column , the post-load column washing regime was made 
with 20 mM phosphate buffer, pH 7.0, followed by 50 mM Tris-HCl buffer 
supplemented with 500 mM NaCl, pH 8.5, and elution was made with 50 mM 
diethylamine, pH 11.5. The chromatogram, SDS-PAGE and Western blotting results 
have been shown in Fig. 3.4. As evident from these results, additional protein was 
released during washing the column with 50 mM Tris-HCl buffer, pH 8.5, and no Fab 
D1.3 existed in the post-load wash fractions according to SDS-PAGE and Western 
blotting results. This indicates that an extra column wash with 50 mM Tris-HCl buffer, 
pH 8.5, prior to column elution step can unbind further impurities. Holmes et al. 
(1998) exploited this two-step post-load wash prior to elution of the Fv fragment of a 
humanized version of the mouse anti-Lysozyme D1.3 (HuLys) by 50 mM 
diethylamine from a Lysozyme-Sepharose affinity column. Western blot analysis also 
confirmed the present of the Fab in the eluates, but concomitant impurities were also 
observed (Figs 3.4). In the purification works done by other scientists using 
Lysozyme-Sepharose column, which discussed earlier in this section, no 
chromatogram or SDS-PAGE/Western blotting figures had been presented; 
therefore, the purity of the purified antibody fragment in those works was not 
manifest. 
 
As the Fab in the elutions originated from the Lysozyme-Sepharose column was 
accompanied with impurities, even when the column was washed with the high salt 
buffer before the elution stage (see Figs 3.3 and 3.4), an extra step of purification on 
HiTrap Protein G was performed following desalting the eluates on PD10. By doing 
this highly pure Fab D1.3 was obtained, as indicated in SDS-PAGE and Western 
blotting results (Figs. 3.5 and 3.6). The top and bottom bands in lane 6 and the 
bottom band in lane 1 of non reducing SDS-PAGE (Fig 3.6) were analysed by mass 
spectroscopy. The mass spectroscopy data were analysed by Mascot search engine 
(http://www.matrixscience.com) to identify proteins from primary sequence database. 
Results (Tables 7.1 to 7.3 presented in the Appendix) demonstrated that the top and 
bottom bands in the lane 6 (corresponding to elution 1 of HiTrap Protein G column) 
were heavy and light chains of Fab D1.3, respectively, and the bottom band in lane 1 
was not antibody fragment.  
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Fig. 3.4 Chromatogram (top), SDS-PAGE (middle) and Western blot (bottom) 
analyses for the purification of Fab D1.3 from OS1 (14 h culture) on a Lysozyme-
activated Sepharose 4FF column. Phosphate buffer (20 mM, pH 7) was employed for 
equilibration and post wash a. The 2nd wash (post wash b) was performed with a 
high salt buffer (50 mM Tris-HCl buffer supplemented with 500 mM NaCl, pH 8.5) 
and elution was achieved with 50 mM diethylamine, pH 11.5. The molecular weight of  
each chain of Fab D1.3 is about 25 kDa. 
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Fig. 3.5 SDS-PAGE gels and corresponding Western blots of selected fractions from 
the purification of partially purified Fab D1.3 on HiTrap Protein G. Eluted fraction 7 
from chromatography on Lysozyme Sepharose 4FF (Fig. 3.3) was desalted on a 
PD10 column prior to loading onto a HiTrap Protein G column. For the non-reducing 
SDS-PAGE gel (far left) and corresponding Western blot (second from the left) a 
common lane designation applies, i.e.: M – molecular weight markers; 1 – pre-load 
elution pool (Fig. 3.3) prior to PD10 desalting; 2 – PD10 desalted load; 3 – 
flowthrough; 4 – post load wash; 5 to 8 – elution fractions. For the reducing SDS-
PAGE gel (second from the right) and corresponding Western blot (far right) lane M 
denotes molecular weight markers and lane 1 is elution fraction 1. 
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Fig. 3.6 SDS-PAGE gel (left) and Western blot (right) analyses following purification 
of partially purified Fab D1.3 on HiTrap protein G. Pooled eluted fractions (15-18) 
from chromatography on Lysozyme Sepharose 4FF (Fig. 3.4) were desalted on 
PD10 columns prior to loading onto a Hitrap Protein G column. Lane: 1 – PD10  
desalted load (non-reduced); 2 – PD10 desalted load (reduced); 3 – flowthrough   
(reduced); 4 – post wash (reduced); 5 – eluate 1 (reduced); 6 – eluate 1 (non-
reduced); M – molecular weight markers.  
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The comparison of isolated proteins on reducing and non-reducing SDS-PAGE 
provides an easy way to determine if a protein of interest might be a multimeric 
complex (Corely, 2004). By doing non-reducing SDS-PAGE, it was revealed that the 
heavy and light chains of the Fab molecule were not associated covalently inasmuch 
as two distinctive close bands observed under non-reducing condition. It is also 
noticeable that in all SDS-PAGE analyses done on the fractions containing Fab, the 
locations of the heavy and light chains on the gel were different under reducing and 
non-reducing conditions. Under reducing conditions, heavy and light bands (with very 
near molecular weight) on the gel were overlapped, most likely, due to a more 
extended structure. In reducing (denaturing) SDS-PAGE, the presence of beta-
mercaptoethanol serves two functions. First, it reduces the covalent bonds that might 
exist between multimeric protein complexes. Second, it reduces covalent bonds that 
exist within a protein so that it achieves a more extended structure when boiled in 
SDS, which improves resolution and permits more accurate estimates of its 
molecular weight mass (Corley, 2004).  Thus, under non-reducing conditions, 
proteins can migrate aberrantly on SDS-PAGE gels. 
 
Tables 3.1 and 3.2 illustrate the chromatography data relevant to the Fab purification 
from culture broth and OS1 fluid, respectively, by a sequential Lysozyme affinity –
desalting Gel filtration (GF) – Protein G affinity chromatography route. It is evident 
from these data that the purification by Lsozyme-Sepharose column yielded 48% and 
55% Fab purities for purification from culture broth sample and osmotic shock fluid, 
respectively. The Fab eluted from the Protein G column was substantially purified, 
i.e. reaching>97%, but the overall yields of the target Fab were rather low (i.e. 3.5 
and 4 mg; or 18% and 33% for purification from the 10 h post induction culture broth 
and 4 h post induction osmotic shock fluid respectively).  
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Table 3.1 Chromatography data for purification of Fab D1.3 from culture broth (21 h 
culture) on Lysozyme-activated Sepharose 4FF/ HiTrap protein G column.  
 
Volume 
(mL)
D1.3 
(mg)
Total 
protein 
(mg)
Target 
yield (%)
Total 
protein 
yield (%)
Purity 
(%) PF
Load 480.00 19.58 1888.20 100.00 100.00 1.04 1.00
FT 480.00 15.55 1864.80 79.42 98.76 0.83
Wash 20.00 0.49 16.53 2.50 0.88 2.96
Elution 12.00 3.43 7.03 17.52 0.37 48.79 47.05
Load 3.50 3.43 7.00 17.52 0.37 49.00
FT 3.50 0.04 0.21 0.20 0.01 19.05
Wash 5.00 0.01 0.02 0.03 0.00 25.00
Elution 4.00 3.40 3.50 17.36 0.19 97.14 93.68
Step
Lysozyme-activated sepharose (5-mL)
HiTrap Pr. G column (1mL) 
 
 
Table 3.2 Chromatography data for purification of Fab D1.3 from OS1 fluid (14 h 
culture) on Lysozyme-activated Sepharose 4FF/ HiTrap protein G column.  
 
Volume 
(mL)
D1.3 
(mg)
Total 
protein 
(mg)
Target 
yield (%)
Total 
protein 
yield (%)
Purity 
(%) PF
Load 250.00 12.23 228.20 100.00 100.00 5.36 1.00
FT 250.00 7.80 202.50 63.78 88.74 3.85
Wash 56.00 0.20 18.30 1.64 8.02 1.09
Elution 12.00 4.14 7.43 33.85 3.26 55.72 10.40
Load 2.50 4.14 7.42 33.85 3.25 55.80
FT 2.50 0.04 2.22 0.33 0.97 1.80
Wash 5.00 0.07 1.34 0.57 0.59 5.22
Elution 8.00 4.00 4.05 32.71 1.77 98.77 18.43
Step
Lysozyme-activated sepharose (5-mL)
HiTrap Pr. G column (1mL) 
 
 
 
3.3.3 Fab D1.3 purification on HiTrap SP Sepharose XL/ HiTrap Protein G 
column 
 
Cation exchange (CEX) chromatography can be used as a very helpful technique for 
concentrating proteins of interest in the beginning of a purification process. In the 
present work, capture of Fab D1.3 from culture broth sample by cation exchange 
chromatography (5-mL HiTrap SP Sepharose XL column) was also investigated. For 
optimal sorption of the Fab on the cation exchange matrix, the pH and conductivity of 
the load were adjusted to 5.0 and 5.0 mS/cm, respectively. The conditions required 
for this purification experiment were obtained from Ljunglöf et al’s work on the ion 
exchange chromatography of antibody fragment (Fab) (Ljunglöf et al., 2007), in which 
they stated a dynamic binding capacity (DBC at 10% breakthrough) of ca. 120 mg 
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Fab/mL adsorbent at pH 5.0 and conductivity 5.0 mS/cm. The binding, washing and 
eluting buffers were also chosen according to Ljunglöf et al’s work. By doing SDS-
PAGE and Western blot analyses, the presence of Fab with concomitant protein 
impurities in the elution fractions of the SP Sepharose column was confirmed (Fig. 
3.7).  
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Fig. 3.7 Chromatogram (Top), non-reducing SDS-PAGE (bottom left) and 
corresponding Western blot (bottom right) analyses for the purification of Fab D1.3 
from culture broth (21 h culture) on a HiTrap SP Sepharose XL column. Sodium 
acetate (15 mM, pH 5.0) was employed for equilibration and the post wash. Elution 
was achieved by 20 mM MES, 4.5 mM sodium MES, 1.5 M NaCl (pH 5.5). Lane: 1 – 
load; 2  – post wash; 3 to 9 – elution fractions; M – molecular weight markers. 
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Fig. 3.8 Non-reducing SDS-PAGE (left) and reducing SDS-PAGE (right) gels 
following purification of partially purified Fab D1.3 on HiTrap protein G. pooled 
fractions (3-9) from chromatography on HiTrap SP Sepharose XL column (Fig. 3.7) 
were desalted on PD10 columns prior to loading into a HiTrap protein G column.  
Lane: 1 – PD10 desalted load; 2 – flowtrough; 3 – post wash; 4 and 5 – eluate 1 and 
2, respectively; M – molecular weight markers. 
 
 
To obtain high pure Fab D1.3, a further step of purification on HiTrap Protein G was 
performed using eluates desalted on PD10 column. Highly pure Fab D1.3 was 
obtained as illustrated in the SDS-PAGE and Western blotting results (Fig. 3.8). 
 
Table 3.3 shows the chromatography data related to the Fab purification from culture 
broth sample by a sequential SP Sepharose XL cation exchange (CEX) – desalting 
Gel filtration (GF) – Protein G affinity chromatography route. When compared to the 
quantity of the Fab measured before dialysis, approximately 60 per cent loss of the 
Fab occurred during overnight dialysis of culture broth sample, done so as to reduce 
conductivity and pH (i.e. the Fab titration was dropped from 40.8 mg/L to 17.3 mg/L). 
The solution obtained from dialysis was cloudy and the precipitates were visible on 
the bottom of tubes after clarification with centrifugation. As it is shown in Table 3.3, 
the Fab capture from the culture broth sample on the cation exchanger was very 
successful (> 97% capture), and the pooled eluate from this CEX step yielded a ca. 
14% Fab purity and a 22.5-fold purification factor. Further Fab purification from 
desalted CEX eluates on Protein G column resulted in a highly pure Fab (with >97% 
purity). The overall yield and purification factor in this ‘CEX–GF–Protein G affinity’ 
route were 83% and 153-fold, respectively, being significantly higher than that 
1     2    3     4            5    M
Non-reducing SDS-PAGE
36 kDa
22 kDa
Reducing SDS-PAGE
1     2    3     4          5       M
36 kDa
22 kDa
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obtained previously using the ‘Lysozyme affinity–GF–Protein G affinity’ procedure 
(see Tables 3.1 and 3.2).  
 
Table 3.3 Chromatography data for purification of Fab D1.3 from culture broth (21 h 
culture) on HiTrap SP Sepharose XL/ HiTrap protein G column. 
 
Volume 
(mL) D1.3 (mg)
Total 
protein 
(mg)
Target yield 
(%)
Total 
protein 
yield (%)
Purity 
(%) PF
Load 480.0 8.3 1303.4 100.0 100.0 0.6 1.0
FT 480.0 0.2 1235.7 1.8 94.8 0.0
Wash 25.0 0.9 17.5 10.2 1.3 4.9
Elution 30.0 7.2 50.2 86.7 3.9 14.3 22.5
Load 7.0 7.2 50.2 86.7 3.9 14.3
FT 7.0 0.2 35.0 2.8 2.7 0.7
Wash 5.0 0.0 0.1 0.6 0.0 46.0
Elution 2.5 6.9 7.0 82.5 0.5 97.9 153.7
SPXL column (5 mL) 
HiTrap Pr. G column (1mL) 
Step
 
 
 
3.4 Conclusions 
 
Streptococcal Protein G can bind strongly to the Fc region (between CH2 and CH3 
domains), and weakly to CH1 domain. Therefore, Protein G can be used for 
purification of whole IgG molecules, and some reports have shown that it is a 
potential ligand for purification of antibody fragments as well (Björck and Kronvall, 
1984; Derrick and Wigley, 1994). In this work purification of Fab D1.3 by various 
chromatography routes has been investigated. Fab D1.3 binds very weakly (<1%) to 
Protein G column, when the culture broth sample (with conductivity ~40 mS/cm and 
pH 7.0) directly is loaded on the Protein G column.  
 
Amongst avian and human Lysozymes, D1.3 monoclonal antibody can specifically 
bind HEWL (Harper et al., 1987). In this work, it has been demonstrated that Fab 
D1.3 can be purified from 480 and 250 mL culture broth and osmotic shock samples, 
respectively, on a 5-mL HEWL column with 48 to 55% purity. The Fab with such 
purity can bind (>97%) to protein G when the pooled HEWL column eluate is 
desalted on PD10 column using 20 mM sodium phosphate, pH 7.0. As a result, Fab 
D1.3 can be purified >97% using coupled HEWL and Protein G affinity columns. 
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However the overall yield of such chromatography step is low (18-33%) due to low 
binding capacity of the Lysozyme column. 
 
Cation exchangers have a very good capacity for capturing and concentrating target 
proteins in the early stage of purification process. HiTrap SP Sepharose XL has been 
shown a high binding capacity for Fab (120 mgFab/mL adsorbant) at pH 5.0 and 
conductivity 5.0 (Ljunglöf et al., 2007). HiTrap SP Sepharose XL binds and captures 
Fab D1.3 (>97%) from 480 mL culture broth (with pH 5.0 and conductivity 5.0 
mS/cm), and as a result concentrated target protein (with 14% purity) is achieved. 
The Fab with such purity can bind greatly to protein G when the pooled CEX column 
eluate is desalted on PD10 column using 20 mM sodium phosphate, pH 7.0. 
Therefore, Fab D1.3 can be purified >97% using coupled HiTrap SP Sepharose XL 
and Protein G columns. The overall yield of coupled HiTrap SP Sepharose XL and 
Protein G columns is considerably high (83%), and therefore appears more suitable 
than coupled HEWL and Protein G affinity columns for purification of Fab D1.3. 
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4   The effect of periplasmic release reagents on the secondary 
structure and biological activity of three periplasmically expressed 
recombinant proteins 
 
 
Abstract 
 
High throughput circular dichroism (ht-CD) system was employed to evaluate the 
structural alterations occurred in bata-lactamase, alpha-amylase, and Fab D1.3 in the 
presence of different chemicals. In the first ht-CD experiments, the suitable protein 
concentration (1 mg/mL) required for such spectroscopic system was determined by 
measuring the intensity of CD spectra recorded for various concentrations (0.2-2 
mg/mL) of bovine serum albumin (BSA). The reproducibility of the CD system was 
confirmed by recording the CD spectra of 1mg/mL BSA run consecutively into the 
system. The CD spectra of various chemicals were recorded, and chemicals which 
did not increase high tension (HT) voltage above 600 V within far-UV region were 
chosen for further ht-CD investigations. The CD spectra of 1mg/mL beta-lactamase, 
alpha-amylase, and Fab D1.3 were recorded in the presence of various chemicals 
(surfactants, chelating agents, chaotropic agents, and solvents), and the extent of 
changes in the secondary structure of proteins was evaluated in far-UV region. The 
changes in the CD spectra increased with increasing the concentration of chemicals. 
The biological activity of beta-lactamase and alpha-amylase, and the binding 
capability of Fab D1.3 to hen egg white HEWL immobilised on microplate were 
measured in the presence of various chemicals. By comparing CD results with 
biological activity results, it was divulged that certain chemicals might induce 
alterations in the secondary structure of proteins without reducing the biological 
activity of proteins, and vice-versa.  
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4.1 Introduction 
 
The periplasm of E. coli has been recognized as a very suitable place for expression 
of recombinant proteins, especially for those having disulphide-bonds in their 
structures. The oxidizing environment of the periplasm, the periplasmic disulphide 
bond-forming (Dsb) proteins, isomerases, and chaperones assist the formation of 
properly folded target protein (Berkmen et al., 2007; Betton, 2007; Derman and 
Beckwith, 1991; Richarme and Caldas, 1997).  In the beginning of a downstream 
process for the extraction and purification of periplasmically-expressed proteins, the 
selective recovery of periplasmically located proteins is of a great interest as this will 
reduce the number, and as a result the cost, of downstream operation units. There 
are many reagents that might be used for targeting and permeabilising the outer 
membrane of E. coli and other gram-negative bacteria (Nikaido and Vaara, 1985; 
Vaara, 1992). These reagents might have adverse impacts on the structure and 
biological activity of periplasmically-located proteins; thus, the influence of such 
reagents on the structure and biological activity of target proteins should be studied 
prior to applying them in cell permeabilisation. ‘Safe’ reagents can be then utilized in 
the outer membrane permeabilisation studies. 
 
Circular dichroism (CD), which is a spectroscopic method based on the differential 
absorption of left- and right-circularly polarized light by optically active molecules, is a 
standard technique for analysis of secondary structure of biopolymers such as 
proteins. CD offers a myriad of advantages over X-ray crystallography and nuclear 
magnetic resonance (NMR) spectroscopy (Manavalan and Johnson, 1985; Miles and 
Wallace, 2006), and is used extensively for structural studies. (Johnson, 1988 and 
1990; Kelly et al., 2005; Wallace et al., 2003; Wallace and Janes, 2001; Whitmore 
and Wallace, 2007). CD is a rapid method requiring small amounts of sample; it 
shows a high sensitivity to diminutive changes in secondary structure; it does not 
entail sample preparations (such as crystallization), high concentrations and extreme 
conditions; it enables users to analyse biomolecules in solutions and can be utilized 
to explore alterations in secondary structure in a broad range of solvent composition, 
experimental solution conditions and temperature. 
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In this chapter we have studied the use of a newly developed high throughput circular 
dichroism (ht-CD) system to rapidly identify safe conditions for chemically-mediated 
release of target proteins from the periplasm of E. coli. The effects of various 
concentrations of a large number of recognised cell permeabilisation reagents on the 
secondary structure of beta-lactamase, alpha-amylase and Fab D1.3 were first 
screened by ht-CD. The impact of such chemicals on the biological activity of these 
proteins was then studied, and any correlations between the CD results and activity 
assays determined.  
 
4.2 Materials and Methods 
 
4.2.1 Materials 
  
Sodium deoxycholate (DOC), cetyltrimethylammonium bromide (CTAB), 
benzalkonium chloride (BAC), Triton X-100, Tween 20, Brij-35, 
ethylenediaminetetraacetic acid (EDTA), diethanolamine (DEA), nitriolotriacetic acid 
(NTA), sodium hexametaphosphate (SHMP), urea, guanidinium chloride (GndCl), 
diethyl ether, pyridine, isoamyl alcohol, (hydroxymethyl)aminomethane (Tris), sodium 
acetate, sodium phosphate monobasic, sodium phosphate dibasic, bovine serum 
albumin (BSA), sodium salt of benzylpenicillin, alpha-amylase from Aspergillus orizae 
and beta-lactamase from Enterobacter cloacae were obtained from Sigma-Aldrich 
(Gillingham, UK). Sodium dodecyl sulphate (SDS) was supplied by Bio-Rad 
Laboratories (Hercules, CA, USA). Hexane, xylene, chloroform, ethanol, acetone, 
glacial acetic acid and potassium iodide were obtained from Fisher Scientific 
(Loughborough, UK). Benzene, toluene and iodine were supplied by BDH Laboratory 
supplies (Poole, UK). Fab D1.3 was from purification from culture broth on HiTrap SP 
Sepharose XL/ HiTrap protein G HP column, as previously described in detail in 
Chapter 3. 
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4.2.2 Methods 
 
4.2.2.1 High throughput method (ht-CD) 
 
4.2.2.1.1 Quartz flow cell sampling analysis 
 
Various concentrations of BSA (0.2-2 mg/mL) were prepared in double distilled water 
(DDH2O). A 96-well microplate was loaded in a repeating pattern of protein and 
control (DDH20), each well containing 200 µl. Plate was placed within the intelligent 
autosampler, and a sampling program initiated. Fifty microlitres of the solution in 
each microplate well was sampled by the autosampler and injected by HPLC pump 
into the quartz flow cell having 2 mm path length. Once the flow in the cell was 
stopped, CD spectrum was taken. The spectrum was measured using parameters 
that allowed for a rapid accumulation of data (three scans were taken at 100 
nm/minute between 270 and 190 nm with a 1 nm bandwidth and averaged). Data 
was viewed using the Spectra Management for Windows program during analysis 
and automatically saved by the program Spectra. 
 
4.2.2.1.2 Ht-CD method reproducibility 
 
A sample of 1 mg/mL BSA was prepared in 25 mM phosphate buffer pH 7.0, 
distributed in several wells on microplate in a repeated pattern of protein solution and 
control (25 mM phosphate buffer pH 7.0), and analysed in the high throughput 
system as mentioned above. 
 
4.2.2.1.3 Ht-CD for combination of chemicals and proteins 
 
The CD spectra of chemicals alone and mixtures of chemicals and proteins were 
measured. For this purpose, a 96-well autosampler was used to deliver the samples 
to the CD spectrometer. Each well of the sample plate was loaded with 100 µL of 
double concentrated chemicals and 100 µL of double concentrated pure proteins (2 
mg/mL made in 50 mM phosphate buffer pH 7.0). For each chemical and protein 
tested, two wells containing 200 µL were produced; one containing desired protein in 
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the buffer and chemical, and the other containing the buffer and chemical, but no 
protein. This second sample provided a baseline CD spectrum which was taken 
away from the spectrum containing the protein to yield the true protein CD spectrum. 
Plates were placed within the intelligent autosampler, and a sampling program 
initiated.  Fifty microlitres of the solution in each microplate well was sampled by the 
autosampler and injected by HPLC pump into a quartz flow cell having 2 mm path 
length. Once the flow in the cell was stopped, CD spectrum was taken. The spectrum 
was measured using parameters that allowed for a rapid accumulation of data (three 
scans were taken at 100 nm/minute between 250 and 190 nm with a 1 nm bandwidth 
and averaged). Data was viewed using the Spectra Management for Windows 
program during analysis and automatically saved by the program Spectra. 
 
After CD measurements were made, the remaining solutions in the microplate were 
utilized in order to assess the retention enzyme activity of the proteins in the 
presence of various chemicals as mentioned below. 
 
4.2.2.2 Analytical Ultra Centrifugation (AUC) studies 
 
Double concentrated proteins and chemicals were mixed together to have 
appropriate final concentrations (ca. 0.5 mg of alpha-amylase, beta-lactamase, or 
Fab D1.3 per mL chemicals). Sedimentation velocity experiments were conducted in 
a ProteomeLab XL-1 Analytical Ultracentrifuge (Beckman Coulter Inc., Fullerton, CA, 
USA). The experiments were performed overnight at 100,000 g and 20°C. The 
velocity data were analysed using SEDFIT (Schuck, 2000). 
 
4.2.2.3 Beta-lactamase assay 
 
Beta-lactamase activity was assayed using a microtitre plate, according to a method 
adapted from Sargent (1968), in which penicilloic acid, the product of reaction 
between beta-lactamase and penicillin G, makes the iodine colourless, and 
consequently, the decrease in absorbance due to iodine can be used as estimation 
for enzyme activity. The following solutions were made freshly prior to the start of the 
assay: 4 mg of sodium salt of benzylpenicillin per mL of 50 mM sodium phosphate 
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buffer, pH 7.0; stock iodine solution containing 20.3 g I2 and 100 g KI in 500 mL of 
distilled water; iodine reagent, prepared by adding 1.25 mL of stock iodine solution to 
98.25 mL of sodium acetate buffer, pH 4.0. Routinely, 100 μL of sample were added 
to 20 μL of sodium salt of benzylpenicillin solution and following incubation at 37°C, 
for 180 s, the reaction was stopped by adding 200 μL of iodine reagent. The 
absorbance of the solution was then read immediately at 450 nm using a Promega 
microplate reader. As chemicals might change the colour intensity of iodine reagent 
in the beta-lactamase activity assay, for each chemical an individual blank containing 
0.1 mL of chemical/buffer, 20 μL of 50 mM Na-phosphate buffer pH 7.0 and 200 μL 
iodine reagent was prepared.  
 
4.2.2.4 Alpha-amylase assay  
 
Alpha-amylase activity was measured using a modified microtitre plate assay based 
on the method of Blanchin-Roland and Masson (Blanchin-Roland and Masson, 
1989), in which activity is determined by measuring the rate of decrease in 
absorbance of a coloured starch/I2 complex. For this purpose, soluble starch 0.5% 
(w/v) was made in 15 mM sodium phosphate buffered pH 5.8, previously heated to 
boiling point and filtered through No. 1 grade Whatman filter paper (Whatman 
International Ltd, Maidstone, UK) whilst hot. The iodine reagent was prepared fresh 
by diluting 0.2 mL of stock solution (2.2% (w/v) iodine and 4.4% (w/v) KI) into 100 mL 
of 2% (w/v) potassium iodine solution. Routinely, 150 μL of the preincubated starch 
solution was added to an equal volume of the preincubated sample and the mixture 
was incubated at 50°C for 180 s (Infors AG type AK120 microplate incubator shaker, 
Infors HT, Bottmingen, Switzerland). Thereafter, 15 μL of the reaction mixture was 
pipetted into 300 μL of the iodine reagent and the absorbance of the solution was 
measured at the wavelength of 600 nm using a Promega microplate reader 
(Promega Glomax-Multi detection system, Turner Biosystems Inc., Sunnyvale, CA, 
USA). As chemicals might change the colour intensity of starch/I2 complex in the 
alpha amylase activity assay, for each chemical an individual blank containing 150 μL 
chemical/buffer and 150 μL starch solution was prepared. 
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4.2.2.5 Sandwich ELISA method for Fab D1.3 quantification 
 
ELISA, without diluting down the samples, was performed according to the procedure 
described in Chapter 2, section 2.2.2.4.2.  
 
As the enzymatic quantifications methods and the sandwich ELISA technique are 
sensitive to the concentration of proteins, and because of this serial dilutions are 
usually made in a buffer. However in this work no dilution was made as there was the 
possibility of removing (diluting) the additions and as a result protein refolding. 
Therefore, due to lack of dilution process, the high sensitivity of these biological 
activity methods may be questionable and as a result minute reduction in the 
biological activity may not be detected. However, where the biological activity of the 
proteins is severely reduced, the high sensitivity of the assays is not debatable. 
 
4.3 Results and Discussion 
 
4.3.1 Checking the accuracy of the ht-CD system by using BSA 
 
CD is an excellent method for analysing the secondary structure of proteins and 
peptides in solution, and valuable estimates of protein conformation can be acquired 
from data obtained only between 240 and 200 nm (Greenfield, 1996). In the present 
work, a newly developed ht-CD system – composing of a spectropolarimeter having 
the quartz flow cell with 2 mm path length, an autosampler, and an HPLC pump 
injector – was employed to study the structural changes of periplasmically-expressed 
proteins in the presence of various chemicals. As the CD spectrum of a protein must 
be adequately intense for interpreting the data and the intensity of a CD spectrum is 
relied directly on the protein concentration; therefore, the CD spectra of different 
concentrations (0.2-2 mg/mL) BSA made in 25 mM phosphate buffer pH 7.0, were 
used for testing the system. Figure 4.1 shows the spectra collected from this 
experiment, and it is evident that the intensity of CD spectra was dependent on the 
concentration of BSA and this correlation was very significant (Fig. 4.1 c). The 
concentration of 1 mg protein/mL solution gave rise to sufficiently strong CD 
spectrum, and was used for further ht-CD investigations.  
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 To check the reproducibility of the ht-CD system, 1 mg/mL BSA in 25 mM phosphate 
buffer (pH 7.0) was sampled seven consecutive times by the autosampler, and after 
each sampling the spectra were recorded. As illustrated in Fig. 4.2, the spectra 
remarkably overlaid each other, and this proved the reproducibility of such system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BSA concentration (mg/mL)
0.0 0.5 1.0 1.5 2.0
C
D
 v
al
ue
 a
t 2
22
 n
m
-70
-60
-50
-40
-30
-20
-10
R2=0.9969
c
C
D
 v
al
ue
 a
t 2
22
 n
m
C
D
 v
al
ue
 a
t 2
22
 n
m
-80
-60
-40
-20
0
20
40
190 200 210 220 230 240 250 260
Wavelength (nm)
E
lli
pt
ic
ity
 (m
de
g)
E
lli
pt
ic
ity
 (m
de
g)
0
100
200
300
400
500
600
190 200 210 220 230 240 250 260
Wavelength (nm)
HT
 (v
)
a b
 
Fig. 4.1 CD spectra (a), the corresponding HT signals (b), and correlation between 
CD signal at 222 nm and BSA concentration (c). Spectra were recorded in a 2 mm 
path length capillary cell on a Jasco J-810 spectropolarimeter at a scan speed of 100 
nm/minute, response 2 s, and a bandwidth of 1 nm. Three scans were accumulated 
for each sample. Key: BSA concentration made in 25 mM phosphate buffer pH 7.0 
(mg/mL): ( ) 0.2; ( ) 0.4; ( ) 0.5; ( ) 1.0; ( ) 2.0. 
 
 
 
 
 
 
 112
 -30
-20
-10
0
10
20
30
40
190 200 210 220 230 240 250 260
Wavelength (nm)
El
lip
tic
ity
 (m
de
g)
El
lip
tic
ity
 (m
de
g)
0
100
200
300
400
500
600
190 200 210 220 230 240 250 260
Wavelength (nm)
HT
 (v
)
a b 
 
 
 
 
 
 
Fig. 4.2 CD spectra (a), the corresponding HT signals (b) of 1 mg/mL BSA sampled 
seven consecutive times in the ht-CD system. Spectra were recorded in a 2 mm path 
length capillary cell on a Jasco J-810 spectropolarimeter at a scan speed of 100 
nm/minute, response 2 s, and a bandwidth of 1 nm. Three scans were accumulated 
for each sample.  
 
4.3.2 Ht-CD studies of beta-lactamase, alpha-amylase, and Fab D1.3 in the 
presence of various chemicals 
The function of a protein is dependent on its three dimensional structure. Change in 
pH can modify the structure of proteins by altering electrostatic interactions between 
charged amino acids. Alteration in pH may also change the charge of the substrates 
and as a result affect their binding to the active site of the enzyme (Nagamine et al., 
1987). 
Histidine (His), glutamic acid (Glu) and aspartic acid (Asp) located in the active site 
cleft of Aspergillus oryzae alpha-amylase participate in substrate binding and 
catalytical activity (Matsuura et al., 1984; Toda et al., 1982). It has been reported that 
this enzyme is stable in the pH range of 4.5 to 9, and is inactivated rapidly at pH 
values below 4 and above 9 (Ebisu et al., 1993).  
Glutamic acid (Glu) and serine in the active site of beta lactamases are involved in 
the catalytical pathway of these enzymes and mutations of Glu results in enzymes 
exhibiting significantly decreased acylation and deacylation activity (Damblon et al., 
1996). The optimum pH for beta-lactamase (from Enterobacter cloacae) activity is 7-
8 (http://www.brenda-
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enzymes.org/php/result_flat.php4?ecno=3.5.2.6&Suchword=&organism[]=Enterobact
er+cloacae&show_tm=0). 
In this study, all chemicals were prepared in 25 mM phosphate buffer (pH 7) to 
prevent pH alterations in the chemical solutions and avoid any potential negative 
effect on enzyme activity due to pH alteration. 
 
During CD measurements, it is important to maintain the total absorbance of the 
sample (i.e., protein and buffer or solvent) within rational ranges to avoid excessive 
noise; therefore, it is crucial that samples must be free of optically active substances 
(e.g. optically active buffers and chemicals) (Miles and Wallace, 2006). The 
absorbance of the sample can be simply checked by measuring the High Tension 
(HT) voltage signal during a CD spectrum measurement of a sample (Kelly et al., 
2005). High Tension voltage is the voltage applied to photomultiplier in order to 
amplify the signal.  For many CD machines a nominal maximum value for HT is 
determined, values over this figure leading to distorted data. For the JASCO 
spectrometer used in this study it is recommended that the HT should be generally 
less than 600 V (Kelly et al., 2005). In the present work, the suitability of various 
concentrations of chemicals, being recognised as cell permeabilisation reagents and 
categorized as surfactants, chelator agents, chaotropic agents, and solvents, for CD 
studies was checked by running blank spectra to ensure that the absorbance of any 
citizen in the solution is not too high. It is evident from HT figures (Figs. 4.3 and 4.4) 
that chemicals such as 1% BAC, 1% CTAB and 2 M urea increase the beyond 600 V 
before the spectrum is complete. This has the effect of increasing the cut off 
wavelength (the lowest wavelength at which a spectrum can accurately be 
measured) preventing the recording of reliable CD data below 221 nm, 212 nm, and 
206 nm, respectively. This, of course, is not a problem if changes in the CD signals at 
222 nm are used to assess the unfolding of a protein.  
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Fig. 4.3 CD spectra (a) and the corresponding HT signals (b) of various surfactants. 
Spectra were recorded in a 2 mm path length capillary cell on a Jasco J-810 
spectropolarimeter at a scan speed of 100 nm/minute, response 2 s, and a 
bandwidth of 1 nm. Three scans were accumulated. Key: ( ) 0.1% BAC; ( ) 
1% BAC; ( ) 0.1% CTAB; ( ) 1% CTAB; ( ) 1% SDS; ( ) 1% DOC; 
( ) 0.05% Triton X-100; ( ) 0.1% Triton X-100; ( ) 0.1% Tween 20; 
( ) 1% Tween 20; ( ) 0.1% Brij; ( ) 1% Brij;( ) water. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.4 CD spectra (a) and the corresponding HT signals (b) of various chelators 
and chaotropic agents. Spectra were recorded in a 2 mm path length capillary cell on 
a Jasco J-810 spectropolarimeter at a scan speed of 100 nm/min, response 2 s, and 
a bandwidth of 1 nm. Three scans were accumulated. Key: ( ) 10 mM EDTA; (
) 10 mM EDA; ( ) 10 mM NTA; ( ) 1% SHMP; ( ) 200 mM Urea; ( ) 2 M 
Urea; ( ) 100 mM GndCl; ( ) 200 mM GndCl; ( ) water. 
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Fig. 4.5 CD spectra (a) and the corresponding HT signals (b) of various solvents. 
Spectra were recorded in a 2 mm path length capillary cell on a Jasco J-810 
spectropolarimeter at a scan speed of 100 nm/min, response 2 s, and a bandwidth of 
1 nm. Three scans were accumulated. Key: ( ) 1% Hexane; ( ) 1% Xylene; 
( ) 1% Toluene; ( ) 1% Benzene; ( ) 1% Diethylether; ( ) 1% Acetone; 
( ) 1% Chloroform; ( ) 1% Pyridine; ( ) 1% Ethanol; ( ) 10% Isoamyl 
alcohol; ( ) water. 
 
One per cent pyridine had strong absorbance below 270 nm (Fig. 4.5), and could not 
be used in CD studies whatsoever. Apart from these, the other chemicals (at the 
concentrations showed in Figs. 4.3 to 4.5) did not cause excessive absorbance in 
UV-region, and deemed to be appropriate for CD studies. 
 
After determining that the concentration of chemicals used in the study were 
complimentary for CD studies, the spectra of alpha-amylase (from Asp. orizae) and 
beta-lactamase (from E. cloacae), and Fab D1.3 (purified on HiTrap SP Sepharose 
XL/ HiTrap protein G HP column) at a concentration of 1 mg/mL in the presence of 
chemicals were measured. Figures 4.6 and 4.7 illustrate the changes in intrinsic CD 
spectra of beta-lactamase in the presence of different kinds of chemicals. 
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Fig. 4.6 Intrinsic CD spectra of
beta-lactamase in the presence
(a): cationic surfactants; (
anionic surfactants; and (
ionic su
recorded at a protein 
concentration of 1 mg/mL in 25 
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The alterations in intrinsic CD spectra of alpha-amylase in the presence of chemicals 
have been shown in Figs. 4.8 and 4.9. 
Fig. 4.7 Intrinsic CD spectra of
beta-lactamase in the presence
(a): chelating agents; (
chaotropic agents;
solvents. Spectra were recorded 
at a protein conc
mg/mL in 25 mM sodium 
phosphate buffer (pH 7.5). CD 
spectra of the protein in the 
presence of 2 M urea and 500 m
GndCl were truncated below 208 
nm and 206 nm, respectively, 
because of excess
HT) at these wavelengths. Key: 
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Fig. 4.8 Intrinsic CD spectra of 
alpha-amylase in the presence of 
(a): cationic surfactants; (b): 
anionic surfactants; and (c): non-
ionic surfactants. Spectra were 
recorded at a protein 
concentration of 1 mg/mL in 25 
mM sodium phosphate buffer (pH 
7.5). Key: ( ) 0.01% BAC; ( ) 
0.05% BAC; ( ) 0.01% CTAB; 
( ) 0.05% CTAB; ( ) 0.1% 
CTAB; ( ) 0.1% SDS; ( ) 
0.1% DOC; ( ) 1% DOC; 
( ) 0.05% Triton X-100; 
( ) 0.1% Triton X-100; ( ) 
0.1% Tween 20; ( ) 1% 
Tween 20; ( ) 0.1% Brij; 
( ) 1% Brij; ( ) water. 
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Alpha-amylase and beta-lactamase are α-helix rich proteins, and the CD spectrum of 
α-helical protein takes over the region between 240 and 200 nm with two reasonably 
intense negative bands at about 222 and 208 nm (Miles and Wallace, 2006). To test 
the hypothesis that CD could act as a measure of protein fold a simple measure was 
devised that used the intensity of the CD spectrum at key wavelengths as an 
indicator of fold. In this case the intensity at 222 nm was used as this wavelength is 
thought to reflect the presence of alpha helix in the sample. Besides, activity of beta-
lactamase and alpha-amylase in the presence of various chemicals was measured, 
Fig. 4.9 Intrinsic CD spectra of 
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essive noise 
 at these wavelength. 
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(a): chelating agents; (b): 
chaotropic agents; and (
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nm because of exc
(high HT)
Key: ( ) 10 mM EDTA; (
-10
-5
0
5
10
15
200 210 220 230 240 250 260 270
El
lip
tic
ity
 (m
de
g)
-10
-5
0
5
10
15
El
lip
tic
ity
 (m
de
g)
) 1 
mM DEA ;  ( ) 10 mM DEA; 
( ) 10 mM NTA; ( ) 0.1% 
SHMP; ( ) 1% SHMP; ( ) 
200 mM Urea; ( ) 2 M Urea; 
( ) 100 mM GndCl; ( ) 200 
mM GndCl; ( ) 500 mM GndCl; 
-10
-5
0
5
10
15
200 210 220 230 240 250 260 270
Wavelength (nm)
-10
-5
0
5
10
15
a
b
c ( ) 1% Hexane; ( ) 1% 
Xylene; ( ) 1% Toluene; 
( ) 1% Benzene; ( ) 1% 
Diethylether; ( ) 1% Acetone; 
( ) 1% Chloroform; ( ) 
1% Ethanol; ( ) 1% Isoamyl 
alcohol; ( ) 10% Isoamyl 
alcohol; ( ) water. 
  
 
 120
and correlation between the CD intensity at 222 nm and enzyme activity in the 
presence of each reagent was drawn (Figs. 4.10 and 4.11). Based on CD signals at 
222 nm, certain chemicals such as 100 mM GndCl, 200 mM urea, 1% hexane, 1% 
chloroform and 1% ethanol caused trivial changes in the intrinsic CD spectra of the 
proteins, while chemicals such as 0.05% BAC and 0.1% CTAB led to large changes 
in the CD spectra of the proteins. Also it is evident that changes in the CD spectra 
increase with increasing the concentration of chemicals. 
Electrostatic interactions between charged amino acids in a protein are important for 
the formation of its three dimensional structure and its function. Charged chemicals 
such as CTAB, BAC and DOC can attach to the charged amino acids in a protein 
and disrupt the electrostatic interactions within the protein, and as a result the active 
site will probably be lost. Organic solvent properties such as solvent hydrophobicity, 
hydrogen bonding capacity and miscibility in water have profound effect on the 
structural integrity of proteins. In hydrophobic water-immiscible solvents, water 
molecules tend to stay at the protein surface because of the solvophobic and 
hydrophilic nature of the protein surface. In contrast, polar solvents that can easily 
strip water from the surface of the protein and compete strongly for hydrogen bonds 
between protein atoms usually denature the structure to an unfolded state (Mattos 
and Ringe, 2001; Ru et al., 1999). Alcohols, having some hydrophilic components, 
are moderate competitors for amide hydrogen bonds, and they tend to disrupt tertiary 
structure and leave secondary structure interactions undisrupted (Babu and Douglas, 
2000; Knubovets et al., 1999, Mattos and Ringe, 2001). 
 
As shown in Figs. 4.10 and 4.11, changes in the secondary structure of beta-
lactamase and alpha amylase do not necessarily lead to loss of enzyme activity. For 
example, while 0.05% CTAB, 1% DOC, and 1% Brij caused substantial changes in 
both CD signals and in the activity of alpha-amylase, other chemicals such as 0.1% 
Triton, 1% SHMP, and 1% diethylether only led to a decrease in the intensity of CD 
signals but not in activity of the protein. Also there are examples where chemicals 
caused a marked reduction in enzyme activity but a small change in the intrinsic CD 
signal (see values for beta-lactamase in the presence of 1% DOC, 0.05% BAC, and 
0.05% CTAB in Fig. 4.10).  These discrepancies may indicate that the chemicals are 
altering the structure of the proteins in ways that are not recorded by CD. For 
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instance if the chemicals disrupt side chain or subunit packing without altering 
secondary structure then very little change would be detected in the CD spectrum.   
These results would therefore suggest that just such subtle changes are being 
induced by these chemicals. These discrepancies may also show that the altered 
structure detected by CD is outside the enzyme active site, in which case the enzyme 
activity would not be afflicted. Therefore, enzymes with insignificantly modified 
secondary structure may or may not have intrinsic activity depending on the site in 
which alteration is occurred. It is also seen in Figs. 4.10 and 4.11 that the changes in 
the CD signals and in the activities of beta-lactamase and alpha-amylase in the 
presence of same chemicals are not identical. 
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Fig. 4.10 Correlation of CD spectra changes and beta-lactamase activity in the 
presence of various chemicals. The growing discrepancies between CD and activity 
results have been shown by star. 
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  % CD signal at 222 nm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.11 Correlation of CD spectra changes and alpha-amylase activity in the 
presence of various chemicals. The growing discrepancies between CD and activity 
results have been shown by star. 
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Anomalously the CD signals of alpha-amylase and beta-lactamase, were greatly 
increased in the presence of 2 M urea, this indicates an overall increase in structure 
under these conditions. One potential explanation for this result would be that the 
protein is aggregating to form a species with an enhanced secondary structure. Such 
occurrences have been observed for proteins that form amyloid like fibres when 
partially denatured. To examine the potential that protein aggregation had occurred 
the size of the protein in solution using analytical ultracentrifugation (AUC) 
(Berkowitz, 2006; Liu et al., 2006) was examined. AUC studies showed that there 
was no aggregation of the enzymes in the presence of 2 M urea (Fig. 4.12); however, 
the location and intensity of alpha-amylase and beta-lactamase AUC peaks were 
changed when compared with the controls. Therefore, from results of sedimentation 
velocity experiments, it is construed that the increase in the proteins CD signals is 
not due to aggregation. It is also noticeable that no remarkable decrease in the 
enzyme activities observed in the presence of 2 M urea (Figs. 4.10 and 4.11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.12 Sedimentation experiment of alpha-amylase (a) and beta-lactamase (b) in 
the presence of urea. Key: ( ) 25 mM sodium phosphate buffer (pH 7.5); (  ) 2 M 
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The effects of various chemical permeabilisation agents on the secondary structure 
of Fab D1.3 and on the Fab ability to bind to immobilized HEWL was also 
investigated. The CD spectra of Fab D1.3 at a concentration of 1 mg/mL and in the 
presence of various chemicals were measured in thhe same manner. Alteration in 
intrinsic CD spectra of Fab D1.3 in the presence of chemicals has been shown in 
Figs. 4.13 and 4.14. Fab D1.3 is β-sheet rich protein, the CD spectrum of which is 
characterised by a small negative band near 217 nm (Miles and Wallace, 2006); 
hence, the wavelength 214 nm was used to indicate the percentage of changes 
taken place in the CD signal as a result of alterations in the secondary structure of 
the protein. As a complementary test, the ability of Fab D1.3 to attach to HEWL in the 
presence of chemicals was also evaluated (Fig. 4.15). β-sheets give rise to 
considerably less intense signals than helices, and show more variations in spectral 
characteristics (Miles and Wallace, 2006). CD results from Fab D1.3 study (Figs. 4.13 
and 4.14) are in agreement with this, and demonstrate that in the presence of 
chemicals (such as 0.1-1% Tween 20, 0.1-1% Brij, 0.01-0.05% BAC, 0.01-0.05% 
CTAB, 10 mM chelators, 200-500 mM GndCl, and 2 M urea) changes in CD signals 
of Fab D1.3 are greater than those of alpha-amylase and beta-lactamase (α-helix rich 
proteins), results of which have been previously shown (i.e. Figs. 4.6 to 4.9). 
However, Fab D1.3 retained its capability to bind to HEWL when in contact with 
chemicals – particularly 1% DOC, 0.05% CTAB and 0.05% BAC, in presence of 
which there was negligible or no alpha-amylase and beta-lactamase activity. This 
demonstrates that although Fab D1.3 shows more variations in spectral 
characteristics in the presence of chemicals, its ability to bind to HEWL remained 
greatly intact at such conditions.  
 
 
 
 
 
 
 
 
 
 126
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-8
-6
-4
-2
0
200 210 220 230 240 250 260 270
-8
-6
-4
-2
0
2
4
6
2
4
6
-8
-6
-4
-2
0
2
4
6
200 210 220 230 240 250 260 270
El
lip
tic
ity
 (m
de
g)
-8
-6
-4
-2
0
2
4
6
El
lip
tic
ity
 (m
de
g)
-8
-6
-4
-2
0
2
4
6
200 210 220 230 240 250 260 270
Wavelength (nm)
-8
-6
-4
-2
0
2
4
6
a
 Intrinsic CD spectra of 
a): 
b): anionic 
c): non-ionic 
surfactants. Spectra were 
recorded at a protein 
b
c
Fig. 4.13
Fab D1.3 in the presence of (
cationic surfactants; (
surfactants; and (
concentration of 1 mg/mL in 25 
mM sodium phosphate buffer (pH 
7.5). Key: ( ) 0.01% BAC; ( ) 
0.05% BAC; ( ) 0.01% CTAB; 
( ) 0.05% CTAB; ( ) 0.1% 
SDS; ( ) 0.1% DOC; ( ) 1% 
DOC; ( ) 0.05% Triton X-100; 
( ) 0.1% Triton X-100; ( ) 
0.1% Tween 20; ( ) 1% 
Tween 20; ( ) 0.1% Brij; 
( ) 1% Brij; ( ) water. 
  
 127
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-8
-6
-4
-2
0
200 210 220 230 240 250 260 270
-8
-6
-4
-2
0
2
4
6
2
4
6
-8
-6
-4
-2
0
2
4
6
200 210 220 230 240 250 260 270
El
lip
tic
ity
 (m
de
g)
-8
-6
-4
-2
0
2
4
6
El
lip
tic
ity
 (m
de
g)
-8
-6
-4
-2
0
2
4
6
200 210 220 230 240 250 260 270
Wavelength (nm)
-8
-6
-4
-2
0
2
4
6
a
Fig. 4.14 Intrinsic CD spectra of 
a): 
): chaotropic 
): solvents. Spectra 
ive noise (high 
ese wavelengths. Key: 
b
c
Fab D1.3 in the presence of (
chelating agents; (b
agents; and (c
were recorded at a protein 
concentration of 1 mg/mL in 25 
mM sodium phosphate buffer (pH 
7.5). CD spectra of the protein in 
the presence of 2 M urea and 500 
mM GndCl were truncated below 
204 nm and 209 nm, respectively, 
because of excess
HT) at th
( ) 10 mM EDTA; ( ) 10 mM 
DEA; ( ) 10 mM NTA; ( ) 1% 
SHMP; ( ) 200 mM Urea; ( ) 
2 M Urea; ( ) 100 mM GndCl; 
( ) 200 mM GndCl; ( ) 500 
mM GndCl; ( ) 1% Hexane; 
( ) 1% Xylene; ( ) 1% 
Toluene; ( ) 1% Benzene; 
( ) 1% Diethylether; ( ) 
1% Acetone; ( ) 1% 
Chloroform; ( ) 1% Ethanol; 
( ) 1% Isoamyl alcohol; 
( ) 10% Isoamyl alcohol; 
( ) water. 
  
 
 
 128
% retention Fab activity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.15 Correlation of CD spectra changes and Fab D1.3 activity in the presence of 
various chemicals. The growing discrepancies between CD and activity results have 
been shown by star. 
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The CD signals of Fab D1.3 were increased in the presence of 2 M urea and 10% 
isoamyl alcohol, and shifted towards positive values of Ellipticity in the presence of 
chemicals such as 1% Tween 20, 1% Brij, and 0.05% CTAB. The formation of the 
Fab aggregates, which can be a potential explanation for such anomalous results, 
was investigated by AUC. AUC results have been shown in Fig. 4.16; it is evident 
that the intensity and location of the AUC peaks have been changed to different 
extents when compared with the control, and there was distinctive Fab aggregation 
(multimeration), being shown by increased number of sedimentation velocity peaks in 
the figure, in the presence of 0.05% CTAB; thus, the alteration in the shape and 
magnitude of the CD spectra in the presence of 0.05% CTAB (Fig 4.13) could be 
attributed to the protein aggregates. Other chemicals did not cause Fab D1.3 
aggregation. It was impossible to study the Fab in the presence of 10% isoamyl 
alcohol by AUC, as 10% isoamyl alcohol solution was interfered with AUC.   
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Fig. 4.16 Sedimentation velocity experiment of Fab D1.3 in the presence of 
chemicals.  
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4.4 Conclusions 
 
In this chapter we have explored the question of what effect chemicals additives used 
in the purification process might have on the secondary structure and biological 
activity of three proteins: beta-lactamase, alpha-amylase and Fab D1.3. The effect of 
chemicals on the secondary structure of the target proteins was investigated through 
a high throughput circular dichroism (ht-CD), given the fact that the instrument is in 
effect at a prototype stage. In a general CD spectroscopy method, samples are 
analyzed by using quartz covetts which can have a range of path lengths. This 
conventional method can be very lengthy and cumbersome when a large number of 
samples are to be analyzed as the cuvett should be manually washed and cleaned 
after each measurement. This problem can be solved in a high throughput format in 
which sampling is done by an autosampler followed by injection into a capillary cell (2 
mm path length) by an HPLC pump. The washing of the capillary cell in such system 
is automatically done by pumping distilled water or a solvent into the capillary cell 
prior to injection of the next sample. A large number of protein samples can be 
structurally analysed by such an ht-CD system within a short period of time. In the 
present study, the reproducibility of a newly developed high-throughput CD system 
was primarily confirmed by using BSA. Blank spectra of cell permeabilization 
reagents at various concentrations were recorded to recognize their suitability for CD 
studies. The blank CD spectra reported in this chapter will be also invaluable for 
those intending to study secondary structure alterations of proteins in the presence of 
these chemical reagents. 
 
In the present work, the ht-CD system has been utilised as a tool in order to assess 
changes in the structure of three pure target proteins (i.e. beta-lactamase, alpha-
amylase, and Fab D1.3) in the presence of various recognised cell permeabilisation 
reagents. The changes in the intrinsic CD spectra of the proteins in the far-UV region 
(approx. 240-200 nm) are evidence of perturbations in the secondary structure of 
proteins. Chemicals such as 0.05% BAC and 0.1% CTAB caused large changes in 
the intrinsic CD spectra of beta-lactamase and alpha-amylase. In Isoamyl alcohol (1 
and 10%) and ethanol (1%), the spectra of beta lactamase and alpha amylase had a 
negative band greater than that of in water in the range from 200 to 240 nm. These 
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results are in agreement with Knubovet and colleagues (1999) studies in which they 
investigated the secondary structure of henn egg white lysozyme in solvents and 
observed a highly developed secondary structure and an increase in α-helix content 
of the protein in the presence of alcohol (i.e. methanol). Metalloproteins contain metal 
ions (e.g. beta-lactamase with Zn2+ ions and alpha-amylase with Ca2+ ions in their 
structure) which are important for the enzyme’s activity and stability (Carenbauer et 
al., 2002; Gacar et al., 2005; Picao et al., 2008; Xu et al., 2008), and chelating agents 
sequester these ions from the proteins. Chelating agents in this study changed the 
secondary structure of alpha-amylase though the enzyme activity retained intact. 
However, they did not cause significant alteration in the secondary structure of beta-
lactamase. According to the spectra recorded in the present work, the secondary 
structure of Fab D1.3 is more vulnerable than that of beta-lactamase and alpha-
amylase to chemicals. The reason for this is that antibodies and their fragments are 
β-sheet rich proteins (Cathou et al., 1968; Doi and Jirgensons, 1970; Feige et al., 
2010; Rehan and Younus, 2006) and changes in their CD signals are greater (Miles 
and Wallace, 2006) than α-helix rich proteins such as beta-lactamase and alpha 
amylase (Carenbauer et al, 2002; Feller et al., 1999; Fitter and Haber-Pohlmeier, 
2004). 
 
After measuring the structural alterations by Ht-CD, the retention biological activity of 
the proteins in the presence of various chemicals has been determined. This was 
done to perceive whether the changes in the secondary structure of proteins lead to 
reduction in the biological activity. This investigation demonstrated that changes in 
the secondary structure of proteins do not necessarily lead to reductions in the 
biological activity, since such structural alterations may occur outside the region 
responsible for biological activity, or take place inside the active site(s) of proteins in 
a manner that the biological activity is retained. Concentration ranges of chemicals 
which do not influence biological activity of the target proteins in this study are 
considered safe and are employed in subsequent periplasmic release experiments 
using recombinant E. coli strains producing the same target proteins (Chapter 5). 
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5   Chemical extraction of target proteins from the periplasm of 
recombinant E. coli 
 
 
 
Abstract 
 
The periplasm of E. coli has been known as a very suitable location for production of 
myriad recombinant proteins, particularly those having disulphide bonds in their 
structure; yet no generic periplasmic recovery methods with the potential for scale up 
exist. This work explains the development of chemical methods for the release of 
recombinant proteins from the periplasm of E. coli. Various chemicals, including 
detergents, chelators, chaotropes, and solvents were used singly and in different 
combinations to extract beta-lactamase, alpha-amylase, and Fab D1.3 expressed in 
the periplasm of E. coli. Prior to commencing main chemical permeabilisation 
experiments, washing bacterial cells with 50 mM Tris buffer pH 7.5 caused beta-
lactamase and Fab D1.3 release (43% and 48%, respectively) from the periplasm. 
Amongst single chemicals made in 200 mM Tris buffer pH 7.5, sodium deoxycholate 
(0.025% to 0.1%) was very efficient generic permeabiliser, being able to release the 
target proteins from the periplasm more efficient than osmotic shock. It caused less 
total cell protein release and consequently higher enzyme specific activity, 
purification factor, and yield factor when compared to the osmotic shock disruption. 
EDTA (1 mM and 10 mM), 10 mM NTA and 0.1% SHMP extracted periplasmic Fab 
D1.3 as efficient as osmotic shock; however, they had low performance for releasing 
beta-lactamase and alpha-amylase. Ten per cent (v/v) isoamyl alcohol was 
exceptionally effective for periplasmic release of alpha-amylase (75%) and Fab D1.3 
(168%), and caused very low amount of total protein release when compared to the 
osmotic shock treatment; nevertheless, the efficacy of 10% isoamyl alcohol for 
extracting beta-lactamase was low.  
 
The release effectiveness of different combinations of chemicals was also 
investigated. It was shown that EDTA can increase the performance of chemicals 
such as 0.1% Brij, 0.1% SDS, 0.01% DOC, 0.1% Triton X-100, 0.01% CTAB, 0.01% 
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BAC and 200 mM urea for discharging beta-lactamase and/or Fab D1.3 from the 
periplasm. It was also demonstrated that 200 mM urea enhanced the efficiency of 
0.1% Tween, 0.1% Brij, 0.1% SDS, 0.01% DOC, 0.01% CTAB and 0.01% BAC to 
release beta-lactamase and alpha-amylase. Combinations of solvents (hexane, 
xylene, benzene, toluene, and isoamyl alcohol) at 1% concentration with 0.025% 
DOC, 0.01 % CTAB, and 0.1% Triton X-100 could release the periplasmic alpha-
amylase or Fab D1.3 up to 100%, and resulted in higher enzyme specific activity, 
purification factor and yield factor due to less total protein release, compared to 
osmotic shock. 
 
5.1 Introduction 
 
There are three locations for the manufacture of recombinant proteins in E. coli: the 
cytoplasm, the culture medium, and the periplasm. The cytoplasm of E. coli lacks the 
oxidative conditions required for high-level protein folding, particularly for proteins 
having disulphide bond(s) in their structures, and as a result production of high-level 
recombinant proteins in the cytoplasm of E. coli in many cases leads to inclusion 
bodies formation, which are insoluble aggregates of misfolded product (Carrió and 
Villaverde, 2002; Heebøll-Nielsen et al., 2003; Ventura and Villaverde, 2006). 
Production of recombinant proteins through inclusion body formation pathway in the 
cytoplasm of E. coli is burdensome, as it needs extensive and expensive 
downstream operation units for the recovery of target protein in a fully refolded and 
biologically-active structure (Rudolph and Lilie, 1996; Singh and Panda, 2005; Vallejo 
and Rinas, 2004). 
  
Directing protein to the extracellular medium (Mergulhao et al., 2005; Pugsley et al., 
1997; Sandkvist, 2001) of E. coli is deemed advantageous; for example, minimum 
product contamination by host proteins occurs and also there is no need for cell 
disruption (Mergulhao et al., 2005). However, production of recombinant proteins in 
E. coli by secretion into culture medium has its own drawbacks. Considerable 
physical damages by shear forces of fermentation processes might happen, and 
highly diluted product requiring high volume capture is resulted in (Humphreys, 
2007). Also, existence of the outer membrane in the structure of the cell envelope of 
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E. coli can be a barrier for secretion of recombinant proteins into the extracellular 
medium, and as a result proteins end up in the periplasm rather than the culture 
medium.   
 
The periplasm of E. coli, on the other hand, is considered a very suitable site for the 
manufacture of recombinant proteins (Joly et al., 1998; Laird et al., 2005; Carter et 
al., 1992; Chen et al., 2004). Periplasmic disulphide bond forming (Dsb) proteins 
(Berkmen et al., 2007) , and periplasmic chaperones and isomerases (Betton, 2007; 
Richarme and Caldas, 1997) support the disulphide bond formation and accurate 
protein folding; hence, the periplasm is deemed a much better location for production 
of recombinant proteins having disulphide bonds in their structures. Additionally, the 
outer membrane is a permeable barrier, and the periplasm can be manipulated by 
being exposed to extracellular chemicals (≤ 600 Da) assisting protein folding (Barth 
et al., 2000; Sandee et al., 2005; Wunderlich and Glockshuber, 1993). The periplasm 
contains only 4-8% of the total cell protein (Park and Lee, 1998), and cytoplasmic 
nucleic acids and proteases – being challenging during product purification and 
recovery – are not present in the periplasm. 
 
The potential of periplasmic expression systems has not been fully exploited at large 
scale, and as to our knowledge, no general method for selective release of 
periplasmically expressed proteins has been reported. The classical procedure for 
releasing proteins from the periplasmic space of E. coli, which is based on 
destabilisation of the outer envelope with EDTA and Lysozyme followed by cold 
osmotic shock (Neu and Heppel, 1965; Moir and Mao, 1990) without destroying the 
cytoplasmic membrane, is not feasible at large scale (Joly and Laird, 2007). The 
large volumes of liquid have to be handled at low temperatures if the shock is to be 
effective, and Lysozyme is expensive. Besides, this technique is time-consuming as 
an extended time is required to resuspend large amount of cells pellet. Thus, 
developing selective methods for release of periplasmically-located recombinant 
proteins is integral in order to exploit the advantages of the periplasmic expression 
systems for downstream processing. 
 
 139
The objective of this work was to study the permeabilisation of E. coli cells, producing 
recombinant proteins in the periplasm, using a wide range of chemicals. In order to 
develop reliable chemical methods for effective selective release of periplasmically 
expressed proteins, the effects of chemicals on the structure and activity of such 
proteins ought to be appraised, prior to applying them for protein release. In chapter 
4, the impacts of a large number of acknowledged cell permeabilisation chemical 
reagents on the secondary structure and activity of beta-lactamase, alpha-amylase, 
and Fab D1.3 were investigated, and ‘safe’ chemical concentrations for cell 
permeabilisation were identified. In this chapter, extraction of target proteins (i.e. 
beta-lactamase, alpha-amylase, and Fab D1.3) by single and combination of ‘safe’ 
reagents from the periplasm of recombinant E. coli was studied. 
 
5.2 Materials and Methods 
 
5.2.1 Materials 
 
E. coli CLD048, expressing the antibody fragment Fab D1.3 in the periplasm was 
obtained from Merck Sharp and Dohme Ltd. (Billingham, UK). E. coli JM107 PQR126 
producing alpha-amylase in the periplasm, and E. coli JM109 producing beta-
lactamase were received as gifts from Professor John Ward (Research Department 
of Structural & Molecular Biology, University College London, UK), and Dr. Tim 
Overton (School of Chemical Engineering, University of Birmingham, UK) 
respectively. Nutrient agar and nutrient broth were purchased from Oxoid 
(Basingstoke, UK). Yeast extract and tryptone were obtained from Becton, Dickinson 
and Co. (BD) (Sparks, MD, USA). Potato starch, kanamycin, ampicillin, tetracycline, 
sodium chloride, sodium deoxycholate (DOC), cetyltrimethylammonium bromide 
(CTAB), benzalkonium chloride (BAC), Triton X-100, Tween 20, Brij-35, 
ethylenediaminetetraacetic acid (EDTA), diethanolamine (DEA), nitriolotriacetic acid 
(NTA), sodium hexametaphosphate (SHMP), urea, guanidinium chloride (GndCl), 
diethyl ether, pyridine, isoamyl alcohol, sucrose, (hydroxymethyl)aminomethane 
(Tris), sodium phosphate monobasic, sodium phosphate dibasic, sodium carbonate, 
sodium hydrogen carbonate, glycine for electrophoresis, dialysis tubing cellulose 
membrane, chicken egg white Lysozyme (HEWL), RNase A (pancreatic), bovine 
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serum albumin (BSA), sodium salt of benzylpenicillin, and anti-human IgG (Fab 
specific) - peroxidise antibody produced in goat were obtained from Sigma-Aldrich 
(Gillingham, UK). Sodium dodecyl sulphate (SDS) was supplied by Bio-Rad 
Laboratories (Hercules, CA, USA). Ammonium hydroxide, phosphoric acid, 
magnesium sulphate, calcium chloride dehydrate, manganese (II) sulphate 
fourhydrate, hexane, xylene, chloroform, ethanol, acetone, glacial acetic acid and 
potassium iodide were obtained from Fisher Scientific (Loughborough, UK). 
Benzene, toluene and iodine were supplied by BDH Laboratory supplies (Poole, UK). 
TMB microwell peroxidase substrate (2-C) was purchased from KPL (Gaithersburg, 
MD, USA). IPTG was purchased from Melford Laboratories (Suffolk, UK).  
 
5.2.2 Methods 
 
5.2.2.1 Agar plate cultures 
 
E. coli JM107 PQR126 cells were grown on nutrient agar plates complemented with 
1% (w/v) potato starch and 20 μg/mL kanamycin. Transformed E. coli K12 JM109 
cells were propagated on nutrient agar containing 100 μg/mL ampicillin. E. coli 
CLD048 cells from the cell bank, stored at -80°C, were propagated overnight on 
Nutrient agar supplemented with 15 mg/L tetracycline. 
 
5.2.2.2 Shake Flask cultivation for the production of beta-lactamase  
 
For this purpose, a single colony of E. coli JM109 was added to 100 mL Luria-Bertani 
(LB) (comprising 1% w/v NaCl, 0.5% yeast extract, 1% tryptone) supplemented with 
100 μg/mL ampicillin and incubated overnight (13 h) at 37°C in an orbital shaker at 
200 rpm. Flasks (1 L) containing 200 mL LB and 100 μg/mL ampicillin were 
inoculated with 0.2 mL (0.1% v/v) of the 13 h preculture and placed on orbital shaker 
at 200 rpm and 37°C for 18 h. The cells were collected by centrifugation at 4,120 g 
for 600 s, and the pellets were frozen at -20°C for further cell fractionation 
experiments.  
 
 
 141
5.2.2.3 Shake Flask cultivation for the production of alpha-amylase  
 
For this purpose, a single colony of E. coli JM107 PQR126 was suspended into 100 
mL nutrient broth containing 10 μg/mL kanamycin and incubated overnight (13 h) at 
200 rpm and 37°C. Flask (1000 mL) containing 200 mL nutrient broth supplemented 
with 10 μg/mL kanamycin was inoculated with 8 mL (4% v/v) of the 13 h preculture 
and placed on orbital shaker at 200 rpm and 37°C for 18 h. The cells were then 
harvested by centrifugation (Jouan C 422 centrifuge, SelectScience Ltd., Bath, UK) 
at 4,120 g for 600 s, and the pellets were frozen at -20°C for further cell fractionation 
experiments.  
 
5.2.2.4 Shake-flask cultivation for the production of Fab D1.3  
 
The complex medium employed for fed-batch fermentation (chapter 2, section 
2.2.2.1) was used for shake-flask cultivation in order to obtain cells for 
permeabilisation experiments. Starting cultures were prepared by inoculating 100 mL 
aliquots of Luria Bertani (LB) broth (comprising 1% NaCl, 0.5% yeast extract and 1% 
tryptone) containing 15 mg/L tetracycline with a fresh single colony of E. coli CLD048 
and shaking at 37°C and 200 rpm for 13 h. Eight millilitres of the 13 h LB broth 
preculture was added to 2 L Erlenmeyer flask containing 200 mL of the complex 
medium (i.e. as a 4% inoculum), and incubated at 37°C and 200 rpm. Fab D1.3 
expression was induced by the addition of IPTG to a final concentration of 0.1 mM 
after 6.5 h cultivation (OD600nm of ~10) and the culture left at 30°C for another 4.5 h, 
with shaking at 200 rpm. After 11 h (i.e. 4.5 h post induction), the bacterial cells were 
harvested by centrifugation (Jouan C 422 centrifuge, SelectScience Ltd., Bath, UK) 
at 4,120 g for 600 s, and the pellets were frozen at -20°C for further cell fractionation 
experiments.  
 
For all three strains mentioned above, the resulting supernatants after centrifugation 
(i.e. culture broth) were analysed by respective analytical method to detect product 
release during shake flask culture. 
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5.2.3 Cell fractionation  
 
Cell pastes were defrosted at room temperature and then resuspended in 50 mM Tris 
buffer pH 7.5, to a final OD600nm of ~5. Aliquots (1 mL) were then centrifuged for 300 
s at 15,800 g using an Eppendorf microfuge (5412 D, Eppendorf, Hamburg, 
Germany). The supernatants were removed and stored at -20°C to be analysed for 
product release, whilst the cell pellets were subjected to various chemical 
permeabilisation and mechanical disruption treatments as described below.  
 
5.2.3.1 Osmotic shock treatment 
 
5.2.3.1.1 Osmotic shock treatment for cells producing beta-lactamase and 
alpha-amylase 
 
Classic osmotic shock method 
 
Routinely, the cell pellets were re-suspended in 1 mL of 200 mM Tris buffer pH 7.5 
containing 1 mM EDTA, 20% sucrose and 500 μg/mL Lysozyme. Following a brief 
incubation (0.25 h) at room temperature, the cells were harvested by centrifugation at 
15,800 g for 300 s, and the supernatants were kept frozen at -20°C for further 
enzyme activity assay. The obtained cell pellet was resuspended in 1 mL cold 
distilled water and harvested at 15,800 g for 300 s, subsequent 0.25 h static 
incubation. All obtained supernatants were kept frozen at -20°C for further enzyme 
activity assay. 
 
Modified osmotic shock method 
 
French and colleagues (1996) have reported a different osmotic shock procedure in 
which cold distilled water is added to the osmotic shock solution (200 mM Tris buffer 
pH 7.5 containing 1 mM EDTA, 20% sucrose and 500 μg/mL Lysozyme) after 0.25 h 
incubation at room temperature. For conducting this modified osmotic shock 
treatment in the present work, the bacterial cell pellet of each strain in each 
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eppendorf tube was resuspended in 0.5 mL of 200 mM Tris buffer pH 7.5 containing 
1 mM EDTA, 20% sucrose and 500 μg/mL Lysozyme. The tubes were then 
incubated statically 0.25 h at room temperature, and 0.5 mL cold distilled water was 
next added. After 0.25 h static incubation, the pellet was separated from supernatant 
by centrifugation at 15,800 g for 300 s. The supernatants containing the periplasmic 
proteins were kept frozen at -20°C for further enzyme activity assay. 
 
5.2.3.1.2. Osmotic shock treatment for cells producing Fab D1.3 
 
The osmotic shock treatment employed was recommended by Merck Sharp and 
Dohme Ltd. Routinely, the cell pellets were resuspended in 1 mL of 20 mM Tris 
buffer pH 8.0 supplemented with 2.5 mM EDTA and 20% sucrose (osmotic solution 
1, OS1). After a static incubation on ice for 600 s, the cells were harvested by 
centrifugation at 15,800 g for 120 s, and the supernatants were immediately frozen at 
-20°C for further Fab D1.3 analysis. The obtained cell pellet was resuspended in 1 
mL of a second osmotic shock solution (designated OS2) lacking sucrose (i.e. 20 mM 
Tris buffer pH 8.0 containing 2.5 mM EDTA), incubated on ice for 600 s, and 
centrifuged at 15,800 g for 120 s. The obtained supernatants were stored at -20°C 
until required.  
 
5.2.3.2 High pressure homogenization 
 
Bacterial cell pellets were resuspended in 50 mL of 200 mM Tris buffer pH 7.5, to a 
final OD600nm of ~5, and then 5 mg RNase A was added to the mixture. The cells 
were subsequently disrupted using a continuous flow TS-Series benchtop disrupter 
(Constant Systems Ltd, Low March, UK) operated at 2.4 Bar and 5°C. The 
supernatant was separated from the cell debris by centrifugation at 15,800 g for 300 
s, and stored at -20°C for further analyses. 
 
5.2.3.3 Chemical permeabilisation  
 
Three categories of chemicals (singly and in various combinations) were used for cell 
perturbation (see Table 5.1): surfactants; chelators & chaotropic agents; and organic 
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solvents. Prior to chemical treatment, the cell pellets were washed once with 50 mM 
Tris buffer pH 7.5, and then re-suspended in 1 mL of the chosen chemical. Following 
incubation for 1 h at room temperature with brief intermittent vortexing (Clifton 
Cyclone, Scientific Laboratory Supplies, Notingham, UK) every 600 s, the 
supernatants were separated from the cells by centrifugation at 15,800 g for 300 s 
and frozen at -20°C for further analyses. 
 
Table 5.1 Chemicals utilised in cell permeabilisation experiment. 
 
Surfactants 
 
    Anionic       Cationic     Non-ionic  
   
Chelators and 
Chaotropic 
agents 
Organic 
solvents 
DOC CTAB Triton X-100 EDTA Hexane 
SDS BAC Tween 20 DEA Benzene 
  Brij 35 NTA Toluene 
   SHMP Diethyl ether 
   Urea Chloroform 
   GndCl Ethanol 
    Acetone 
    Pyridine 
    Isoamyl alcohol 
 
 
5.2.4  Analytical techniques 
 
5.2.4.1 Enzyme assays and Fab D1.3 quantification 
 
Beta-lactamase and alpha-amylase quantifications were done according to the 
technique described in Chapter 4 (sections 4.2.2.3 and 4.2.2.4). The amount of beta-
lactamase in each sample was calculated using beta-lactamase from Enterobacter 
cloacae as a standard (concentration range: 0.1-1 Units per mL of 200 mM Tris 
buffer, pH 7.5). The amount of alpha-amylase in each sample was calculated using 
 145
alpha-amylase from Aspergillus orizae as a standard (concentration range: 1-10 
Units per mL of 200 mM Tris pH 7.5 buffer). ELISA described in Chapter 2 (section 
2.2.2.4.2) was used for Fab D1.3 quantification. 
 
5.2.4.2 Total protein quantification 
 
The amount of total protein present in the samples was measured using 
bicinchoninic acid assay (BCA assay kit, Thermoscientific, Rockford, IL, USA) 
employing bovine serum albumin (BSA) as a standard. 
 
5.3 Results and Discussion 
 
Analysis of the broth culture media at the end of shake flask cultivation of the strains 
producing recombinant periplasmic proteins (i.e. beta-lactamase, alpha-amylase, and 
Fab D1.3) showed that none of the target proteins secreted into the extracellular 
medium. After shake flask cultivations, E. coli cells were harvested and washed with 
50 mM Tris buffer pH 7.5 prior to chemical permeabilisation. Washing cells with 50 
mM Tris buffer pH 7.5 could result in product release from the periplasm, and it was 
demonstrated that the amounts of product release by this washing step were not the 
same in different recombinant strains producing various periplasmic proteins. 
Washing cells with 50 mM Tris buffer pH 7.5 released 43% and 48% of the 
periplasmic beta-lactamase and Fab D1.3, respectively, whilst this cell washing step 
released only 1% of the periplasmic alpha-amylase (Figs 5.1 to 5.3). This can show 
that alpha amylase is more difficult to release from the periplasm than beta-
lactamase and Fab D1.3. It has been previously reported that Tris at moderately high 
concentrations (e.g. up to 200 mM) can permeabilise the outer membrane, by 
interacting with LPS and replacing stabilizing cations, and sensitize gram negative 
bacteria to other agents such as Lysozyme, detergents and antibiotics. High 
concentration of Tris alone (100 mM, pH 7.2), without EDTA has been shown to 
release 20% of LPS from smooth S. typhimurium. (Hancock, 1984; Nikaido and 
Vaara, 1985; Vaara, 1992). In the present work, it was shown that Tris could 
individually release the periplasmic proteins in disparate extents. 
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Classic and modified osmotic shock procedures were used in order to recover beta-
lactamase and alpha-amylase from the periplasm of bacterial cell. Beta-lactamase 
and alpha-amylase recovery figures obtained from the modified osmotic shock 
treatment were respectively 11% and 21% higher than those achieved from the 
classic osmotic shock (Figs 5.1 and 5.2). The efficiency of the modified osmotic 
shock in releasing periplasmic beta-lactamase and alpha-amylase was similar to the 
performance of homogenization. As mentioned earlier, in the modified osmotic shock 
treatment cold water is added to the osmotic shock solution 
(EDTA/sucrose/Lysozyme) containing bacterial cells after 0.25 h incubation at room 
temperature. This method has been previously employed to increase alpha-amylase 
recovery from the periplasm of E. coli PQR126 cells (French et al., 1996). It has been 
demonstrated that a rapid influx of water into the periplasm can expand the 
periplasmic space and increase the distance between the polysaccharide chains of 
peptidoglycan which are stacked together; subsequently, this can increase the 
binding of Lysozyme to the peptidoglycan matrix and assist cell disruption (French et 
al., 1996; Witholt et al., 1976). 
 
For recovery of Fab D1.3 from the periplasm by osmotic shock, it was not feasible to 
include HEWL in the osmotic shock solution because HEWL is specific antigen for 
Fab D1.3, and including it in the osmotic shock solution compromises the Fab assay 
by ELISA, being based on attachment of Fab D1.3 to immobilised HEWL on 
microplate. Even in the absence of HEWL, osmotic shock was very efficient for 
releasing Fab D1.3 from the periplasm (Fig 5.3). 
 
Various concentrations of chemicals were used to permeabilise E. coli cells and to 
extract beta-lactamase, alpha-amylase, and Fab D1.3. These chemicals were 
screened by ht-CD and activity assay experiments explained in Chapter 4. By 
sequence similarity searching against protein databases using the FASTA program 
(http://www.ebi.ac.uk/Tools/fasta33/), before conducting CD and activity assay 
experiments, it was shown that these enzymes were genetically most similar to the 
enzyme produced in the periplasm of E. coli JM107 PQR126 and E. coli K12 JM109 
transformed with the cloning vector pBR322; there was 25.9% identity (51.2% 
similarity) between alpha amylase Asp. orizae and the alpha-amylase produced in E. 
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coli, and 33.1% identity (69.8% similarity) between beta lactamase E. cloacae and 
the beta- lactamase produced in E. coli. 
 
Three categories of chemicals, all prepared in 200 mM Tris buffer pH 7.5, were singly 
utilized for bacterial cell permeabilisation in this study. Detergents (nonionic, anionic, 
and cationic), the first category of chemicals, resulted in different extent of product 
release from the periplasm of three bacterial strains in this study (Figs. 5.1 to 5.3). It 
is evident from the results that sodium deoxycholate at concentrations ranged from 
0.025% to 0.1% is very efficient permeabiliser amongst the experimented detergents. 
However, increasing concentration of this anionic detergent resulted in a gradual rise 
in total protein release from the bacterial cells and subsequently lowered specific 
activity, purification factor and yield factor (Tables 5.2 and 5.3). However, total cell 
protein released by the highest concentration of DOC (i.e. 0.1%) was less than that 
released by osmotic shock, and as a result specific activity, purification factor and 
yield factor values obtained from cell permeabilisation by 1% (and lower 
concentrations) DOC were much higher than those acquired by osmotic shock. 
Increasing concentration of DOC from 0.05% to 0.1% did not enhance beta-
lactamase discharge from the periplasm; also, there was no rise in D1.3 Fab release 
at concentrations above 0.025% of DOC. However, more alpha-amylase was 
discharged by higher concentration of DOC. These results show that Fab D1.3 and 
beta-lactamase are easier to release by DOC. Mechanism(s) by which DOC 
permeabilises the OM and releases the periplasmic proteins in a higher rate than 
other experimented detergents is not known. 
 
It is apparent from the results that increasing the concentration of cationic detergents 
(CTAB and BAC) from 0.01% to 0.05% decreased the product release from the 
periplasm. This is due to negative impact of the cationic detergents on the structure 
and activity of the proteins. Circular dichroism and biological activity analyses 
(Chapter 4) of the proteins (i.e. beta-lactamase, alpha-amylae and Fab D1.3) 
demonstrated that there were substantial protein secondary structure alterations and 
loss of activity in the presence of increasing concentrations of CTAB and BAC. Also 
sedimentation velocity studies (Chapter 4) confirmed the formation of Fab D1.3 
multimers (aggregates) in the presence of 0.05% CTAB. Bansal- Mutalik and Gaikar 
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(2003) have also reported that treatment of E. coli cells with aqueous CTAB solutions 
(10 mM) caused substantial penicillin acylase release, but the enzyme activity 
recovered was only 18% due to deactivation of the enzyme by CTAB. Therefore, 
cationic detergents do not look conducive for E. coli cell permeabilisation because of 
their detrimental impacts on protein structure and activity. 
 
As illustrated in the figures 5.1 to 5.3, the most efficient non-ionic detergents could 
release maximum 25 to 40 per cent of the periplasmic proteins, when compared to 
osmotic shock treatment. It is known that the outer membrane of gram-negative 
bacteria is resistant to non-ionic and anionic detergents, but sensitive to cationic 
detergents which bind to the negatively charged LPS and phospholipids in the cell 
envelope (Bansal-Mutalik and Gaikar, 2003; Burman et al., 1972; D’mello and Yotis, 
1987; Filip et al., 1973; Vaara, 1992). The main specificity of the detergents is for 
phospholipids and the proteins in the cytoplasmic membrane, modifying of which 
leads to the discharge of cytoplasmic proteins. However, neutral and anionic 
detergents may cause disruption of gram-negative bacterial cells provided that the 
cells are pretreated (e.g., by EDTA) (Middelberg, 1995). It can be construed that 200 
mM Tris buffer pH 7.5 utilized in this work destabilized the OM of the bacterial cells 
and alleviated the action of detergents, particularly non-ionic and anionic ones, to 
release recombinant proteins to different extents from the periplasm. 
 
The second category of chemicals used for permeabilisation included chelators 
(EDTA, DEA, NTA, and SHMP) and chaotropic agents (urea and GndCl), all 
prepared in 200 mM Tis buffer pH 7.5. Chelating agents can permeabilise the OM by 
chelating Mg2+ and Ca2+ crossbridging adjacent LPS molecules and as a result 
releasing a proportion of LPS from the bacterial cells, replacement of which with 
phospholipids from the inner leaflet of the OM or from the cytoplasmic membrane 
creates phospholipid bilayer channels through which hydrophobic compounds can 
surpass. Weakening the LPS-LPS interaction by the removal of divalent cations may 
also allow the penetration of small hydrophobic molecules (Nikaido and Vaara, 
1985). It has been shown that Tris buffer can synergistically assist the action of 
chelators (Nikaido and Vaara, 1985; Varra 1992). It has been reported that EDTA 
(0.3 to 3.0 mM) enhanced excretion of beta lactamase from immobilized E. coli cells 
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and released alkaline phosphatase from the periplasm (Neu and Heppel, 1965; Ryan 
and Parulekar, 1991). Other chelators, such as HMP and NTA, have been also 
shown to increase the permeability of the OM and the sensitivity of gram negative 
bacteria to hydrophobic drugs and detergents (Hancock, 1984; Vaara and Jaakkola, 
1989).  In the present work, 1 mM EDTA and 10 mM DEA were the most efficient 
chelators for discharging the periplasmic beta-lactamase and alpha-amylase, and 
released  44 and 27 per cent beta-lactamase and alpha-amylase from the periplasm, 
correspondingly (Figs 5.1 and 5.2). As shown in Fig 5.3, EDTA at concentrations of 1 
mM and 10 mM discharged the Fab from the periplasm more efficient than osmotic 
shock (108% and 138%, correspondingly). 10 mM NTA and 0.1% SHMP, releasing 
respectively 81% and 95% of periplasmic Fab D1.3, were less effectual than EDTA. 
These chelators caused much less total protein release from the cells when 
compared to the osmotic shock treatment, and consequently led to much higher 
specific activity, purification factor and yield factor (Tables 5.2 and 5.3).  
 
Chaotropes, such as urea and GndCl, disorganize the structure of water, by 
interfering with hydrogen bonds, rendering it less hydrophilic, and weaken solute-
solute hydrophobic interactions bringing them into aqueous solution. Chaotropes 
should usually be employed at high concentration while they are exploited singly for 
extraction of cytoplasmic proteins (Falconer et al., 1997 and 1999). Nonetheless, it 
has been evinced that the outer membrane in the presence of low concentrations of 
chaotropes (e.g. 0.2 mM GndCl) can be disrupted leading to selective protein 
recovery with high purity from the periplasm (Naglak and Wang, 1990). In recent 
work, urea at concentrations up to 200 mM released the periplasmic recombinant 
proteins (31.5% beta-lactamase, and 28% alpha-amylase and Fab D1.3) with a 
product yield less than that of osmotic shock, although less total protein released by 
urea caused higher specific activity and purification factor when compared to the 
osmotic shock treatment. By and large, the efficiency of 200 mM GndCl for 
permeabilising the cells producing beta-lactamase was the same as urea; however, 
this concentration of GndCl had no or negligible permeabilisation effect on the strains 
producing alpha-amylase and Fab D1.3.  
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The third class of chemicals used for cell permeabilisation in this work included 
solvents. Solvents probably act by dissolving hydrophobic components, such as the 
inner and outer membrane of gram negative bacteria (Middelberg, 1995). Solvents 
have been used for protein recovery from cytoplasm and periplasm of gram negative 
bacteria. It has been shown that cytoplasmic proteins of E. coli are released with a 
relatively low efficiency by toluene (1-5%), the frequently employed solvent (De Smet 
et al., 1978; Jackson and Demoss, 1965). Chloroform has been employed 
successfully for the extraction of the biodegradable storage polymer, 
polyhydroxybutyrate, from various bacteria (Braunegg et al., 1978; Lundgren et al., 
1965). Ames and colleagues (1984) employed different solvents (chloroform, 
chloroform-toluene, phenethyl alcohol, ether, ether-chloroform and dimethyl 
sulfoxide) for extraction of periplasmic proteins from gram negative bacteria, and 
concluded from SDS-PAGE results that chloroform was the most effective solvent 
leading to total protein recovery and purity comparable to those obtained by osmotic 
shock. Geckil and colleagues (2004) investigated membrane permeabilisation for the 
release of periplasmic L-asparaginase from Enterobacter aerogenes and 
Pseudomonas aeroginosa using various solvents (hexane, toluene, xylene, benzene 
and diethylether) made in potassium phosphate buffer, and showed that 1% hexane 
was the most efficient solvent for permeabilisation in both strains, releasing the 
periplasmic enzyme with much higher specific activity than that achieved by 
mechanical disruption (sonication). The higher efficiency of hexane in comparison 
with other solvents can be attributed to its small size enabling it to penetrate into the 
outer membrane. In the present work solvents (hexane, xylene, toluene, benzene, 
diethylether, acetone, chloroform, pyridine, ethanol, and isoamyl alcohol) at 1% 
concentration were made in 200 mM Tris buffer pH 7.5 and utilized for cell 
permeabilisation. In terms of priplasmic protein release, in general solvents at 1% 
concentration were not as effective as osmotic shock treatment. Ten per cent (v/v) 
isoamyl alcohol was exceptionally effective for periplasmic release of alpha-amylase 
(75%) and Fab D1.3 (168%), and yielded much higher specific activity, purification 
factor and yield factor – due to nominal amount of total protein release – when 
compared to the osmotic shock treatment (Figs 5.1 & 5.2 and Tables 5.2 & 5.3).  
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Fig. 5.1 Release of beta-lactamase from transformed E. coli JM109 cells by 
homogenization, osmotic shock and single chemicals made in 200 mM Tris buffer pH 
7.5. Results are averages of two measurements. 
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Fig. 5.2 Release of alpha-amylase from E. coli JM107 PQR126 cells by 
homogenization, osmotic shock and single chemicals made in 200 mM Tris buffer pH 
7.5. Results are averages of two measurements. 
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Fig. 5.3 Release of Fab D1.3 from E. coli CLD048 cells by homogenization, osmotic 
shock and single chemicals made in 200 mM Tris buffer pH 7.5. Results are 
averages of two measurements. 
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Table 5.2 Comparison between efficiency of homogenization, osmotic shock and 
various chemicals which release beta-lactamase and alpha-amylase from the 
periplasm of E. coli cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Continued) 
 
Chemicals (prepared 
in 200mM Tris buffer 
pH 7.5) 
Average 
recovered 
enzyme 
(U/mL/min) 
 
amy.f  lac.g 
Average 
Total 
protein 
(mg/mL) 
 
amy.     lac. 
Enzyme 
specific activity 
 (U/mg) 
 
  amy.         lac. 
Enzyme yield a 
 
  amy.         lac. 
Total  b 
 protein yield  
    
amy.        lac. 
PF c 
 
amy.     lac. 
YF%  d 
 
amy.  lac. 
Washing cells with 50 mM Tris  
buffer pH 7.5 4.48 0.30 0.07 0.14 67.98 2.18 9.73 77.37 12.34 26.11 0.79 2.96 0.08 2.29 
Homogenization 45.03 0.41 1.12 1.33 40.34 0.31 97.85 104.90 209.06 251.87 0.47 0.42 0.46 0.44 
Osmotic shock followed by 
water dilution 46.02 0.39 0.53 0.53 86.20 0.74 100.00 100.00 100.00 100.00 1.00 1.00 1.00 1.00 
Osmotic shock 36.40 0.35 0.54 0.51 67.56 0.68 79.09 89.69 100.89 97.35 0.78 0.92 0.62 0.83 
Cold water wash 5.09 0.06 1.04 0.92 4.90 0.06 11.06 14.69 194.52 173.78 0.06 0.08 0.01 0.01 
0.05% Triton X-100  9.99 0.15 0.04 0.07 229.97 2.15 21.71 38.92 8.13 13.34 2.67 2.92 0.58 1.14 
0.1% Triton X-100 11.58 0.10 0.07 0.09 168.41 1.11 25.16 24.74 12.88 16.32 1.95 1.52 0.49 0.38 
0.01% Tween 20  10.30 0.12 0.02 0.04 472.26 2.70 22.38 29.90 4.08 8.13 5.48 3.68 1.23 1.10 
0.1% Tween 20 9.47 0.13 0.05 0.08 176.35 1.69 20.58 34.54 10.06 14.98 2.05 2.31 0.42 0.80 
0.001% Brij  14.12 0.09 0.03 0.05 487.06 2.02 30.68 23.71 5.43 8.62 5.65 2.75 1.73 0.65 
0.01% Brij  14.98 0.15 0.05 0.06 281.95 2.47 32.55 39.69 9.95 11.82 3.27 3.36 1.06 1.33 
0.1% Brij  6.68 0.15 0.09 0.11 76.99 1.36 14.52 38.66 16.25 20.84 0.89 1.86 0.13 0.72 
0.001% SDS 8.57 0.13 0.02 0.05 415.86 2.31 18.62 32.73 3.86 10.40 4.83 3.15 0.90 1.03 
0.01% SDS 10.06 0.14 0.04 0.06 287.18 2.28 21.86 35.82 6.56 11.53 3.33 3.11 0.73 1.11 
0.1% SDS  13.99 0.18 0.08 0.09 173.94 2.02 30.40 45.88 15.06 16.70 2.02 2.75 0.61 1.26 
0.01% DOC 14.45 0.13 0.05 0.05 269.09 2.51 31.40 34.02 10.06 9.96 3.12 3.42 0.98 1.16 
0.025%  DOC 32.28 0.27 0.06 0.10 572.65 2.65 70.14 69.07 10.56 19.14 6.64 3.61 4.66 2.49 
0.05% DOC  40.27 0.38 0.14 0.19 288.14 1.97 87.51 97.42 26.17 36.41 3.34 2.68 2.93 2.61 
0.1% DOC 49.71 0.38 0.25 0.18 196.47 2.06 108.02 97.42 47.38 34.76 2.28 2.80 2.46 2.73 
0.001% BAC 6.96 0.10 0.01 0.03 853.99 3.33 15.12 25.52 1.53 5.63 9.91 4.53 1.50 1.16 
0.01% BAC  9.27 0.12 0.02 0.04 389.82 3.14 20.14 31.44 4.45 7.35 4.52 4.28 0.91 1.34 
0.05% BAC  8.02 0.08 0.02 0.03 343.32 2.42 17.43 20.10 4.37 6.10 3.98 3.30 0.69 0.66 
0.001% CTAB  14.00 0.13 0.03 0.05 507.98 2.51 30.42 33.76 5.16 9.87 5.89 3.42 1.79 1.15 
0.01% CTAB  11.65 0.17 0.04 0.07 290.67 2.29 25.32 43.81 7.51 14.07 3.37 3.11 0.85 1.36 
0.05% CTAB  2.76 0.06 0.04 0.06 77.38 1.04 6.00 15.21 6.68 10.79 0.90 1.41 0.05 0.21 
1 mM EDTA  6.29 0.18 0.05 0.06 126.41 2.97 13.67 45.36 9.32 11.22 1.47 4.04 0.20 1.83 
10 mM EDTA 2.20 0.14 0.01 0.02 260.36 8.42 4.78 35.57 1.58 3.11 3.02 11.45 0.14 4.07 
10 mM DEA 12.60 0.15 0.03 0.07 362.28 2.22 27.38 39.69 6.51 13.17 4.20 3.01 1.15 1.20 
10 mM NTA 5.59 0.12 0.03 0.03 208.35 4.30 12.15 30.67 5.02 5.25 2.42 5.85 0.29 1.79 
0.1% SHMP 8.00 0.14 0.05 0.07 167.75 1.87 17.38 35.05 8.93 13.75 1.95 2.55 0.34 0.89 
1% SHMP  5.46 0.12 0.04 0.06 150.33 1.94 11.86 31.96 6.80 12.14 1.74 2.63 0.21 0.84 
10 mM Urea   6.11 0.14 0.01 0.05 485.69 2.61 13.28 34.79 2.36 9.81 5.64 3.55 0.75 1.23 
50 mM Urea 7.43 0.14 0.03 0.05 290.69 2.75 16.15 36.60 4.79 9.79 3.37 3.74 0.54 1.37 
100 mM Urea   8.50 0.13 0.03 0.06 264.72 2.30 18.47 33.25 6.01 10.61 3.07 3.13 0.57 1.04 
200 mM Urea  12.90 0.12 0.03 0.08 391.38 1.54 28.03 30.93 6.17 14.80 4.54 2.09 1.27 0.65 
200 mM GndCl   1.29 0.10 0.00 0.02 586.36 4.23 2.80 26.03 0.41 4.52 6.80 5.75 0.19 1.50 
1% Hexane   9.78 0.11 0.04 0.04 256.36 2.82 21.25 27.84 7.14 7.25 2.97 3.84 0.63 1.07 
1% Xylene  7.20 0.13 0.03 0.06 214.48 2.18 15.65 33.51 6.29 11.31 2.49 2.96 0.39 0.99 
1% Benzene   9.08 0.17 0.03 0.07 346.83 2.32 19.73 43.04 4.90 13.66 4.02 3.15 0.79 1.36 
1% Toluene   3.20 0.15 0.01 0.06 265.56 2.27 6.95 37.37 2.26 12.09 3.08 3.09 0.21 1.16 
1% Diethylether  5.29 0.15 0.01 0.05 608.05 3.13 11.50 38.66 1.63 9.09 7.06 4.25 0.81 1.64 
1% Chloroform   9.79 0.12 0.03 0.05 352.67 2.20 21.27 30.67 5.20 10.25 4.09 2.99 0.87 0.92 
1% Ethanol   7.91 0.15 0.02 0.05 377.21 3.04 17.19 37.37 3.93 9.03 4.38 4.14 0.75 1.55 
1% Acetone  11.99 0.13 0.03 0.04 458.33 3.02 26.05 32.73 4.90 7.97 5.32 4.11 1.39 1.34 
1% Pyridine   4.88 0.16 0.03 0.06 153.07 2.77 10.60 41.75 5.97 11.10 1.78 3.76 0.19 1.57 
1% Isoamyl alcohol   5.42 0.12 0.02 0.04 306.73 3.32 11.78 30.67 3.31 6.79 3.56 4.52 0.42 1.39 
10% Isoamyl alcohol  34.01 0.14 0.11 0.07 300.73 2.13 73.90 35.82 21.18 12.38 3.49 2.89 2.58 1.04 
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Table 5.2     Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chemicals (prepared 
in 200mM Tris buffer 
pH 7.5) 
Average 
recovered 
enzyme 
(U/mL/min) 
 
amy.f  lac.g 
Average 
Total 
protein 
(mg/mL) 
 
amy.     lac. 
Enzyme 
specific activity 
 (U/mg) 
 
  amy.         lac. 
Enzyme yield a 
 
  amy.         lac. 
Total  b 
 protein yield  
    
amy.        lac. 
PF c 
 
amy.     lac. 
YF%  d 
 
amy.  lac. 
1 mM EDTA + 0.1% Brij   2.55 0.24 0.08 0.18 31.09 1.31 5.54 60.57 15.36 33.87 0.36 1.79 0.02 1.08 
1 mM EDTA + 0.1% Triton X-
100   6.29 0.06 0.16 0.22 38.26 0.27 13.67 15.46 30.79 42.29 0.44 0.37 0.06 0.06 
1 mM EDTA + 0.1% SDS   7.35 0.22 0.11 0.13 69.03 1.65 15.97 56.70 19.94 25.19 0.80 2.25 0.13 1.28 
1 mM EDTA + 0.01% DOC  7.33 0.32 0.07 0.11 108.43 2.94 15.93 82.47 12.66 20.65 1.26 3.99 0.20 3.29 
1 mM EDTA + 0.01% CTAB   0.26 0.11 0.01 0.04 26.69 3.07 0.56 28.09 1.82 6.73 0.31 4.17 0.00 1.17 
1 mM EDTA + 200 mM Urea   1.32 0.23 0.02 0.08 53.72 2.91 2.87 58.76 4.60 14.84 0.62 3.96 0.02 2.33 
1 mM EDTA + 200 mM GndCl  0.00 0.09 0.00 0.02 0.00 4.66 0.00 22.16 0.03 3.50 0.00 6.33 0.00 1.40 
1 mM EDTA + 0.01% BAC  0.13 0.10 0.01 0.04 9.04 2.72 0.27 26.80 2.61 7.25 0.10 3.70 0.00 0.99 
200 mM Urea + 0.1% Triton X-
100 7.41 0.04 0.06 0.12 120.86 0.31 16.10 9.79 11.48 23.39 1.40 0.42 0.23 0.04 
200 mM Urea + 0.1% Tween 
20   6.65 0.17 0.06 0.07 115.25 2.32 14.45 42.78 10.81 13.58 1.34 3.15 0.19 1.35 
200 mM Urea + 0.1% Brij  26.12 0.05 0.12 0.14 217.56 0.38 56.76 13.14 22.48 25.67 2.52 0.51 1.43 0.07 
200 mM Urea + 0.1% SDS  34.48 0.18 0.09 0.11 396.60 1.62 74.92 46.39 16.28 20.99 4.60 2.21 3.45 1.03 
200 mM Urea + 0.01% DOC 20.91 0.20 0.04 0.10 506.17 2.01 45.44 50.52 7.74 18.46 5.87 2.74 2.67 1.38 
200 mM Urea + 0.025% DOC 20.82 0.10 0.05 0.11 391.87 0.90 45.24 25.77 9.95 21.05 4.55 1.22 2.06 0.32 
200 mM Urea + 0.01% BAC 7.07 0.19 0.02 0.05 285.54 3.90 15.36 48.20 4.64 9.09 3.31 5.30 0.51 2.55 
200 mM Urea + 0.01% CTAB  39.94 0.03 0.40 0.26 98.95 0.11 86.79 7.73 75.59 49.76 1.15 0.16 1.00 0.01 
200 mM GndCl + 0.1% Triton 
X-100  1.57 0.02 0.04 0.06 43.71 0.38 3.41 5.93 6.73 11.33 0.51 0.52 0.02 0.03 
200 mM GndCl + 0.1% Tween 
20   0.89 0.09 0.03 0.05 26.06 1.60 1.93 22.42 6.40 10.33 0.30 2.17 0.01 0.49 
200 mM GndCl + 0.1% Brij  1.28 0.11 0.04 0.08 31.81 1.29 2.78 27.32 7.54 15.57 0.37 1.75 0.01 0.48 
200 mM GndCl + 0.1% SDS  4.17 0.11 0.02 0.03 200.58 3.64 9.06 27.58 3.89 5.57 2.33 4.95 0.21 1.37 
200 mM GndCl + 0.01% DOC 2.01 0.13 0.01 0.03 190.88 4.11 4.37 32.47 1.97 5.81 2.21 5.59 0.10 1.82 
200 mM GndCl + 0.025% DOC 3.01 0.14 0.02 0.05 151.26 3.01 6.54 36.08 3.73 8.83 1.76 4.09 0.11 1.48 
200 mM GndCl + 0.01% BAC 0.96 0.11 0.02 0.05 52.46 2.38 2.09 27.84 3.43 8.59 0.61 3.24 0.01 0.90 
200 mM GndCl + 0.01% CTAB 1.63 0.03 0.00 0.02 705.63 1.44 3.54 8.76 0.43 4.49 8.19 1.95 0.29 0.17 
1% Hexane + 0.1% Triton X-
100 9.70 0.16 0.06 0.07 171.74 2.41 21.08 40.98 10.58 12.50 1.99 3.28 0.42 1.34 
1%Hexane + 0.025% DOC 13.90 0.22 0.07 0.07 196.88 3.22 30.20 56.70 13.22 12.96 2.28 4.38 0.69 2.48 
1% Hexane + 0.01% CTAB  9.53 0.10 0.02 0.04 411.31 2.70 20.71 26.55 4.34 7.22 4.77 3.68 0.99 0.98 
1% Xylene + 0.1% Triton X-100 13.10 0.04 0.05 0.08 250.67 0.50 28.47 10.77 9.79 15.95 2.91 0.68 0.83 0.07 
1% Xylene + 0.025% DOC  41.60 0.17 0.10 0.08 431.31 2.09 90.40 42.53 18.06 14.95 5.00 2.84 4.52 1.21 
1% Xylene + 0.01% CTAB  40.88 0.15 0.10 0.09 390.78 1.76 88.83 39.43 19.59 16.43 4.53 2.40 4.03 0.95 
1% Benzene + 0.1% Triton X-
100 14.40 0.06 0.07 0.10 201.74 0.54 31.29 14.18 13.37 19.40 2.34 0.73 0.73 0.10 
1% Benzene + 0.025% DOC 44.93 0.17 0.10 0.08 428.48 2.10 97.63 42.53 19.64 14.89 4.97 2.86 4.85 1.21 
1% Benzene + 0.01% CTAB 42.50 0.13 0.12 0.09 363.87 1.50 92.35 33.51 21.87 16.40 4.22 2.04 3.90 0.68 
1% Toluene + 0.1% Triton X-
100  14.13 0.03 0.06 0.08 242.49 0.43 30.70 8.51 10.91 14.56 2.81 0.58 0.86 0.05 
1% Toluene + 0.025% DOC 28.86 0.15 0.10 0.09 294.52 1.76 62.71 39.43 18.35 16.43 3.42 2.40 2.14 0.95 
1% Toluene + 0.01% CTAB  34.19 0.15 0.10 0.08 333.43 1.95 74.29 38.66 19.20 14.54 3.87 2.66 2.87 1.03 
1% Diethyether + 0.1% Triton 
X-100  10.48 0.17 0.06 0.06 182.36 2.69 22.77 43.30 10.76 11.84 2.12 3.66 0.48 1.58 
1% Diethylether + 0.025% DOC 16.70 0.18 0.08 0.08 217.67 2.15 36.29 46.65 14.37 15.92 2.53 2.93 0.92 1.37 
1% Diethylether + 0.01% CTAB 13.15 0.11 0.06 0.06 221.79 1.68 28.57 28.09 11.10 12.30 2.57 2.28 0.74 0.64 
1% Chloroform + 0.1% Triton 
X-100  14.39 0.02 0.07 0.06 202.85 0.37 31.27 5.41 13.28 10.64 2.35 0.51 0.74 0.03 
1% Chloroform + 0.025% DOC 24.28 0.08 0.07 0.05 334.48 1.58 52.76 20.88 13.59 9.72 3.88 2.15 2.05 0.45 
1% Chloroform + 0.01% CTAB  15.39 0.05 0.06 0.04 277.70 1.24 33.44 12.89 10.38 7.61 3.22 1.69 1.08 0.22 
(Continued) 
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Table 5.2     Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chemicals (prepared 
in 200mM Tris buffer 
pH 7.5) 
Average 
recovered 
enzyme 
(U/mL/min) 
 
amy.f  lac.g 
Average 
Total 
protein 
(mg/mL) 
 
amy.     lac. 
Enzyme 
specific activity 
 (U/mg) 
 
  amy.         lac. 
Enzyme yield a 
 
  amy.         lac. 
Total  b 
 protein yield  
    
amy.        lac. 
PF c 
 
amy.     lac. 
YF%  d 
 
amy.  lac. 
1% Ethanol + 0.1% Triton X-
100  12.14 0.18 0.07 0.06 164.61 2.70 26.38 45.10 13.81 12.27 1.91 3.68 0.50 1.66 
1% Ethanol + 0.025% DOC 16.70 0.18 0.07 0.09 227.09 1.85 36.29 45.10 13.77 17.95 2.64 2.51 0.96 1.13 
1% Ethanol + 0.01% CTAB  28.48 0.18 0.07 0.08 383.00 2.21 61.89 45.62 13.93 15.16 4.44 3.01 2.75 1.37 
1% Acetone + 0.1% Triton X-
100  12.41 0.16 0.08 0.05 163.61 2.88 26.97 40.46 14.20 10.32 1.90 3.92 0.51 1.59 
1% Acetone + 0.025% DOC  17.65 0.18 0.07 0.10 247.03 1.74 38.35 45.88 13.38 19.39 2.87 2.37 1.10 1.09 
1% Acetone + 0.01% CTAB 24.53 0.14 0.09 0.06 280.70 2.12 53.30 35.31 16.37 12.26 3.26 2.88 1.74 1.02 
1% Pyridine + 0.1% Triton X-
100  2.60 0.19 0.55 0.57 4.76 0.33 5.65 48.97 102.28 107.95 0.06 0.45 0.00 0.22 
1% Pyridine + 0.025% DOC 18.01 0.26 0.08 0.10 233.32 2.58 39.14 66.24 14.46 18.85 2.71 3.51 1.06 2.33 
1% Pyridine + 0.01% CTAB  25.89 0.15 0.08 0.07 317.24 2.25 56.26 38.92 15.28 12.70 3.68 3.06 2.07 1.19 
1% Isoamyl alcohol + 0.1% 
Triton X-100  14.40 0.01 0.09 0.14 164.33 0.06 31.29 2.32 16.41 26.50 1.91 0.09 0.60 0.00 
1% Isoamyl alcohol + 0.025% 
DOC 18.31 0.19 0.06 0.08 322.02 2.45 39.79 47.94 10.65 14.39 3.74 3.33 1.49 1.60 
1% Isoamyl alcohol + 0.01% 
CTAB  17.55 0.14 0.07 0.06 235.82 2.19 38.14 35.82 13.94 12.02 2.74 2.98 1.04 1.07 
a and b Relative to extraction by osmotic shock followed by water dilution 
c Enzyme yield divided to total protein yield 
d Enzyme yield multiply by PF divided to 100 
f  Strain producing alpha-amylase 
g Strain producing beta-lactamase 
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Table 5.3 Comparison between efficiency of homogenization, osmotic shock and 
various chemicals which release Fab D1.3 from the periplasm of E. coli cells. 
 
 
 
 
 
 
 
Chemicals (prepared in 200 
mM Tris beffer pH 7.5 
 
 
Average D1.3 
concentration 
(mg/mL) 
 
 
 
 
Average 
Total protein 
(mg/mL) 
 
D1.3 yield a 
   
 
 
Total  b 
 protein yield  
 
 
PF c 
 
 
 
YF%  d 
 
 
 
 Washing cells with 50 mM Tris HCl  0.77 62.7 93.67 14.22 6.59 6.17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Homogenisation  0.90 916.39 109.73 207.87 0.53 0.58
OS1 0.82 440.85 100.00 100.00 1.00 1.00
OS2 0.18 652.35 21.65 147.98 0.15 0.03
0.05% Triton X-100  0.20 184.18 24.70 41.78 0.59 0.15 
0.1% Triton X-100 0.33 395.78 40.39 89.78 0.45 0.18 
0.01% Tween 20  0.04 132.93 5.23 30.15 0.17 0.01 
0.1% Tween 20 0.24 123.03 28.95 27.91 1.04 0.30 
0.001% Brij  0.12 133.50 14.84 30.28 0.49 0.07 
0.01% Brij  0.10 106.97 12.53 24.26 0.52 0.06 
0.1% Brij  0.03 127.21 3.28 28.86 0.11 0.00 
0.01% DOC  0.38 202.38 46.23 45.91 1.01 0.47 
0.025%  DOC  1.31 193.35 159.73 43.86 3.64 5.82
0.05% DOC   1.34 298.41 162.65 67.69 2.40 3.91
0.1% DOC 1.36 403.81 165.33 91.60 1.80 2.98
0.001% BAC 0.03 84.12 3.04 19.08 0.16 0.00 
0.01% BAC  0.35 143.59 42.58 32.57 1.31 0.56 
0.05% BAC 0.08 89.09 9.73 20.21 0.48 0.05 
0.001% CTAB  0.00 82.07 0.00 18.62 0.00 0.00 
0.01% CTAB  0.39 135.39 47.69 30.71 1.55 0.74 
0.05% CTAB  0.09 107.75 10.34 24.44 0.42 0.04 
1 mM EDTA  0.90 173.78 109.49 39.42 2.78 3.04
10 mM EDTA 1.13 101.52 136.98 23.03 5.95 8.15
10 mM DEA  0.11 133.77 13.26 30.34 0.44 0.06 
10 mM NTA 0.68 109.05 82.97 24.74 3.35 2.78
0.1% SHMP  0.79 184.77 96.11 41.91 2.29 2.20
1% SHMP  0.57 171.26 69.34 38.85 1.78 1.24 
10 mM Urea   0.20 138.41 24.09 31.40 0.77 0.18 
50 mM Urea 0.21 163.94 25.67 37.19 0.69 0.18 
100 mM Urea   0.21 142.60 26.03 32.35 0.80 0.21 
200 mM Urea  0.23 160.04 28.10 36.30 0.77 0.22 
200 mM GndCl   0.00 76.78 0.00 17.42 0.00 0.00 
1% Hexane   0.26 104.62 32.00 23.73 1.35 0.43 
1% Xylene  0.31 120.34 37.47 27.30 1.37 0.51 
1% Benzene   0.29 234.39 34.91 53.17 0.66 0.23 
1% Toluene   0.27 87.84 33.21 19.93 1.67 0.55 
1% Diethylether  0.24 86.55 29.44 19.63 1.50 0.44 
1% Chloroform   0.44 106.11 53.41 24.07 2.22 1.19 
1% Ethanol   0.34 109.00 41.36 24.72 1.67 0.69 
1% Acetone  0.42 120.42 51.58 27.32 1.89 0.97 
1% pyridine   0.00 176.09 0.00 39.94 0.00 0.00 
1% Isoamyl alcohol   0.59 111.05 71.17 25.19 2.83 2.01 
10% Isoamyl alcohol  1.38 130.04 167.88 29.50 5.69 9.55 
(Continued) 
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Table 5.3     Continued 
 
 
 
 
 
 
 
Chemicals (prepared in 200 
mM Tris beffer pH 7.5 
 
 
Average D1.3 
concentration 
(mg/mL) 
 
 
 
 
Average 
Total protein 
(mg/mL) 
 
D1.3 yield a 
   
 
 
Total  b 
 protein yield  
 
 
PF c 
 
 
 
YF%  d 
 
 
 
1 mM EDTA + 0.1% Brij   1.12 246.02 136.50 55.81 2.45 3.34
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 mM EDTA + 0.1% Triton X-100   1.20 396.29 145.99 89.89 1.62 2.37
1 mM EDTA + 0.01% DOC 1.11 230.17 135.04 52.21 2.59 3.49
1 mM EDTA + 0.01% CTAB   1.11 163.29 135.04 37.04 3.65 4.92
1 mM EDTA + 200 mM Urea   0.94 203.43 113.75 46.14 2.46 2.80
1 mM EDTA + 200 mM GndCl  0.00 89.62 0.00 20.33 0.00 0.00 
1 mM EDTA + 0.01% BAC   0.89 172.63 107.91 39.16 2.76 2.97
200 mM Urea + 0.1% Triton X-100 0.41 259.47 49.64 58.86 0.84 0.42 
200 mM Urea + 0.1% Tween 20   0.00 140.74 0.00 31.92 0.00 0.00 
200 mM Urea + 0.1% Brij  0.06 152.24 7.30 34.53 0.21 0.02 
200 mM Urea + 0.01% DOC 0.08 129.52 9.73 29.38 0.33 0.03 
200 mM Urea + 0.025% DOC 0.06 123.58 7.30 28.03 0.26 0.02 
200 mM Urea + 0.01% BAC 0.25 132.81 30.41 30.13 1.01 0.31 
200 mM Urea + 0.01% CTAB  0.00 350.72 0.00 79.56 0.00 0.00 
200 mM GndCl + 0.1% Triton X-100  0.00 152.05 0.00 34.49 0.00 0.00 
200 mM GndCl + 0.1% Tween 20   0.00 101.28 0.00 22.97 0.00 0.00 
200 mM GndCl + 0.1% Brij  0.00 116.63 0.00 26.46 0.00 0.00 
200 mM GndCl + 0.01% DOC 0.00 73.60 0.00 16.70 0.00 0.00 
200 mM GndCl + 0.025% DOC 0.00 97.20 0.00 22.05 0.00 0.00 
200 mM GndCl + 0.01% BAC 0.00 99.07 0.00 22.47 0.00 0.00 
200 mM GndCl + 0.01% CTAB 0.00 58.09 0.00 13.18 0.00 0.00 
1% Hexane + 0.1% Triton X-100 0.82 133.68 99.64 30.32 3.29 3.27
1% Hexane + 0.025% DOC  1.33 134.42 161.56 30.49 5.30 8.56
1% Hexane + 0.01% CTAB  0.57 139.66 69.59 31.68 2.20 1.53 
1% Xylene + 0.1% Triton X-100 0.86 310.16 104.74 70.35 1.49 1.56
1% Xylene + 0.025% DOC 0.27 137.29 32.73 31.14 1.05 0.34 
1% Xylene + 0.01% CTAB  0.51 141.30 62.53 32.05 1.95 1.22 
1% Benzene + 0.1% Triton X-100 1.35 301.09 164.48 68.30 2.41 3.96 
1% Benzene + 0.025% DOC 0.31 146.64 38.08 33.26 1.14 0.44 
1% Benzene + 0.01% CTAB 0.32 156.66 39.29 35.54 1.11 0.43 
1% Toluene + 0.1% Triton X-100  0.87 216.71 105.84 49.16 2.15 2.28
1% Toluene + 0.025% DOC  0.21 147.90 25.79 33.55 0.77 0.20 
1% Toluene + 0.01% CTAB  0.00 144.55 0.00 32.79 0.00 0.00 
1% Diethyether + 0.1% Triton X-100  0.69 132.35 84.06 30.02 2.80 2.35 
1% Diethylether + 0.025% DOC  0.19 159.04 22.87 36.08 0.63 0.14 
1% Diethylether + 0.01% CTAB 0.43 156.81 52.19 35.57 1.47 0.77 
1% Chloroform + 0.1% Triton X-100  0.64 187.42 77.37 42.51 1.82 1.41 
1% Chloroform + 0.025% DOC 0.59 174.71 71.29 39.63 1.80 1.28 
1% Chloroform + 0.01% CTAB  0.34 154.33 41.85 35.01 1.20 0.50 
 
 
 
 
 
 
 
 
 
 
 
(Continued) 
 
 159
 
Table 5.3     Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemicals (prepared in 200 
mM Tris beffer pH 7.5 
 
 
Average D1.3 
concentration 
(mg/mL) 
 
 
 
 
Average 
Total protein 
(mg/mL) 
 
D1.3 yield a 
   
 
 
Total  b 
 protein yield  
 
 
PF c 
 
 
 
YF%  d 
 
 
 
1% Ethanol + 0.1% Triton X-100  0.62 142.16 74.94 32.25 2.32 1.74 
1% Ethanol + 0.025% DOC 0.48 165.73 57.91 37.59 1.54 0.89 
1% Ethanol + 0.01% CTAB  0.47 160.93 57.54 36.50 1.58 0.91 
1% Acetone + 0.1% Triton X-100  0.66 141.64 79.93 32.13 2.49 1.99 
1% Acetone + 0.025% DOC 0.16 162.81 19.83 36.93 0.54 0.11 
1% Acetone + 0.01% CTAB 0.46 151.30 56.33 34.32 1.64 0.92 
1% Pyridine + 0.1% Triton X-100  0.00 826.65 0.00 187.51 0.00 0.00 
1% Pyridine + 0.025% DOC 0.00 163.63 0.00 37.12 0.00 0.00 
1% Pyridine + 0.01% CTAB  0.00 139.01 0.00 31.53 0.00 0.00 
1% Isoamyl alcohol + 0.1% Triton X-100  0.80 242.34 96.96 54.97 1.76 1.71 
1% Isoamyl alcohol + 0.025% DOC 0.12 137.97 14.36 31.30 0.46 0.07 
1% Isoamyl alcohol + 0.01% CTAB  0.74 173.26 90.51 39.30 2.30 2.08
 
 
 
a and b Relative to extraction by osmotic shock solution 1 
c Fab D1.3 yield divided to total protein yield 
d Fab D1.3 yield multiply by PF divided to 100 
 
In the present work, the influences of different combinations of chemicals on protein 
release from the periplasm were also investigated. Detergents can be employed at 
low concentration and in combination with other treatments (e.g., EDTA and 
chaotropes) for destabilizing the OM of gram-negative bacteria and cell disrupting 
(Hettwer and Wang, 1989; Middelberg, 1995). The LPS layer in gram negative 
bacteria is deemed to protect the phospholipids in the inner leaflet of the OM and in 
the inner (cytoplasmic) membrane from destructive agents such as neutral and 
anionic detergents. EDTA chelates Mg2+ and Ca2+ crossbridging adjacent LPS and 
releases a proportion of LPS from the bacterial cells. The released LPS can be 
replaced with phospholipids from the inner leaflet of the OM or from the cytoplasmic 
membrane creating phospholipid bilayer channels which detergents can act on. In 
the present work, EDTA and detergents/chaotropes were combined and utilised for 
cell permeabilisation to extract periplasmic proteins from E. coli cells. EDTA (1 mM ) 
did not increase the efficiency of detergents and chaotropes to release alpha-
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amylase; however; 1 mM EDTA enhanced to some extent the beta-lactamase 
release efficacy of 0.1% Brij, 0.1% SDS, 0.01% DOC, and 200 mM urea (Figs 5.4 
and 5.5). Combination of 1 mM EDTA with 0.1% Brij, 0.1% Triton X-100, 0.01% 
DOC, 0.01% CTAB, 0.01% BAC, and 200 mM urea could also release Fab D1.3 
considerably higher than either of single chemicals (Fig 5.6). These combinations of 
chemicals, which had synergetic effects, discharged a smaller amount of total protein 
from the cells when compared to osmotic shock treatment, and as a result led to 
higher enzyme specific activity, purification factor and yield factor (Tables 5.2 and 
5.3). Novella and colleagues (1994) showed that 95% of penicillin acylase with a 
purification factor of 25, when compared to disruption by sonication, was extracted 
from the periplasm of E. coli by combined use of 10 mM EDTA and 10 mM GndCl at 
room temperature for 10 h. However in the present study, the amount of periplasmic 
release by combination of 1 mM EDTA and 200 mM GndCl was less than 1 mM 
EDTA alone. The reason for this antagonism is not known. 
 
The effect of chaotropes on release efficiency of cationic, anionic and non-anionic 
detergents was also studied. Urea (200 mM) partly increased the efficiency of 0.1% 
Tween, 0.1% SDS, 0.01% DOC and 0.01% BAC for releasing beta-lactamase (Fig 
5.4). It has been shown that the combination of Triton X-100 (0.5%) and GndCl (100 
mM) can results in significant amount of protein release from the cytoplasm of E. coli, 
while these are individually incapable of inducing a noticeable amount of protein 
release (Hettwer and Wang, 1989); however in the recent study, GndCl (200 mM) 
had negative impact on the efficiency of the detergents to release beta-lactamase. 
Urea (200 mM) also enhanced the alpha-amylase release effectiveness of 0.1% Brij, 
0.1% SDS, 0.01% DOC, and 0.01% CTAB, while 200 mM GndCl had negative effect 
on the efficiency of the detergents to release alpha-amylase (Fig 5.5). The reason for 
the antagonism between 200 mM GndCl and the detergents is not known. The 
maximum synergetic effects were attributed to the combination of 200 mM urea/0.1% 
SDS and 200 mM urea/0.01% CTAB which discharged approximately 90 and 100 per 
cent of periplasmic alpha-amylase, respectively. Urea and GndCl (200 mM) had no 
positive effects on the performance of detergents to extract Fab D1.3 from the cells 
(Fig 5.6).  
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The combinations of solvents (at 1% concentration) and detergents were finally used 
to evaluate their performances for release of periplasmic proteins. While the 
combination of solvents and detergents did not increase beta-lactamase release 
figures attributable to either single chemicals, such combinations could augment the 
release of alpha-amylase from the cells. For example, combinations of xylene, 
benzene, and toluene (at 1% concentration) with 0.025% DOC and 0.01 % CTAB 
considerably enhanced alpha-amylase discharge (up to 100%) from the periplasm 
(Fig 5.5). Total protein release by such combinations was much less than osmotic 
shock, and as a result higher enzyme specific activity, purification factor and yield 
factor were obtained (Table 5.2). Also, such chemical combinations can be more 
effective than single chemicals in releasing Fab D1.3 from the periplasm; for 
instance, combining hexane, xylene, toluene and isoamyl alcohol at 1% 
concentration with 0.1% Triton X-100 could release the periplasmic Fab as efficiently 
as osmotic shock and greater than either single chemical (Fig 5.6, and Table 5.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 162
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.4 Release of beta-lactamase from transformed E. coli JM109 cells by 
combinations of chemicals made in 200 mM Tris buffer pH 7.5. Results are averages 
of two measurements. 
Lactamase (U/mL)
1% Isoamyl alcohol + 0.01% CTAB 
1% Isoamyl alcohol + 0.025% DOC
1% Isoamyl alcohol + 0.1% Triton X-100 
1% Pyridine + 0.01% CTAB 
1% Pyridine + 0.025% DOC
1% Pyridine + 0.1% Triton X-100 
1% Acetone + 0.01% CTAB
1% Acetone + 0.025% DOC 
1% Acetone + 0.1% Triton X-100 
1% Ethanol + 0.01% CTAB 
1% Ethanol + 0.025% DOC
1% Ethanol + 0.1% Triton X-100 
1% Chloroform + 0.01% CTAB 
1% Chloroform + 0.025% DOC
1% Chloroform + 0.1% Triton X-100 
1% Diethylether + 0.01% CTAB
1% Diethylether + 0.025% DOC 
1% Diethyether + 0.1% Triton X-100 
1% Toluene + 0.01% CTAB 
1% Toluene + 0.025% DOC
1% Toluene + 0.1% Triton X-100 
1% Benzene + 0.01% CTAB
1% Benzene + 0.025% DOC
1% Benzene + 0.1% Triton X-100
1% Xylene + 0.01% CTAB 
1% Xylene + 0.025% DOC
1% Xylene + 0.1% Triton X-100
1% Hexane + 0.01% CTAB 
1%Hexane + 0.025% DOC 
1% Hexane + 0.1% Triton X-100
200 mM GndCl + 0.01% CTAB
200 mM GndCl + 0.01% BAC
200 mM GndCl + 0.01% DOC
200 mM GndCl + 0.1% SDS 
200 mM GndCl + 0.1% Brij 
200 mM GndCl + 0.1% Tween 20  
200 mM GndCl + 0.1% Triton X-100 
200 mM Urea + 0.01% CTAB
200 mM Urea + 0.01% BAC
200 mM Urea + 0.01% DOC
200 mM Urea + 0.1% SDS 
200 mM Urea + 0.1% Brij 
200 mM Urea + 0.1% Tween 20  
200 mM Urea + 0.1% Triton X-100
1 mM EDTA + 200 mM GndCl 
1 mM EDTA + 200 mM Urea  
1 mM EDTA + 0.01% BAC
1 mM EDTA + 0.01% CTAB  
1 mM EDTA + 0.01% DOC  
1 mM EDTA + 0.1% SDS  
1 mM EDTA + 0.1% Triton X-100  
1 mM EDTA + 0.1% Brij  
0.0 0.1 0.2 0.3 0.4 0.50.10.20.30.40.50.6
Total protein (mg/mL)
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Amylase (U/mL)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.5 Release of alpha-amylase from E. coli JM107 PQR126 cells by combinations 
of chemicals made in 200 mM Tris buffer pH 7.5. Results are averages of two 
measurements. 
1% Isoamyl alcohol + 0.01% CTAB 
1% Isoamyl alcohol + 0.025% DOC
1% Isoamyl alcohol + 0.1% Triton X-100 
1% Pyridine + 0.01% CTAB 
1% Pyridine + 0.025% DOC
1% Pyridine + 0.1% Triton X-100 
1% Acetone + 0.01% CTAB
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Fig. 5.6 Release of Fab D1.3 from E. coli CLD048 cells by combinations of chemicals 
made in 200 mM Tris buffer pH 7.5. Results are averages of two measurements. 
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5.4 Conclusions 
 
Prior to commencing cell permeabilization experiments, the influences of different 
concentrations of various chemicals, having been recognized as potential bacterial 
cell permeabilisers, on the structure and biological activity of three model proteins 
were investigated in Chapter 4, and the results obtained were used in this chapter to 
design and evaluate extraction procedures for the three test proteins (i.e. beta-
lactamase, alpha-amylase and Fab D1.3) from the periplasm of recombinant E. coli. 
It was shown that washing cells with 50 mM Tris buffer pH 7.5 could release 
recombinant protein from the periplasm; for instance, 43% and 48% of the 
periplasmic beta-lactamase and Fab D1.3, respectively, were discharged by this 
step.  
 
The efficiency of classic and modified osmotic shock procedures for releasing 
periplasmic beta-lactamase and alpha-amylase was evaluated and it was shown that 
the modified osmotic shock procedure was more efficient than the classic one and as 
efficient as high pressure homogenization. The higher efficiency of the modified 
osmotic shock has been also demonstrated by other researchers (French et al., 
1996). 
 
It was not possible to include HEWL in the osmotic shock fluid used for periplasmic 
extraction of Fab D1.3, because HEWL is the specific antigen for the Fab and its 
strong attachment to the antibody fragment interferes with the Fab D1.3 analysis, 
which is based on the attachment of Fab D1.3 to the immobilised HEWL on 
microplate. However, osmotic shock solution lacking HEWL was almost as effective 
as high pressure homogenization for periplasmic release of Fab D1.3. 
 
The safe chemicals, not having detrimental impacts on the biological activity of the 
target proteins, were applied at low concentrations – singly and in various 
combinations – for protein release from the periplasm of recombinant E. coli. Highly 
selective high yielding chemical extraction treatments were identified in all three 
cases. Amongst single chemicals, sodium DOC at concentrations ranged from 
0.025% to 0.1% seems to be a general efficient permeabiliser, and is capable to 
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extract the three target proteins even more effectual than osmotic shock disruption. 
The amount of total protein release by DOC at the mentioned concentrations was 
less than that by osmotic shock, and as a result DOC treatment resulted in higher 
specific activity, purification factor and yield factor. These higher values improve the 
yield of recombinant protein purification in downstream processing. Apart from DOC, 
the influence of the exposure to other chemicals is product dependent. For example, 
ten per cent (v/v) isoamyl alcohol is able to effectively extract periplasmic alpha-
amylase (75%) and Fab D1.3 (168%), but its performance for beta-lactamase 
extraction from the periplasm is low (26%). Also chelating agents such as 1-10 mM 
EDTA, 10 mM NTA, and 0.1-1% SHMP only released Fab D1.3 from the periplasm 
very efficiently, while the release of beta-lactamase and alpha-amylase by chelating 
agents was much less efficient than osmotic shock. 
 
Certain chemicals showed synergetic effects on each other; for example, 1 mM 
EDTA can increase Fab D1.3 and/or beta-lactamase release when combined with 
detergents such as 0.1% Brij, 0.1% SDS, 0.1% Triton X-100, 0.01% DOC, 0.01% 
CTAB, 0.01% BAC and 200 mM urea. Also detergents, such as 0.1% Tween, 0.1% 
Brij, 0.1% SDS, 0.01% DOC, 0.01% CTAB and 0.01% BAC could release greater 
beta-lactamase and/or alpha-amylase when combined with 200 mM urea. One per 
cent solvents (e.g. hexane, xylene, benzene, toluene and isoamyl alcohol) showed 
marked capability for releasing alpha-amylase and and/or Fab D1.3 when they are 
used in combination with detergents such as 0.025% DOC, 0.01 % CTAB and 0.1% 
Triton X-100. These combinations of chemicals caused higher specific activity, 
purification factor and yield factor. 
 
The low concentrations of single and combined chemicals can be considered as 
alternatives to osmotic shock disruption for selective extraction of periplasmically-
expressed recombinant proteins. These can be superior selective extraction 
techniques at large scale, where the classic osmotic shock can not be used, because 
of being expensive and unfeasible.  
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6   Concluding remarks  
 
 
Escherichia coli has been used for many years for manufacturing many recombinant 
proteins. When secretory proteins containing disulphide bonds in the final structure 
are produced without signal peptides, they remain in the cytoplasm and can 
aggregate and form inclusion bodies. This is undesirable outcome particularly if the 
protein contains multiple non-linear disulphide bonds and consequently difficult to 
solubilise and refold into its active conformation. Therefore in recent years, many 
industrially important recombinant proteins, which contain disulphide bonds in their 
structure, have been directed into the periplasm of E. coli, inasmuch as the periplasm 
provides the conditions required for appropriate disulphide bond formation and 
protein folding. The quantity of soluble periplasmic recombinant protein can be 
maximized by manipulation of the solute composition of the periplasm, via adjusting 
the culture medium composition, and/or by genetic manipulation of E. coli (Chapter 
1). 
 
In spite of the advances in high level production of recombinant proteins in the 
periplasm,  periplasmic expression systems have not yet fulfilled their potential, due 
to the lack of reliable general methods for proficient selective release of 
periplasmically expressed proteins at large-scale. Classical osmotic shock is the only 
reliable technique for selective extraction of periplasmic proteins; however, this 
technique is labour intense and can only be used on small volumes. Thus, 
developing new methods, being able to selectively release the periplasmic proteins 
and able to scale up, is urgently required. Therefore, the motivation for the works 
presented in this thesis has been to develop new ‘gentle’ chemical methods for 
selective release of recombinant proteins from the periplasm of E. coli. The E. coli 
strains used in this work produced beta-lactamase, alpha-amylase, and Fab D1.3 in 
the periplasm. 
 
Prior to developing chemical methods for periplasmic extraction of recombinant 
proteins, the influence of such chemicals on the structure and biological activity of 
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such target proteins ought to be investigated. Therefore, pure proteins were required 
for such investigations. 
 
A common characteristic of many E. coli secretion systems is that the product may 
appear in many various locations within and outside the cells In Chapter 2, fed-batch 
cultivation was conducted at 37°C for production of Fab D1.3 in a recombinant E. 
coli. It was demonstrated that Fab D1.3 produced in the periplasm and then secreted 
into the culture medium. The variations in the titre of the soluble Fab in different 
locations (i.e. the cytoplasm, the periplasm, and the culture medium) over the course 
of fed-batch cultivation were determined. It was shown that Fab D1.3 was largely 
secreted into the culture medium after 4 h induction with 0.1 mM IPTG.  
 
Based on the results obtained in Chapter 2, further chromatographic purification 
works were carried out to purify Fab D1.3 from the culture broth (Chapter 3). By 
using coupled HiTrap SP Sepharose XL and Protein G columns, highly purified 
(>97%) Fab D1.3 was achieved. It was shown that the performance of coupled 
HiTrap SP Sepharose XL and Protein G columns was much higher than the 
performance of coupled HEWL and Protein G affinity columns.  
 
The purified Fab D1.3 by coupled HiTrap SP Sepharose XL and Protein G columns 
and pure beta-lactamase and alpha-amylase purchased from Sigma-Aldrich 
(Gillingham, UK) were used for structural and biological activity studies in the 
presence of a numerous recognised cell permeabilisation reagents (Chapter 4). The 
alterations in the secondary structure of the proteins, when exposed to different 
chemicals, were investigated by a newly developed high throughput circular 
dichroism (ht-CD). Ht-CD could use for detecting changes in the secondary structure 
of the proteins occurred by chemicals, for instance by measuring the intensity of the 
CD spectra at key wavelengths (i.e. 222 nm for beta-lactamase and alpha-amylase, 
and 214 nm for Fab D1.3). However, the changes in the secondary structure of 
proteins were compared with the changes in the biological activity of the proteins in 
the presence of various chemicals. This comparison, demonstrated that some 
chemicals might have deleterious impact on biological activity of the proteins and 
subtly alter the structure of proteins in way that are not recorded by ht-CD. Also, 
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some chemicals might change the secondary structures protein, which could be 
recorded by ht-CD, but might not cause any reduction in the biological activity of the 
proteins; for example, because such structural changes happened outside the active 
site of proteins or occurred in a manner that the biological activity remained intact.  
 
Certain chemicals, such as chelating agents, surfactants, chaotropes, and solvents, 
have been recognised to induce protein release by altering the cell envelope 
structure and allowing diffusion of the product from gram-negative bacteria. Many 
raucous chemical methods have been developed to extract intracellular proteins from 
E. coli by permeabilising outer wall barriers. However, very few attempts have been 
made for developing gentle and selective chemical methods to extract recombinant 
proteins from the periplasm of E. coli. Chemicals which did not influence the 
biological activity of the proteins (Chapter 4) were utilised – singly and in various 
combinations – for permeabilisation of E. coli cells harbouring the same target 
species (Chapter 5).  Amongst chemicals, which were singly used for extraction of 
proteins from the periplasm of E. coli, sodium deoxycholate (DOC) at low 
concentrations ranged from 0.025% to 0.1% was shown to be a general 
permeabiliser because it was able to release all three target periplasmic proteins 
even more efficient than osmotic shock. The influence of exposure to certain single 
chemicals was obviously product dependent; for instance, 10% isoamyl alcohol was 
exceptionally effective for periplasmic release of alpha-amylase (75%) and Fab D1.3 
(168%). It was shown that when certain chemicals used together at low 
concentrations, they exerted synergistic effects. However, the effects of exposure to 
combinations of chemicals varied from protein to protein (see Figs 5.4 to 5.6, and 
Tables 5.2 and 5.3 presented in Chapter 5). It was demonstrated in this thesis that 
selective extraction of periplasmic proteins, with releasing only small amount of total 
cell protein, from E. coli could be achieved. The permeabilised cells are not 
fragmented and the viscosity of the treatment solution is low; thus, the permeabilised 
cells can easily separated by centrifugation. This avoidance of extensive clarification 
steps can help out subsequent recovery and purification of periplasmic proteins in a 
downstream process.  
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Clearly, future application of the developed chemical cocktails in this thesis is of 
interest. Effect of chemicals additives on the tertiary structure of these target proteins 
may need to be investigated by measuring CD spectra in near-UV region using this 
ht-CD system. In the present work, the Michaelis-Menten constant (KM) of enzymes 
in the presence of different chemicals was not determined; therefore, for each 
chemical the enzymes reaction rates may need to be measured in the presence of 
various concentrations of the substrates in order to measure values of KM. Further 
studies are to be done to demonstrate exploitation of the developed chemical 
permeabilisers in this thesis for selective release of other industrially relevant 
proteins (such as various antibody fragments, etc.) from the periplasm of 
recombinant E. coli. The influence of upstream changes (i.e. media composition, 
point of induction, phase of growth) on the optimal release is to be investigated. 
Given the marked changes that can occur in composition of cell envelopes under 
different growth regimes it will be interesting to see whether the make-up of the 
chemical cocktail used to permeabilise the cells needs adjusting. 
7   Appendix 
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Fig. 7.1 Calibration curve used for calculation of Fab D1.3 concentration in the samples 
by ELISA. 
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Fig. 7.2 Calibration curve used for calculation of beta-lactamase concentration via 
absorbance measurements at 450 nm. 
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Fig. 7.3 Calibration curve used for calculation of alpha-amylase concentration via 
absorbance measurements at 600 nm.  
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Fig. 7.4 Calibration curve used for calculation of total cell protein via absorbance 
measurements at 562 nm.  
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Table 7.1 Mascot search results for the mass spectrometry analysis of the top band of lane 6 in figure 3.6. 
User            : Jonathan James 
Email           : j.d.james.1@bham.ac.uk 
Search title    :  
MS data file    : C:\Documents and Settings\jamesjdz\Desktop\RJ_260808.pkl 
Database        : MSDB 20060831 (3239079 sequences; 1079594700 residues) 
Timestamp       : 29 Aug 2008 at 09:49:18 GMT 
Protein hits    :  E1007993  SYNTHETIC PUC19 FABD1.3 SEQUENCE.- vectors. 
   Q6PI81_HUMAN  IGHM protein.- Homo sapiens (Human).
   AAS85976  AY393038 NID: - Homo sapiens
   Q4CR60_TRYCR  Trans-sialidase, putative (Fragment).- Trypanosoma cruzi.
   PH1422  Ig heavy chain V region (clone P3-69) - human (fragment) 
   TRPGTR  trypsin (EC 3.4.21.4) precursor - pig (tentative sequence) 
   Q5CJY7_CRYHO  Hypothetical protein.- Cryptosporidium hominis.
   Q2QUE5_ORYSA  Wall-associated kinase-like 1, putative, expressed.- Oryza sativa (japonica cultivar-group).
   Q245R9_TETTH  Hypothetical protein.- Tetrahymena thermophila SB210. 
   AAM72802  AE006470 NID: - Chlorobium tepidum TLS
   Q1NG56_9SPHN  Hypothetical protein.- Sphingomonas sp. SKA58.
   Q38AS5_9TRYP  Hypothetical protein.- Trypanosoma brucei.
   Q4CFT1_CLOTM  Hypothetical protein precursor.- Clostridium thermocellum ATCC 27405.
   Q4N8Y0_THEPA  Hypothetical protein.- Theileria parva.
   Q9ZTY0_EMIHU  Putative calcium binding protein.- Emiliania huxleyi. 
   Q4LB11_9RODE  Erythropoietin receptor.- Spalax galili.
   Q4EB11_9RICK  Preprotein translocase, YajC subunit.- Wolbachia endosymbiont of Drosophila ananassae.
   Q26YD4_MYCFV  Transposase IS3/IS911.- Mycobacterium flavescens PYR-GCK.
   Q4DG98_TRYCR  Hypothetical protein.- Trypanosoma cruzi.
   Q69KB7_ORYSA  Hypothetical protein B1047H05.26 (Hypothetical protein OSJNBb0035K09.33).- Oryza sativa (japonica cultivar-group).
Mascot Score Histogram 
Ions score is -10*Log(P), where P is the probability that the observed match is a random event. 
Individual ions scores > 56 indicate identity or extensive homology (p<0.05). 
Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. 
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 Protein View 
 
Match to: E1007993 Score: 261 
SYNTHETIC PUC19 FABD1.3 SEQUENCE.- vectors. 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\RJ_260808.pkl 
 
Nominal mass (Mr): 51653; Calculated pI value: 8.80 
NCBI BLAST search of E1007993 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: vectors 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 15% 
 
Matched peptides shown in Bold  
 
     1 MKYLLPTAAA GLLLLAAQPA MAQVQLQESG PGLVAPSQSL SITCTVSGFS  
    51 LTGYGVNWVR QPPGKGLEWL GMIWGDGNTD YNSALKSRLS ISKDNSKSQV  
   101 FLKMNSLHTD DTARYYCARE RDYRLDYWGQ GTTVTVSSAS TKGPSVFPLA  
   151 PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL  
   201 YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS SMKYLLPTAA  
   251 AGLLLLAAQP AMADIELTQS PASLSASVGE TVTITCRASG NIHNYLAWYQ  
   301 QKQGKSPQLL VYYTTTLADG VPSRFSGSGS GTQYSLKINS LQPEDFGSYY  
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   351 CQHFWSTPRT FGGGTKLEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN  
   401 NFYPREAKVQ WKVDNALQSG NSQESVTEQD SKDSTYSLSS TLTLSKADYE  
   451 KHKVYACEVT HQGLSSPVTK SFNRGES 
 
 
Match to: Q6PI81_HUMAN Score: 199 
IGHM protein.- Homo sapiens (Human). 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\RJ_260808.pkl 
 
Nominal mass (Mr): 53317; Calculated pI value: 7.50 
NCBI BLAST search of Q6PI81_HUMAN against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Homo sapiens 
Links to retrieve other entries containing this sequence from NCBI Entrez: 
AAH41037 from Homo sapiens 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 7% 
 
Matched peptides shown in Bold  
 
     1 MELGLSWVFL VAILEGVQCE VQLVESGGGL VQPGGSLRLS CAASGFTFSS  
    51 YWMSWVRQAP GKGLEWVANI KQDGSEKYYV DSVKGRFTIS RDNAKNSLYL  
   101 QMNSLRAEDT AVYYCAREFE STMTTVNADY YYFYMDVWGK GTTVTVSSAS  
   151 TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT  
   201 FPAVLQSSGL YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKRVEPKS  
   251 CDKTHTCPPC PAPELLGGPS VFLFPPKPKD TLMISRTPEV TCVVVDVSHE  
   301 DPEVKFNWYV DGVEVHNAKT KPREEQYNST YRVVSVLTVL HQDWLNGKEY  
   351 KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT KNQVSLTCLV  
   401 KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ  
   451 GNVFSCSVMH EALHNHYTQK SLSLSPGK 
 
 
Match to: AAS85976 Score: 160 
AY393038 NID:  - Homo sapiens 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\RJ_260808.pkl 
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Nominal mass (Mr): 18392; Calculated pI value: 7.86 
NCBI BLAST search of AAS85976 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Homo sapiens 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 15% 
 
Matched peptides shown in Bold  
 
     1 KPTQTLTMTC TFSGFSLSTS GVGVGWIRQP PGKALDWLAL IYWDDDKRYS  
    51 PSLKSRLTIT KDTSKNQVVL TMTNMDPVDT ATYYCAHRPD YYDSIGALFD  
   101 YWGQGTLVTV SSASTKGPSV FPLAPSSKST SGGTXALGCL VKDYFPEPVT  
   151 VSWNSGALTS GVHTFPAVL 
 
 
Match to: Q4CR60_TRYCR Score: 72 
Trans-sialidase, putative (Fragment).- Trypanosoma cruzi. 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\RJ_260808.pkl 
 
Nominal mass (Mr): 93181; Calculated pI value: 5.03 
NCBI BLAST search of Q4CR60_TRYCR against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Trypanosoma cruzi 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 1% 
 
Matched peptides shown in Bold  
 
     1 MLSRVAAVKA PRTHNRRRVT GSSGRRREGR ESEPQRPNMS RRVFTSAMLL  
    51 LLLVVMMCCG SGGAAQAGVE EPSSESTFEW RGINDGGGET VESLGVPSLL  
   101 KVGSDVFAVA EAQCKNGGVS FTGVTSQPLK TQTAKTPVEV LKKPKDETQV  
   151 LEEGASEDQK KKVDVSRPTT AVKGSDIYML VGQYSSAAVG ASDAAQLGLL  
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   201 LVKGSVNSGV ANNKKIDWKD TESSPQRLFE KQPDSWTRLI GSGGSGVKMK  
   251 DETLVFPVEG TKKKADGTEV DVKTVSLIIH SKDNTDWKLS KGMSDGGCSD  
   301 PSVVEWEDDK LIMMAACDGG RRRVYESGDK GESWTEALGT LSRVWGNNKK  
   351 GEEAKAVRSG FITATVGNDG DKRNVMLVTL PVYAEKNVEK GKLHLWLTDN  
   401 THIVDIGPVS GDDDDAAASS LLYNSGENTD ENNEEELIAL YEKKKDGGKP  
   451 SPGVVSVLLT EQLQRVKGVL TTWKEVDKRV SQLCTSLIAQ KERASTDDVC  
   501 GAVKITAGLV GFLSGKFSEN TWRDEYLGVN ATVTKERAEE VENGVKFTGS  
   551 GAGAEWPVGK QGENQLYHFA NYNFTLVATV SIDNVPEGNT PISLVGVKMN  
   601 GDENNVLLGL SYDSEKKWHV LCGDKTTTKL SSTLGAETPQ HVVILLKNGT  
   651 QGSVYVDGQR VGNEECALGN GESKEISHFY IGGDGANAEN KEGVSVTVTN  
   701 VLLYNRPLDD TEIAAFNPNK APIEVQVDGS IEGDAIQPSG GGRQEEPRQS  
   751 LGSSGAGVVP ASTVSSAKTS SGGEGSATQL VKEESSDGSK NVGGASSPGS  
   801 DAAVETGDRS TVQGDGSSET LVGTPATADA YAPDAEAMGH DGTAVNPGAS  
   851 ASSGADGETA EGTNGQEKKE IHAQNGGVKA A 
 
 
Match to: PH1422 Score: 71 
Ig heavy chain V region (clone P3-69) - human (fragment) 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\RJ_260808.pkl 
 
Nominal mass (Mr): 15108; Calculated pI value: 6.84 
NCBI BLAST search of PH1422 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Homo sapiens 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 8% 
 
Matched peptides shown in Bold  
 
     1 EVQLVQSGAE VKKPGESLKI SCKGSGYSFI TYWIAWVRQM PGKGLEWMGI  
    51 IYPGDSDTRY SPSFQGQVTI SVDKSISTAY LQWSSLKASD TAMYYCARHG  
   101 MEYYYGSGSS DYYYYYMDVW GKGTTVTVSS ASTQ 
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Table 7.2 Mascot search results for the mass spectrometry analysis of the bottom band of lane 6 in figure 3.6. 
User            : Jonathan James 
Email           : j.d.james.1@bham.ac.uk 
Search title    :  
MS data file    : C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
Database        : MSDB 20060831 (3239079 sequences; 1079594700 residues) 
Timestamp       : 15 Aug 2008 at 09:16:09 GMT 
 Protein 
hits    :  E1007993  SYNTHETIC PUC19 FABD1.3 SEQUENCE.- vectors. 
   TRPGTR  trypsin (EC 3.4.21.4) precursor - pig (tentative sequence)
   1BBJL  Fab' fragment of monoclonal antibody b72.3 (murineHUMAN CHIMERA), chain L - synthetic
   AAA92435  REARRANGED IMMUNOGLOBULIN LIGHT CHAIN VARIABLE REGION (FRAGMENT).- Mus musculus (Mouse).
   Q4CR60_TRYCR  Trans-sialidase, putative (Fragment).- Trypanosoma cruzi. 
   AAF05528  Immunoglobulin kappa light chain constant region (fragment).- Aotus nancymaae (Ma's night monkey).
   TRRT1  trypsin (EC 3.4.21.4) I precursor - rat
   BAC01690  Immunoglobulin kappa light chain VLJ region (Fragment).- Homo sapiens (Human).
   K2C1_HUMAN 
 Keratin, type II cytoskeletal 1 (Cytokeratin-1) (CK-1) (Keratin-1) (K1) (67 kDa cytokeratin) (Hair alpha protein).- Homo 
sapiens (Human).
   S24539  Ig kappa chain V region - mouse
   AAA79897  MOUSE IG REARRANGED KAPPA-CHAIN MRNA FROM HYBRIDOMA (CBA/N X BALB.B), CLONE 7D6 (FRAGMENT).- Mus musculus (Mouse).
   Q9Z1R9_MOUSE  Trypsinogen 16 (Protease, serine, 1).- Mus musculus (Mouse). 
   AAO84653  AF491643 NID: - Tachyglossus aculeatus
   Q7S1V9_NEUCR  Predicted protein.- Neurospora crassa. 
   AAB50667  Idiotopes and metatopes of anti-fluorescein antibody 4-4-20-specific antibody (Fragment).- Cricetulus migratorius (Armenian hamster).
   Q569I9_HUMAN  IGKC protein.- Homo sapiens (Human). 
   T07620  dnaK-type molecular chaperone hsp70 - Cyanophora paradoxa (fragment)
   Q6NRB8_XENLA  LOC431933 protein (Fragment).- Xenopus laevis (African clawed frog). 
   Q2JE60_FRASC  Hypothetical protein.- Frankia sp. (strain CcI3). 
   Q1AUE5_9A  Lycopene beta and epsilon cyclase.- Rubrobacter xylanophilus DSM 9941.
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CTN 
 
Mascot Score Histogram 
Ions score is -10*Log(P), where P is the probability that the observed match is a random event. 
Individual ions scores > 55 indicate identity or extensive homology (p<0.05). 
Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. 
 
 
 
 
Protein View 
 
Match to: E1007993 Score: 360 
SYNTHETIC PUC19 FABD1.3 SEQUENCE.- vectors. 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 51653; Calculated pI value: 8.80 
NCBI BLAST search of E1007993 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: vectors 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
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Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 22% 
 
Matched peptides shown in Bold  
 
     1 MKYLLPTAAA GLLLLAAQPA MAQVQLQESG PGLVAPSQSL SITCTVSGFS  
    51 LTGYGVNWVR QPPGKGLEWL GMIWGDGNTD YNSALKSRLS ISKDNSKSQV  
   101 FLKMNSLHTD DTARYYCARE RDYRLDYWGQ GTTVTVSSAS TKGPSVFPLA  
   151 PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL  
   201 YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS SMKYLLPTAA  
   251 AGLLLLAAQP AMADIELTQS PASLSASVGE TVTITCRASG NIHNYLAWYQ  
   301 QKQGKSPQLL VYYTTTLADG VPSRFSGSGS GTQYSLKINS LQPEDFGSYY  
   351 CQHFWSTPRT FGGGTKLEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN  
   401 NFYPREAKVQ WKVDNALQSG NSQESVTEQD SKDSTYSLSS TLTLSKADYE  
   451 KHKVYACEVT HQGLSSPVTK SFNRGES 
 
 
 
Match to: 1BBJL Score: 118 
Fab' fragment of monoclonal antibody b72.3 (murineHUMAN CHIMERA), chain L - synthetic 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 23345; Calculated pI value: 6.34 
NCBI BLAST search of 1BBJL against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: synthetic construct 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 22% 
 
Matched peptides shown in Bold  
 
     1 DIQMTQSPAS LSVSVGETVT ITCRASENIY SNLAWYQQKQ GKSPQLLVYA  
    51 ATNLADGVPS RFSGSGSGTQ YSLKINSLQS EDFGSYYCQH FWGTPYTFGG  
   101 GTRLEIKRAD AAPTVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV  
   151 DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG  
   201 LSSPVTKSFN R 
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Match to: AAA92435 Score: 70 
REARRANGED IMMUNOGLOBULIN LIGHT CHAIN VARIABLE REGION (FRAGMENT).- Mus musculus (Mouse). 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 9272; Calculated pI value: 10.14 
NCBI BLAST search of AAA92435 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Mus musculus 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 32% 
 
Matched peptides shown in Bold  
 
     1 TVTITCRASG NIHNYLAWYQ QKQGKSPQLL VYNAKTLADG VPSRFSGSGS  
    51 GHNILSRSTA CSLKILGVIT VNIFGVLRGR SVEAPS 
 
 
Match to: AAF05528 Score: 66 
Immunoglobulin kappa light chain constant region (fragment).- Aotus nancymaae (Ma's night monkey). 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 9488; Calculated pI value: 4.65 
NCBI BLAST search of AAF05528 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Aotus nancymaae 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 18% 
 
Matched peptides shown in Bold  
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     1 AVAAPSVFIF QPSEEQVKSG TASVVCLLND FYPRDVSVKW KVDDVVQSSN  
    51 VQDSITEQDS KDNTYSLSST LTLSSTEYQR HKVYA 
 
 
Match to: BAC01690 Score: 51 
Immunoglobulin kappa light chain VLJ region (Fragment).- Homo sapiens (Human). 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 29191; Calculated pI value: 7.60 
NCBI BLAST search of BAC01690 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Homo sapiens 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 12% 
 
Matched peptides shown in Bold  
 
     1 MKYLLPTAAA GLLLLAAQPA MAEIVLTQLP GTLSLSPGER ATLSCRASQS  
    51 ISSSHLAWYQ QKPGQAPRLV IYGASNRATG IPDRFSGSGS GTDFTLTISR  
   101 LEPEDFAVYH CQQYDRSVVT FGSGTRLDIK RTVAAPSVFI FPPSNEQLKS  
   151 GTASVVCLLN NFYPREAKVQ WKVDNAPQSG NSQESVTEQD SKDSTYSLSS  
   201 TLTLSKADYE KHKVYACEVT HQGLSSPVTK SFNRGECSAR QSTPFVCEYQ  
   251 GQSSDLPQPP VNAGGGSGGG  
 
 
Match to: S24539 Score: 48 
Ig kappa chain V region - mouse 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 13087; Calculated pI value: 8.64 
NCBI BLAST search of S24539 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Mus musculus 
 
Fixed modifications: Carbamidomethyl (C) 
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Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 11% 
 
Matched peptides shown in Bold  
 
     1 MKLPVRLLVL MFWIPASSSD VVMTQTPXSL PVSLGDQAXI SCRSSQSIVH  
    51 SNGNTYLEWY LQKXGQSXKL LIYKVSNRXS GVPDRFSGSG SGTDXTLKIS  
   101 RVEAEDXGVY YCFQGSHV 
 
 
Match to: AAA79897 Score: 47 
MOUSE IG REARRANGED KAPPA-CHAIN MRNA FROM HYBRIDOMA (CBA/N X BALB.B), CLONE 7D6 (FRAGMENT).- Mus musculus 
(Mouse). 
Found in search of C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_2.pkl 
 
Nominal mass (Mr): 12455; Calculated pI value: 8.66 
NCBI BLAST search of AAA79897 against nr 
Unformatted sequence string for pasting into other applications 
 
Taxonomy: Mus musculus 
 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 11% 
 
Matched peptides shown in Bold  
 
     1 DVVMTQTPLS LPVSLGDQAS ISCRSSQSLV HSNGNTYLHW YLQKPGQSPK  
    51 LLIYKVSNRF YGAPDRFSGS GSGTDFTXKI SRGEXEDXGV YFCSQSTHVP  
   101 LTFGAGTXLE LKR 
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Table 7.3 Mascot search results for the mass spectrometry analysis of the bottom band of lane 1 in figure 3.6. 
User            : Jonathan James 
Email           : j.d.james.1@bham.ac.uk 
Search title    :  
MS data file    : C:\Documents and Settings\jamesjdz\Desktop\New Folder\RJ_140808_1.pkl 
Database        : MSDB 20060831 (3239079 sequences; 1079594700 residues) 
Timestamp       : 15 Aug 2008 at 09:13:13 GMT 
 Protein 
hits    :  Q9DUB9_9VIRU  ORF4.- Torque teno virus. 
   Q9XIL5_ARATH  Expressed protein (At2g15820).- Arabidopsis thaliana (Mouse-ear cress).
   Q73N03_TREDE  Rod shape-determining protein RodA.- Treponema denticola.
   Q5L186_GEOKA  TRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase.- Geobacillus kaustophilus.
   Q6CDE9_YARLI  Similarity.- Yarrowia lipolytica (Candida lipolytica).
   Q60WB1_CAEBR  Hypothetical protein CBG19196.- Caenorhabditis briggsae. 
   Q8DIZ1_SYNEL  Malic enzyme.- Synechococcus elongatus (Thermosynechococcus elongatus).
   CAE22265  BX572101 NID: - Prochlorococcus marinus str. MIT 9313 
   Q4FX43_LEIMA  Hypothetical protein.- Leishmania major strain Friedlin. 
   Q4PBH3_USTMA Predicted protein.- Ustilago maydis (Smut fungus).
   T35762  probable amino acid decarboxylase - Streptomyces coelicolor
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   Q4DFB5_TRYCR  Spliced leader RNA PSE-promoter transcription factor, putative.- Trypanosoma cruzi.
   Q2J5D2_FRASC  Putative replication initiation protein.- Frankia sp. (strain CcI3).
   Q36S26_MARHY  Flagellin.- Marinobacter aquaeolei VT8.
   Q5FLG6_LACAC  Uridine kinase (EC 2.7.1.48).- Lactobacillus acidophilus. 
   Q3J1B1_RHOS4  Outer membrane efflux protein.- Rhodobacter sphaeroides (strain ATCC 17023 / 2.4.1 / NCIB 8253 / DSM 158).
   Q28T66_JANSC  NADH-quinone oxidoreductase, F subunit (EC 1.6.99.5).- Jannaschia sp. (strain CCS1).
   G6BPT4  baseplate protein gp6 - phage T4
   Q6XA63_9BETA  IE1 protein.- Human herpesvirus 6.
   Q2K920_RHIEC  Poly-beta-hydroxybutyrate polymerase protein.- Rhizobium etli (strain CFN 42 / ATCC 51251).
 
Mascot Score Histogram 
Ions score is -10*Log(P), where P is the probability that the observed match is a random event. 
Individual ions scores > 56 indicate identity or extensive homology (p<0.05). 
Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. 
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Fig. 7.5 Correlation of beta-lactamase activity and alpha-helix content in the 
presence of various chemicals. 
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Fig. 7.6 Correlation of beta-lactamase activity and beta-sheet content in the 
presence of various chemicals. 
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Fig. 7.7 Correlation of beta-lactamase activity and unordered content in the presence 
of various chemicals. 
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Fig. 7.8 Correlation of alpha-amylase activity and alpha-helix content in the presence 
of various chemicals. 
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Fig. 7.9 Correlation of alpha-amylase activity and beta-sheet content in the presence 
of various chemicals. 
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Fig. 7.10 Correlation of alpha-amylase activity and unordered content in the 
presence of various chemicals. 
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Fig. 7.11 Correlation of Fab D1.3  activity and alpha-helix content in the presence of 
various chemicals. 
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Fig. 7.12 Correlation of Fab D1.3 activity and beta-sheet content in the presence of 
various chemicals. 
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Fig. 7.13 Correlation of Fab D1.3 activity and unordered content in the presence of 
various chemicals. 
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